id	sid	tid	token	lemma	pos
iajs-3608	1	1	10	10	NUM
iajs-3608	1	2	©	©	PROPN
iajs-3608	1	3	2025	2025	NUM
iajs-3608	1	4	the	the	DET
iajs-3608	1	5	author(s	author(s	NOUN
iajs-3608	1	6	)	)	PUNCT
iajs-3608	1	7	.	.	PUNCT
iajs-3608	2	1	published	publish	VERB
iajs-3608	2	2	by	by	ADP
iajs-3608	2	3	college	college	NOUN
iajs-3608	2	4	of	of	ADP
iajs-3608	2	5	education	education	NOUN
iajs-3608	2	6	for	for	ADP
iajs-3608	2	7	pure	pure	ADJ
iajs-3608	2	8	science	science	NOUN
iajs-3608	2	9	(	(	PUNCT
iajs-3608	2	10	ibn	ibn	PROPN
iajs-3608	2	11	al	al	PROPN
iajs-3608	2	12	-	-	PUNCT
iajs-3608	2	13	haitham	haitham	PROPN
iajs-3608	2	14	)	)	PUNCT
iajs-3608	2	15	,	,	PUNCT
iajs-3608	2	16	university	university	NOUN
iajs-3608	2	17	of	of	ADP
iajs-3608	2	18	baghdad	baghdad	PROPN
iajs-3608	2	19	.	.	PUNCT
iajs-3608	3	1	this	this	PRON
iajs-3608	3	2	is	be	AUX
iajs-3608	3	3	an	an	DET
iajs-3608	3	4	open	open	ADJ
iajs-3608	3	5	-	-	PUNCT
iajs-3608	3	6	access	access	NOUN
iajs-3608	3	7	article	article	NOUN
iajs-3608	3	8	distributed	distribute	VERB
iajs-3608	3	9	under	under	ADP
iajs-3608	3	10	the	the	DET
iajs-3608	3	11	terms	term	NOUN
iajs-3608	3	12	of	of	ADP
iajs-3608	3	13	the	the	DET
iajs-3608	3	14	creative	creative	ADJ
iajs-3608	3	15	commons	common	NOUN
iajs-3608	3	16	attribution	attribution	NOUN
iajs-3608	3	17	4.0	4.0	NUM
iajs-3608	3	18	international	international	ADJ
iajs-3608	3	19	license	license	NOUN
iajs-3608	3	20	investigation	investigation	NOUN
iajs-3608	3	21	of	of	ADP
iajs-3608	3	22	matrix	matrix	NOUN
iajs-3608	3	23	metalloproteinase-2	metalloproteinase-2	NUM
iajs-3608	3	24	and	and	CCONJ
iajs-3608	3	25	9	9	NUM
iajs-3608	3	26	in	in	ADP
iajs-3608	3	27	patients	patient	NOUN
iajs-3608	3	28	with	with	ADP
iajs-3608	3	29	chronic	chronic	ADJ
iajs-3608	3	30	renal	renal	ADJ
iajs-3608	3	31	failure	failure	NOUN
iajs-3608	3	32	hala	hala	PROPN
iajs-3608	3	33	basil	basil	PROPN
iajs-3608	3	34	abdulameer	abdulameer	PROPN
iajs-3608	3	35	1	1	NUM
iajs-3608	3	36	*	*	PUNCT
iajs-3608	3	37	,	,	PUNCT
iajs-3608	3	38	and	and	CCONJ
iajs-3608	3	39	may	may	AUX
iajs-3608	3	40	khaleel	khaleel	VERB
iajs-3608	3	41	ismael	ismael	PROPN
iajs-3608	3	42	2	2	NUM
iajs-3608	3	43	1,2	1,2	NUM
iajs-3608	3	44	department	department	NOUN
iajs-3608	3	45	of	of	ADP
iajs-3608	3	46	biology	biology	NOUN
iajs-3608	3	47	,	,	PUNCT
iajs-3608	3	48	college	college	NOUN
iajs-3608	3	49	of	of	ADP
iajs-3608	3	50	science	science	NOUN
iajs-3608	3	51	,	,	PUNCT
iajs-3608	3	52	university	university	NOUN
iajs-3608	3	53	of	of	ADP
iajs-3608	3	54	baghdad	baghdad	PROPN
iajs-3608	3	55	,	,	PUNCT
iajs-3608	3	56	baghdad	baghdad	PROPN
iajs-3608	3	57	,	,	PUNCT
iajs-3608	3	58	iraq	iraq	PROPN
iajs-3608	3	59	corresponding	correspond	VERB
iajs-3608	3	60	author	author	NOUN
iajs-3608	3	61	*	*	AUX
iajs-3608	3	62	received	receive	VERB
iajs-3608	3	63	:	:	PUNCT
iajs-3608	3	64	20	20	NUM
iajs-3608	3	65	june	june	PROPN
iajs-3608	3	66	2023	2023	NUM
iajs-3608	3	67	accepted	accept	VERB
iajs-3608	3	68	:	:	PUNCT
iajs-3608	3	69	1	1	NUM
iajs-3608	3	70	august	august	PROPN
iajs-3608	3	71	2023	2023	NUM
iajs-3608	3	72	published	publish	VERB
iajs-3608	3	73	:	:	PUNCT
iajs-3608	3	74	20	20	NUM
iajs-3608	3	75	october	october	NOUN
iajs-3608	3	76	2025	2025	NUM
iajs-3608	3	77	doi.org/10.30526/38.4.3608	doi.org/10.30526/38.4.3608	NOUN
iajs-3608	3	78	abstract	abstract	ADJ
iajs-3608	3	79	the	the	DET
iajs-3608	3	80	family	family	NOUN
iajs-3608	3	81	of	of	ADP
iajs-3608	3	82	zinc	zinc	NOUN
iajs-3608	3	83	-	-	PUNCT
iajs-3608	3	84	dependent	dependent	ADJ
iajs-3608	3	85	endopeptidases	endopeptidase	NOUN
iajs-3608	3	86	known	know	VERB
iajs-3608	3	87	as	as	ADP
iajs-3608	3	88	matrix	matrix	NOUN
iajs-3608	3	89	metalloproteinases	metalloproteinase	NOUN
iajs-3608	3	90	(	(	PUNCT
iajs-3608	3	91	mmps	mmp	NOUN
iajs-3608	3	92	)	)	PUNCT
iajs-3608	3	93	has	have	AUX
iajs-3608	3	94	been	be	AUX
iajs-3608	3	95	linked	link	VERB
iajs-3608	3	96	to	to	ADP
iajs-3608	3	97	both	both	CCONJ
iajs-3608	3	98	healthy	healthy	ADJ
iajs-3608	3	99	and	and	CCONJ
iajs-3608	3	100	unhealthy	unhealthy	ADJ
iajs-3608	3	101	kidney	kidney	NOUN
iajs-3608	3	102	physiology	physiology	NOUN
iajs-3608	3	103	.	.	PUNCT
iajs-3608	4	1	members	member	NOUN
iajs-3608	4	2	of	of	ADP
iajs-3608	4	3	the	the	DET
iajs-3608	4	4	mmp	mmp	PROPN
iajs-3608	4	5	family	family	NOUN
iajs-3608	4	6	known	know	VERB
iajs-3608	4	7	as	as	ADP
iajs-3608	4	8	gelatinases	gelatinase	NOUN
iajs-3608	4	9	(	(	PUNCT
iajs-3608	4	10	mmp-2	mmp-2	NUM
iajs-3608	4	11	,	,	PUNCT
iajs-3608	4	12	mmp-9	mmp-9	NUM
iajs-3608	4	13	)	)	PUNCT
iajs-3608	4	14	are	be	AUX
iajs-3608	4	15	essential	essential	ADJ
iajs-3608	4	16	for	for	ADP
iajs-3608	4	17	the	the	DET
iajs-3608	4	18	degradation	degradation	NOUN
iajs-3608	4	19	of	of	ADP
iajs-3608	4	20	the	the	DET
iajs-3608	4	21	extracellular	extracellular	ADJ
iajs-3608	4	22	matrix	matrix	NOUN
iajs-3608	4	23	(	(	PUNCT
iajs-3608	4	24	ecm	ecm	PROPN
iajs-3608	4	25	)	)	PUNCT
iajs-3608	4	26	.	.	PUNCT
iajs-3608	5	1	this	this	DET
iajs-3608	5	2	effect	effect	NOUN
iajs-3608	5	3	plays	play	VERB
iajs-3608	5	4	a	a	DET
iajs-3608	5	5	significant	significant	ADJ
iajs-3608	5	6	role	role	NOUN
iajs-3608	5	7	in	in	ADP
iajs-3608	5	8	the	the	DET
iajs-3608	5	9	progression	progression	NOUN
iajs-3608	5	10	of	of	ADP
iajs-3608	5	11	chronic	chronic	ADJ
iajs-3608	5	12	kidney	kidney	NOUN
iajs-3608	5	13	disease	disease	NOUN
iajs-3608	5	14	(	(	PUNCT
iajs-3608	5	15	ckd).and	ckd).and	X
iajs-3608	5	16	as	as	ADP
iajs-3608	5	17	an	an	DET
iajs-3608	5	18	indicator	indicator	NOUN
iajs-3608	5	19	of	of	ADP
iajs-3608	5	20	chronic	chronic	ADJ
iajs-3608	5	21	renal	renal	ADJ
iajs-3608	5	22	failure	failure	NOUN
iajs-3608	5	23	(	(	PUNCT
iajs-3608	5	24	crf	crf	NOUN
iajs-3608	5	25	)	)	PUNCT
iajs-3608	5	26	,	,	PUNCT
iajs-3608	5	27	which	which	PRON
iajs-3608	5	28	is	be	AUX
iajs-3608	5	29	a	a	DET
iajs-3608	5	30	permanent	permanent	ADJ
iajs-3608	5	31	loss	loss	NOUN
iajs-3608	5	32	of	of	ADP
iajs-3608	5	33	kidney	kidney	NOUN
iajs-3608	5	34	function	function	NOUN
iajs-3608	5	35	that	that	PRON
iajs-3608	5	36	occurs	occur	VERB
iajs-3608	5	37	when	when	SCONJ
iajs-3608	5	38	the	the	DET
iajs-3608	5	39	glomerular	glomerular	ADJ
iajs-3608	5	40	filtration	filtration	NOUN
iajs-3608	5	41	rate	rate	NOUN
iajs-3608	5	42	(	(	PUNCT
iajs-3608	5	43	gfr	gfr	NOUN
iajs-3608	5	44	)	)	PUNCT
iajs-3608	5	45	falls	fall	VERB
iajs-3608	5	46	below	below	ADP
iajs-3608	5	47	60	60	NUM
iajs-3608	5	48	ml	ml	NOUN
iajs-3608	5	49	/	/	SYM
iajs-3608	5	50	min/1.73	min/1.73	NOUN
iajs-3608	5	51	m²	m²	NOUN
iajs-3608	5	52	for	for	ADP
iajs-3608	5	53	more	more	ADJ
iajs-3608	5	54	than	than	ADP
iajs-3608	5	55	3	3	NUM
iajs-3608	5	56	months	month	NOUN
iajs-3608	5	57	.	.	PUNCT
iajs-3608	6	1	the	the	DET
iajs-3608	6	2	presented	present	VERB
iajs-3608	6	3	study	study	NOUN
iajs-3608	6	4	was	be	AUX
iajs-3608	6	5	established	establish	VERB
iajs-3608	6	6	to	to	PART
iajs-3608	6	7	investigate	investigate	VERB
iajs-3608	6	8	the	the	DET
iajs-3608	6	9	mmp-2	mmp-2	ADJ
iajs-3608	6	10	and	and	CCONJ
iajs-3608	6	11	-9	-9	ADV
iajs-3608	6	12	concentrations	concentration	NOUN
iajs-3608	6	13	in	in	ADP
iajs-3608	6	14	the	the	DET
iajs-3608	6	15	urine	urine	NOUN
iajs-3608	6	16	and	and	CCONJ
iajs-3608	6	17	serum	serum	NOUN
iajs-3608	6	18	among	among	ADP
iajs-3608	6	19	iraqi	iraqi	ADJ
iajs-3608	6	20	patients	patient	NOUN
iajs-3608	6	21	with	with	ADP
iajs-3608	6	22	crf	crf	NOUN
iajs-3608	6	23	undergoing	undergo	VERB
iajs-3608	6	24	regular	regular	ADJ
iajs-3608	6	25	weekly	weekly	ADJ
iajs-3608	6	26	dialysis	dialysis	NOUN
iajs-3608	6	27	at	at	ADP
iajs-3608	6	28	the	the	DET
iajs-3608	6	29	hamida	hamida	PROPN
iajs-3608	6	30	al	al	PROPN
iajs-3608	6	31	-	-	PUNCT
iajs-3608	6	32	misfaa	misfaa	PROPN
iajs-3608	6	33	dialysis	dialysis	NOUN
iajs-3608	6	34	center	center	PROPN
iajs-3608	6	35	of	of	ADP
iajs-3608	6	36	alkadhimiyah	alkadhimiyah	PROPN
iajs-3608	6	37	educational	educational	ADJ
iajs-3608	6	38	hospital	hospital	NOUN
iajs-3608	6	39	as	as	ADV
iajs-3608	6	40	well	well	ADV
iajs-3608	6	41	as	as	ADP
iajs-3608	6	42	the	the	DET
iajs-3608	6	43	dialysis	dialysis	NOUN
iajs-3608	6	44	center	center	NOUN
iajs-3608	6	45	of	of	ADP
iajs-3608	6	46	al	al	PROPN
iajs-3608	6	47	yarmouk	yarmouk	PROPN
iajs-3608	6	48	hospital	hospital	NOUN
iajs-3608	6	49	in	in	ADP
iajs-3608	6	50	baghdad	baghdad	PROPN
iajs-3608	6	51	between	between	ADP
iajs-3608	6	52	november	november	PROPN
iajs-3608	6	53	2022	2022	NUM
iajs-3608	6	54	and	and	CCONJ
iajs-3608	6	55	january	january	PROPN
iajs-3608	6	56	2023	2023	NUM
iajs-3608	6	57	.	.	PUNCT
iajs-3608	7	1	detection	detection	NOUN
iajs-3608	7	2	was	be	AUX
iajs-3608	7	3	done	do	VERB
iajs-3608	7	4	using	use	VERB
iajs-3608	7	5	the	the	DET
iajs-3608	7	6	sandwich	sandwich	NOUN
iajs-3608	7	7	enzyme	enzyme	NOUN
iajs-3608	7	8	-	-	PUNCT
iajs-3608	7	9	linked	link	VERB
iajs-3608	7	10	immunosorbent	immunosorbent	ADJ
iajs-3608	7	11	assay	assay	NOUN
iajs-3608	7	12	technique	technique	NOUN
iajs-3608	7	13	.	.	PUNCT
iajs-3608	8	1	the	the	DET
iajs-3608	8	2	results	result	NOUN
iajs-3608	8	3	indicated	indicate	VERB
iajs-3608	8	4	that	that	SCONJ
iajs-3608	8	5	mmp-2	mmp-2	NUM
iajs-3608	8	6	and	and	CCONJ
iajs-3608	8	7	mmp-9	mmp-9	NOUN
iajs-3608	8	8	expression	expression	NOUN
iajs-3608	8	9	levels	level	NOUN
iajs-3608	8	10	in	in	ADP
iajs-3608	8	11	both	both	CCONJ
iajs-3608	8	12	serum	serum	NOUN
iajs-3608	8	13	and	and	CCONJ
iajs-3608	8	14	urine	urine	NOUN
iajs-3608	8	15	were	be	AUX
iajs-3608	8	16	considerably	considerably	ADV
iajs-3608	8	17	higher	high	ADJ
iajs-3608	8	18	in	in	ADP
iajs-3608	8	19	-	-	PUNCT
iajs-3608	8	20	patient	patient	NOUN
iajs-3608	8	21	groups	group	NOUN
iajs-3608	8	22	compared	compare	VERB
iajs-3608	8	23	to	to	ADP
iajs-3608	8	24	healthy	healthy	ADJ
iajs-3608	8	25	individuals	individual	NOUN
iajs-3608	8	26	.	.	PUNCT
iajs-3608	9	1	keywords	keyword	NOUN
iajs-3608	9	2	:	:	PUNCT
iajs-3608	9	3	crf	crf	NOUN
iajs-3608	9	4	,	,	PUNCT
iajs-3608	9	5	mmps	mmps	PROPN
iajs-3608	9	6	,	,	PUNCT
iajs-3608	9	7	elisa	elisa	NOUN
iajs-3608	9	8	,	,	PUNCT
iajs-3608	9	9	detection	detection	NOUN
iajs-3608	9	10	.	.	PUNCT
iajs-3608	10	1	1.introduction	1.introduction	NUM
iajs-3608	10	2	chronic	chronic	ADJ
iajs-3608	10	3	renal	renal	ADJ
iajs-3608	10	4	failure	failure	NOUN
iajs-3608	10	5	(	(	PUNCT
iajs-3608	10	6	crf	crf	NOUN
iajs-3608	10	7	)	)	PUNCT
iajs-3608	10	8	is	be	AUX
iajs-3608	10	9	a	a	DET
iajs-3608	10	10	major	major	ADJ
iajs-3608	10	11	public	public	ADJ
iajs-3608	10	12	health	health	NOUN
iajs-3608	10	13	problem	problem	NOUN
iajs-3608	10	14	that	that	PRON
iajs-3608	10	15	affects	affect	VERB
iajs-3608	10	16	around	around	ADP
iajs-3608	10	17	10	10	NUM
iajs-3608	10	18	%	%	NOUN
iajs-3608	10	19	of	of	ADP
iajs-3608	10	20	the	the	DET
iajs-3608	10	21	adult	adult	NOUN
iajs-3608	10	22	population	population	NOUN
iajs-3608	10	23	globally	globally	ADV
iajs-3608	10	24	.	.	PUNCT
iajs-3608	11	1	it	it	PRON
iajs-3608	11	2	is	be	AUX
iajs-3608	11	3	characterized	characterize	VERB
iajs-3608	11	4	by	by	ADP
iajs-3608	11	5	1	1	NUM
iajs-3608	11	6	)	)	PUNCT
iajs-3608	11	7	an	an	DET
iajs-3608	11	8	irreversible	irreversible	ADJ
iajs-3608	11	9	in	in	ADP
iajs-3608	11	10	renal	renal	ADJ
iajs-3608	11	11	function	function	NOUN
iajs-3608	11	12	.	.	PUNCT
iajs-3608	12	1	2	2	X
iajs-3608	12	2	)	)	PUNCT
iajs-3608	12	3	by	by	ADP
iajs-3608	12	4	a	a	DET
iajs-3608	12	5	gradual	gradual	ADJ
iajs-3608	12	6	decrease	decrease	NOUN
iajs-3608	12	7	of	of	ADP
iajs-3608	12	8	kidney	kidney	NOUN
iajs-3608	12	9	function	function	NOUN
iajs-3608	12	10	,	,	PUNCT
iajs-3608	12	11	leading	lead	VERB
iajs-3608	12	12	to	to	ADP
iajs-3608	12	13	end	end	NOUN
iajs-3608	12	14	-	-	PUNCT
iajs-3608	12	15	stage	stage	NOUN
iajs-3608	12	16	renal	renal	ADJ
iajs-3608	12	17	disease	disease	NOUN
iajs-3608	12	18	(	(	PUNCT
iajs-3608	12	19	esrd	esrd	PROPN
iajs-3608	12	20	)	)	PUNCT
iajs-3608	12	21	(	(	PUNCT
iajs-3608	12	22	1	1	NUM
iajs-3608	12	23	)	)	PUNCT
iajs-3608	12	24	,	,	PUNCT
iajs-3608	12	25	when	when	SCONJ
iajs-3608	12	26	less	less	ADJ
iajs-3608	12	27	than	than	ADP
iajs-3608	12	28	10	10	NUM
iajs-3608	12	29	%	%	NOUN
iajs-3608	12	30	of	of	ADP
iajs-3608	12	31	renal	renal	ADJ
iajs-3608	12	32	function	function	NOUN
iajs-3608	12	33	persists	persist	VERB
iajs-3608	12	34	;	;	PUNCT
iajs-3608	12	35	this	this	DET
iajs-3608	12	36	irreversible	irreversible	ADJ
iajs-3608	12	37	loss	loss	NOUN
iajs-3608	12	38	of	of	ADP
iajs-3608	12	39	renal	renal	ADJ
iajs-3608	12	40	function	function	NOUN
iajs-3608	12	41	results	result	NOUN
iajs-3608	12	42	in	in	ADP
iajs-3608	12	43	signs	sign	NOUN
iajs-3608	12	44	and	and	CCONJ
iajs-3608	12	45	symptoms	symptom	NOUN
iajs-3608	12	46	known	know	VERB
iajs-3608	12	47	as	as	ADP
iajs-3608	12	48	uremia	uremia	NOUN
iajs-3608	12	49	(	(	PUNCT
iajs-3608	12	50	2	2	NUM
iajs-3608	12	51	)	)	PUNCT
iajs-3608	12	52	.	.	PUNCT
iajs-3608	13	1	it	it	PRON
iajs-3608	13	2	is	be	AUX
iajs-3608	13	3	believed	believe	VERB
iajs-3608	13	4	that	that	SCONJ
iajs-3608	13	5	crf	crf	PROPN
iajs-3608	13	6	is	be	AUX
iajs-3608	13	7	linked	link	VERB
iajs-3608	13	8	to	to	ADP
iajs-3608	13	9	an	an	DET
iajs-3608	13	10	increased	increase	VERB
iajs-3608	13	11	risk	risk	NOUN
iajs-3608	13	12	of	of	ADP
iajs-3608	13	13	early	early	ADJ
iajs-3608	13	14	mortality	mortality	NOUN
iajs-3608	13	15	has	have	AUX
iajs-3608	13	16	recently	recently	ADV
iajs-3608	13	17	gained	gain	VERB
iajs-3608	13	18	widespread	widespread	ADJ
iajs-3608	13	19	acceptance	acceptance	NOUN
iajs-3608	13	20	in	in	ADP
iajs-3608	13	21	both	both	CCONJ
iajs-3608	13	22	the	the	DET
iajs-3608	13	23	medical	medical	ADJ
iajs-3608	13	24	community	community	NOUN
iajs-3608	13	25	and	and	CCONJ
iajs-3608	13	26	society	society	NOUN
iajs-3608	13	27	at	at	ADP
iajs-3608	13	28	large	large	ADJ
iajs-3608	13	29	(	(	PUNCT
iajs-3608	13	30	3	3	NUM
iajs-3608	13	31	)	)	PUNCT
iajs-3608	13	32	.	.	PUNCT
iajs-3608	14	1	given	give	VERB
iajs-3608	14	2	that	that	SCONJ
iajs-3608	14	3	the	the	DET
iajs-3608	14	4	majority	majority	NOUN
iajs-3608	14	5	of	of	ADP
iajs-3608	14	6	crf	crf	PROPN
iajs-3608	14	7	cases	case	NOUN
iajs-3608	14	8	were	be	AUX
iajs-3608	14	9	not	not	PART
iajs-3608	14	10	clinically	clinically	ADV
iajs-3608	14	11	recognized	recognize	VERB
iajs-3608	14	12	,	,	PUNCT
iajs-3608	14	13	primarily	primarily	ADV
iajs-3608	14	14	because	because	SCONJ
iajs-3608	14	15	patients	patient	NOUN
iajs-3608	14	16	were	be	AUX
iajs-3608	14	17	unaware	unaware	ADJ
iajs-3608	14	18	of	of	ADP
iajs-3608	14	19	crf	crf	NOUN
iajs-3608	14	20	risk	risk	NOUN
iajs-3608	14	21	factors	factor	NOUN
iajs-3608	14	22	,	,	PUNCT
iajs-3608	14	23	the	the	DET
iajs-3608	14	24	global	global	ADJ
iajs-3608	14	25	rise	rise	NOUN
iajs-3608	14	26	in	in	ADP
iajs-3608	14	27	crf	crf	PROPN
iajs-3608	14	28	prevalence	prevalence	NOUN
iajs-3608	14	29	necessitates	necessitate	VERB
iajs-3608	14	30	improvements	improvement	NOUN
iajs-3608	14	31	in	in	ADP
iajs-3608	14	32	the	the	DET
iajs-3608	14	33	global	global	ADJ
iajs-3608	14	34	strategy	strategy	NOUN
iajs-3608	14	35	for	for	ADP
iajs-3608	14	36	crf	crf	PROPN
iajs-3608	14	37	prevention	prevention	NOUN
iajs-3608	14	38	,	,	PUNCT
iajs-3608	14	39	particularly	particularly	ADV
iajs-3608	14	40	through	through	ADP
iajs-3608	14	41	the	the	DET
iajs-3608	14	42	identification	identification	NOUN
iajs-3608	14	43	of	of	ADP
iajs-3608	14	44	risk	risk	NOUN
iajs-3608	14	45	factors	factor	NOUN
iajs-3608	14	46	.	.	PUNCT
iajs-3608	15	1	hypertension	hypertension	NOUN
iajs-3608	15	2	and	and	CCONJ
iajs-3608	15	3	diabetes	diabetes	NOUN
iajs-3608	15	4	mellitus	mellitus	NOUN
iajs-3608	15	5	are	be	AUX
iajs-3608	15	6	the	the	DET
iajs-3608	15	7	two	two	NUM
iajs-3608	15	8	most	most	ADV
iajs-3608	15	9	prominent	prominent	ADJ
iajs-3608	15	10	risk	risk	NOUN
iajs-3608	15	11	factors	factor	NOUN
iajs-3608	15	12	for	for	ADP
iajs-3608	15	13	developing	develop	VERB
iajs-3608	15	14	crf	crf	PROPN
iajs-3608	15	15	.	.	PUNCT
iajs-3608	16	1	these	these	DET
iajs-3608	16	2	two	two	NUM
iajs-3608	16	3	disorders	disorder	NOUN
iajs-3608	16	4	cause	cause	VERB
iajs-3608	16	5	vascular	vascular	ADJ
iajs-3608	16	6	changes	change	NOUN
iajs-3608	16	7	,	,	PUNCT
iajs-3608	16	8	which	which	PRON
iajs-3608	16	9	raise	raise	VERB
iajs-3608	16	10	the	the	DET
iajs-3608	16	11	risk	risk	NOUN
iajs-3608	16	12	of	of	ADP
iajs-3608	16	13	macro	macro	ADJ
iajs-3608	16	14	and	and	CCONJ
iajs-3608	16	15	microvascular	microvascular	ADJ
iajs-3608	16	16	consequences	consequence	NOUN
iajs-3608	16	17	,	,	PUNCT
iajs-3608	16	18	including	include	VERB
iajs-3608	16	19	kidney	kidney	NOUN
iajs-3608	16	20	impairment	impairment	NOUN
iajs-3608	16	21	.	.	PUNCT
iajs-3608	17	1	hemodialysis	hemodialysis	NOUN
iajs-3608	17	2	and	and	CCONJ
iajs-3608	17	3	renal	renal	ADJ
iajs-3608	17	4	replacement	replacement	NOUN
iajs-3608	17	5	therapy	therapy	NOUN
iajs-3608	17	6	is	be	AUX
iajs-3608	17	7	acquired	acquire	VERB
iajs-3608	17	8	for	for	ADP
iajs-3608	17	9	those	those	PRON
iajs-3608	17	10	with	with	ADP
iajs-3608	17	11	crf	crf	NOUN
iajs-3608	17	12	,	,	PUNCT
iajs-3608	17	13	hemodialysis	hemodialysis	NOUN
iajs-3608	17	14	is	be	AUX
iajs-3608	17	15	also	also	ADV
iajs-3608	17	16	can	can	AUX
iajs-3608	17	17	be	be	AUX
iajs-3608	17	18	used	use	VERB
iajs-3608	17	19	for	for	ADP
iajs-3608	17	20	those	those	PRON
iajs-3608	17	21	with	with	ADP
iajs-3608	17	22	chronic	chronic	ADJ
iajs-3608	17	23	liver	liver	NOUN
iajs-3608	17	24	diseases	disease	NOUN
iajs-3608	17	25	to	to	PART
iajs-3608	17	26	eliminate	eliminate	VERB
iajs-3608	17	27	toxins	toxin	NOUN
iajs-3608	17	28	that	that	PRON
iajs-3608	17	29	the	the	DET
iajs-3608	17	30	liver	liver	NOUN
iajs-3608	17	31	should	should	AUX
iajs-3608	17	32	https://orcid.org/0009-0003-4955-0230	https://orcid.org/0009-0003-4955-0230	VERB
iajs-3608	17	33	mailto:hala.bassel1602a@sc.uobaghdad.edu.iq	mailto:hala.bassel1602a@sc.uobaghdad.edu.iq	PROPN
iajs-3608	17	34	https://orcid.org/0000-0001-7662-8038	https://orcid.org/0000-0001-7662-8038	PROPN
iajs-3608	17	35	mailto:may.khaleel@sc.uobaghdad.edu.iq	mailto:may.khaleel@sc.uobaghdad.edu.iq	PROPN
iajs-3608	17	36	https://orcid.org/0009-0003-4955-0230	https://orcid.org/0009-0003-4955-0230	PROPN
iajs-3608	17	37	mailto:hala.bassel1602a@sc.uobaghdad.edu.iq	mailto:hala.bassel1602a@sc.uobaghdad.edu.iq	PROPN
iajs-3608	17	38	https://orcid.org/0000-0001-7662-8038	https://orcid.org/0000-0001-7662-8038	PROPN
iajs-3608	18	1	mailto:may.khaleel@sc.uobaghdad.edu.iq	mailto:may.khaleel@sc.uobaghdad.edu.iq	PROPN
iajs-3608	18	2	https://orcid.org/0009-0003-4955-0230	https://orcid.org/0009-0003-4955-0230	PROPN
iajs-3608	18	3	mailto:hala.bassel1602a@sc.uobaghdad.edu.iq	mailto:hala.bassel1602a@sc.uobaghdad.edu.iq	PROPN
iajs-3608	18	4	https://orcid.org/0000-0001-7662-8038	https://orcid.org/0000-0001-7662-8038	PROPN
iajs-3608	18	5	mailto:may.khaleel@sc.uobaghdad.edu.iq	mailto:may.khaleel@sc.uobaghdad.edu.iq	PROPN
iajs-3608	18	6	https://orcid.org/0009-0003-4955-0230	https://orcid.org/0009-0003-4955-0230	PROPN
iajs-3608	18	7	mailto:hala.bassel1602a@sc.uobaghdad.edu.iq	mailto:hala.bassel1602a@sc.uobaghdad.edu.iq	PROPN
iajs-3608	18	8	https://orcid.org/0000-0001-7662-8038	https://orcid.org/0000-0001-7662-8038	PROPN
iajs-3608	18	9	mailto:may.khaleel@sc.uobaghdad.edu.iq	mailto:may.khaleel@sc.uobaghdad.edu.iq	PROPN
iajs-3608	18	10	https://orcid.org/0009-0003-4955-0230	https://orcid.org/0009-0003-4955-0230	PROPN
iajs-3608	18	11	mailto:hala.bassel1602a@sc.uobaghdad.edu.iq	mailto:hala.bassel1602a@sc.uobaghdad.edu.iq	PROPN
iajs-3608	18	12	https://orcid.org/0000-0001-7662-8038	https://orcid.org/0000-0001-7662-8038	PROPN
iajs-3608	18	13	mailto:may.khaleel@sc.uobaghdad.edu.iq	mailto:may.khaleel@sc.uobaghdad.edu.iq	PROPN
iajs-3608	18	14	https://orcid.org/0009-0003-4955-0230	https://orcid.org/0009-0003-4955-0230	PROPN
iajs-3608	18	15	mailto:hala.bassel1602a@sc.uobaghdad.edu.iq	mailto:hala.bassel1602a@sc.uobaghdad.edu.iq	PROPN
iajs-3608	18	16	https://orcid.org/0000-0001-7662-8038	https://orcid.org/0000-0001-7662-8038	PROPN
iajs-3608	18	17	mailto:may.khaleel@sc.uobaghdad.edu.iq	mailto:may.khaleel@sc.uobaghdad.edu.iq	PROPN
iajs-3608	18	18	ihjpas	ihjpas	PROPN
iajs-3608	18	19	.	.	PUNCT
iajs-3608	19	1	2025	2025	NUM
iajs-3608	19	2	,	,	PUNCT
iajs-3608	19	3	38(4	38(4	NUM
iajs-3608	19	4	)	)	PUNCT
iajs-3608	19	5	11	11	NUM
iajs-3608	19	6	normally	normally	ADV
iajs-3608	19	7	detoxifies	detoxifie	NOUN
iajs-3608	19	8	(	(	PUNCT
iajs-3608	19	9	4	4	NUM
iajs-3608	19	10	)	)	PUNCT
iajs-3608	19	11	.	.	PUNCT
iajs-3608	20	1	hemodialysis	hemodialysi	NOUN
iajs-3608	20	2	patients	patient	NOUN
iajs-3608	20	3	are	be	AUX
iajs-3608	20	4	at	at	ADP
iajs-3608	20	5	risk	risk	NOUN
iajs-3608	20	6	of	of	ADP
iajs-3608	20	7	contracting	contract	VERB
iajs-3608	20	8	viral	viral	ADJ
iajs-3608	20	9	diseases	disease	NOUN
iajs-3608	20	10	due	due	ADP
iajs-3608	20	11	to	to	ADP
iajs-3608	20	12	the	the	DET
iajs-3608	20	13	intrusive	intrusive	ADJ
iajs-3608	20	14	nature	nature	NOUN
iajs-3608	20	15	of	of	ADP
iajs-3608	20	16	therapy	therapy	NOUN
iajs-3608	20	17	and	and	CCONJ
iajs-3608	20	18	equipment	equipment	NOUN
iajs-3608	20	19	contamination	contamination	NOUN
iajs-3608	20	20	(	(	PUNCT
iajs-3608	20	21	5	5	NUM
iajs-3608	20	22	)	)	PUNCT
iajs-3608	20	23	.	.	PUNCT
iajs-3608	21	1	individuals	individual	NOUN
iajs-3608	21	2	on	on	ADP
iajs-3608	21	3	hemodialysis	hemodialysis	NOUN
iajs-3608	21	4	are	be	AUX
iajs-3608	21	5	more	more	ADV
iajs-3608	21	6	vulnerable	vulnerable	ADJ
iajs-3608	21	7	to	to	ADP
iajs-3608	21	8	infections	infection	NOUN
iajs-3608	21	9	due	due	ADJ
iajs-3608	21	10	to	to	ADP
iajs-3608	21	11	compromised	compromise	VERB
iajs-3608	21	12	immune	immune	ADJ
iajs-3608	21	13	systems	system	NOUN
iajs-3608	21	14	(	(	PUNCT
iajs-3608	21	15	6	6	NUM
iajs-3608	21	16	)	)	PUNCT
iajs-3608	21	17	.	.	PUNCT
iajs-3608	22	1	the	the	DET
iajs-3608	22	2	human	human	ADJ
iajs-3608	22	3	matrix	matrix	NOUN
iajs-3608	22	4	metalloproteinases	metalloproteinase	NOUN
iajs-3608	22	5	(	(	PUNCT
iajs-3608	22	6	mmps	mmp	NOUN
iajs-3608	22	7	)	)	PUNCT
iajs-3608	22	8	belong	belong	VERB
iajs-3608	22	9	to	to	ADP
iajs-3608	22	10	the	the	DET
iajs-3608	22	11	subfamily	subfamily	NOUN
iajs-3608	22	12	of	of	ADP
iajs-3608	22	13	zinc	zinc	NOUN
iajs-3608	22	14	-	-	PUNCT
iajs-3608	22	15	dependent	dependent	ADJ
iajs-3608	22	16	endopeptidases	endopeptidase	NOUN
iajs-3608	22	17	that	that	PRON
iajs-3608	22	18	were	be	AUX
iajs-3608	22	19	discovered	discover	VERB
iajs-3608	22	20	over	over	ADP
iajs-3608	22	21	50	50	NUM
iajs-3608	22	22	years	year	NOUN
iajs-3608	22	23	ago	ago	ADV
iajs-3608	22	24	.	.	PUNCT
iajs-3608	23	1	they	they	PRON
iajs-3608	23	2	are	be	AUX
iajs-3608	23	3	a	a	DET
iajs-3608	23	4	category	category	NOUN
iajs-3608	23	5	of	of	ADP
iajs-3608	23	6	24	24	NUM
iajs-3608	23	7	endoproteinases	endoproteinase	NOUN
iajs-3608	23	8	that	that	PRON
iajs-3608	23	9	are	be	AUX
iajs-3608	23	10	released	release	VERB
iajs-3608	23	11	in	in	ADP
iajs-3608	23	12	human	human	ADJ
iajs-3608	23	13	body	body	NOUN
iajs-3608	23	14	.	.	PUNCT
iajs-3608	24	1	mmps	mmp	NOUN
iajs-3608	24	2	are	be	AUX
iajs-3608	24	3	multifunctional	multifunctional	ADJ
iajs-3608	24	4	enzymes	enzyme	NOUN
iajs-3608	24	5	that	that	PRON
iajs-3608	24	6	can	can	AUX
iajs-3608	24	7	cleave	cleave	VERB
iajs-3608	24	8	extracellular	extracellular	ADJ
iajs-3608	24	9	matrix	matrix	NOUN
iajs-3608	24	10	elements	element	NOUN
iajs-3608	24	11	such	such	ADJ
iajs-3608	24	12	fibrillar	fibrillar	ADJ
iajs-3608	24	13	and	and	CCONJ
iajs-3608	24	14	non	non	ADJ
iajs-3608	24	15	-	-	ADJ
iajs-3608	24	16	fibrillar	fibrillar	ADJ
iajs-3608	24	17	collagen	collagen	NOUN
iajs-3608	24	18	,	,	PUNCT
iajs-3608	24	19	proteoglycans	proteoglycan	NOUN
iajs-3608	24	20	,	,	PUNCT
iajs-3608	24	21	glycoproteins	glycoprotein	NOUN
iajs-3608	24	22	,	,	PUNCT
iajs-3608	24	23	elastin	elastin	NOUN
iajs-3608	24	24	,	,	PUNCT
iajs-3608	24	25	and	and	CCONJ
iajs-3608	24	26	denatured	denature	VERB
iajs-3608	24	27	collagen	collagen	NOUN
iajs-3608	24	28	as	as	ADV
iajs-3608	24	29	well	well	ADV
iajs-3608	24	30	as	as	ADP
iajs-3608	24	31	the	the	DET
iajs-3608	24	32	basement	basement	NOUN
iajs-3608	24	33	membrane	membrane	NOUN
iajs-3608	24	34	.	.	PUNCT
iajs-3608	25	1	in	in	ADP
iajs-3608	25	2	addition	addition	NOUN
iajs-3608	25	3	,	,	PUNCT
iajs-3608	25	4	in	in	ADP
iajs-3608	25	5	cell	cell	NOUN
iajs-3608	25	6	surface	surface	NOUN
iajs-3608	25	7	-	-	PUNCT
iajs-3608	25	8	associated	associate	VERB
iajs-3608	25	9	adhesion	adhesion	NOUN
iajs-3608	25	10	and	and	CCONJ
iajs-3608	25	11	signaling	signal	VERB
iajs-3608	25	12	receptors	receptor	NOUN
iajs-3608	25	13	,	,	PUNCT
iajs-3608	25	14	chemokines	chemokine	NOUN
iajs-3608	25	15	,	,	PUNCT
iajs-3608	25	16	growth	growth	NOUN
iajs-3608	25	17	factors	factor	NOUN
iajs-3608	25	18	,	,	PUNCT
iajs-3608	25	19	cytokines	cytokine	NOUN
iajs-3608	25	20	(	(	PUNCT
iajs-3608	25	21	7	7	NUM
iajs-3608	25	22	)	)	PUNCT
iajs-3608	25	23	.	.	PUNCT
iajs-3608	26	1	mmps	mmp	NOUN
iajs-3608	26	2	have	have	VERB
iajs-3608	26	3	proteolytic	proteolytic	ADJ
iajs-3608	26	4	characteristics	characteristic	NOUN
iajs-3608	26	5	and	and	CCONJ
iajs-3608	26	6	are	be	AUX
iajs-3608	26	7	crucial	crucial	ADJ
iajs-3608	26	8	for	for	ADP
iajs-3608	26	9	a	a	DET
iajs-3608	26	10	number	number	NOUN
iajs-3608	26	11	of	of	ADP
iajs-3608	26	12	physiological	physiological	ADJ
iajs-3608	26	13	and	and	CCONJ
iajs-3608	26	14	pathological	pathological	ADJ
iajs-3608	26	15	processes	process	NOUN
iajs-3608	26	16	,	,	PUNCT
iajs-3608	26	17	such	such	ADJ
iajs-3608	26	18	as	as	ADP
iajs-3608	26	19	tissue	tissue	NOUN
iajs-3608	26	20	remodeling	remodeling	NOUN
iajs-3608	26	21	and	and	CCONJ
iajs-3608	26	22	organ	organ	NOUN
iajs-3608	26	23	development	development	NOUN
iajs-3608	26	24	,	,	PUNCT
iajs-3608	26	25	control	control	NOUN
iajs-3608	26	26	of	of	ADP
iajs-3608	26	27	inflammatory	inflammatory	ADJ
iajs-3608	26	28	processes	process	NOUN
iajs-3608	26	29	,	,	PUNCT
iajs-3608	26	30	and	and	CCONJ
iajs-3608	26	31	the	the	DET
iajs-3608	26	32	development	development	NOUN
iajs-3608	26	33	of	of	ADP
iajs-3608	26	34	cancer	cancer	NOUN
iajs-3608	26	35	(	(	PUNCT
iajs-3608	26	36	8)	8)	NUM
iajs-3608	26	37	.	.	PUNCT
iajs-3608	27	1	the	the	DET
iajs-3608	27	2	connective	connective	ADJ
iajs-3608	27	3	tissue	tissue	NOUN
iajs-3608	27	4	,	,	PUNCT
iajs-3608	27	5	vasculature	vasculature	NOUN
iajs-3608	27	6	,	,	PUNCT
iajs-3608	27	7	and	and	CCONJ
iajs-3608	27	8	nephron	nephron	NOUN
iajs-3608	27	9	compartments	compartment	NOUN
iajs-3608	27	10	of	of	ADP
iajs-3608	27	11	the	the	DET
iajs-3608	27	12	kidney	kidney	NOUN
iajs-3608	27	13	all	all	PRON
iajs-3608	27	14	contain	contain	VERB
iajs-3608	27	15	mmps	mmp	NOUN
iajs-3608	27	16	.	.	PUNCT
iajs-3608	28	1	(	(	PUNCT
iajs-3608	28	2	9	9	NUM
iajs-3608	28	3	)	)	PUNCT
iajs-3608	28	4	,	,	PUNCT
iajs-3608	28	5	(	(	PUNCT
iajs-3608	28	6	10	10	NUM
iajs-3608	28	7	)	)	PUNCT
iajs-3608	28	8	.	.	PUNCT
iajs-3608	29	1	with	with	ADP
iajs-3608	29	2	a	a	DET
iajs-3608	29	3	few	few	ADJ
iajs-3608	29	4	exceptions	exception	NOUN
iajs-3608	29	5	,	,	PUNCT
iajs-3608	29	6	mmp	mmp	PROPN
iajs-3608	29	7	levels	level	NOUN
iajs-3608	29	8	in	in	ADP
iajs-3608	29	9	normal	normal	ADJ
iajs-3608	29	10	adult	adult	NOUN
iajs-3608	29	11	tissues	tissue	NOUN
iajs-3608	29	12	are	be	AUX
iajs-3608	29	13	generally	generally	ADV
iajs-3608	29	14	modest	modest	ADJ
iajs-3608	29	15	,	,	PUNCT
iajs-3608	29	16	and	and	CCONJ
iajs-3608	29	17	their	their	PRON
iajs-3608	29	18	secretion	secretion	NOUN
iajs-3608	29	19	levels	level	NOUN
iajs-3608	29	20	and	and	CCONJ
iajs-3608	29	21	effectiveness	effectiveness	NOUN
iajs-3608	29	22	are	be	AUX
iajs-3608	29	23	unnoticeably	unnoticeably	ADV
iajs-3608	29	24	regulated	regulate	VERB
iajs-3608	29	25	.	.	PUNCT
iajs-3608	30	1	mmps	mmp	NOUN
iajs-3608	30	2	have	have	AUX
iajs-3608	30	3	long	long	ADV
iajs-3608	30	4	been	be	AUX
iajs-3608	30	5	suspected	suspect	VERB
iajs-3608	30	6	of	of	ADP
iajs-3608	30	7	contributing	contribute	VERB
iajs-3608	30	8	to	to	ADP
iajs-3608	30	9	crf	crf	PROPN
iajs-3608	30	10	development	development	NOUN
iajs-3608	30	11	and	and	CCONJ
iajs-3608	30	12	progression	progression	NOUN
iajs-3608	30	13	(	(	PUNCT
iajs-3608	30	14	11	11	NUM
iajs-3608	30	15	)	)	PUNCT
iajs-3608	30	16	.	.	PUNCT
iajs-3608	31	1	gelatinases	gelatinase	NOUN
iajs-3608	31	2	are	be	AUX
iajs-3608	31	3	thought	think	VERB
iajs-3608	31	4	to	to	PART
iajs-3608	31	5	play	play	VERB
iajs-3608	31	6	a	a	DET
iajs-3608	31	7	substantial	substantial	ADJ
iajs-3608	31	8	part	part	NOUN
iajs-3608	31	9	in	in	ADP
iajs-3608	31	10	crf	crf	PROPN
iajs-3608	31	11	,	,	PUNCT
iajs-3608	31	12	which	which	PRON
iajs-3608	31	13	is	be	AUX
iajs-3608	31	14	linked	link	VERB
iajs-3608	31	15	to	to	ADP
iajs-3608	31	16	a	a	DET
iajs-3608	31	17	number	number	NOUN
iajs-3608	31	18	of	of	ADP
iajs-3608	31	19	cells	cell	NOUN
iajs-3608	31	20	signaling	signal	VERB
iajs-3608	31	21	pathways	pathway	NOUN
iajs-3608	31	22	,	,	PUNCT
iajs-3608	31	23	endocytosis	endocytosis	NOUN
iajs-3608	31	24	,	,	PUNCT
iajs-3608	31	25	and	and	CCONJ
iajs-3608	31	26	the	the	DET
iajs-3608	31	27	emergence	emergence	NOUN
iajs-3608	31	28	of	of	ADP
iajs-3608	31	29	renal	renal	ADJ
iajs-3608	31	30	inflammation	inflammation	NOUN
iajs-3608	31	31	,	,	PUNCT
iajs-3608	31	32	according	accord	VERB
iajs-3608	31	33	to	to	ADP
iajs-3608	31	34	2017	2017	NUM
iajs-3608	31	35	research	research	NOUN
iajs-3608	31	36	.	.	PUNCT
iajs-3608	32	1	additionally	additionally	ADV
iajs-3608	32	2	,	,	PUNCT
iajs-3608	32	3	their	their	PRON
iajs-3608	32	4	non	non	ADJ
iajs-3608	32	5	-	-	ADJ
iajs-3608	32	6	proteolytic	proteolytic	ADJ
iajs-3608	32	7	actions	action	NOUN
iajs-3608	32	8	could	could	AUX
iajs-3608	32	9	be	be	AUX
iajs-3608	32	10	directly	directly	ADV
iajs-3608	32	11	related	relate	VERB
iajs-3608	32	12	to	to	ADP
iajs-3608	32	13	the	the	DET
iajs-3608	32	14	onset	onset	NOUN
iajs-3608	32	15	and	and	CCONJ
iajs-3608	32	16	development	development	NOUN
iajs-3608	32	17	of	of	ADP
iajs-3608	32	18	crf	crf	PROPN
iajs-3608	32	19	.	.	PUNCT
iajs-3608	33	1	studies	study	NOUN
iajs-3608	33	2	on	on	ADP
iajs-3608	33	3	gelatinase	gelatinase	NOUN
iajs-3608	33	4	frequently	frequently	ADV
iajs-3608	33	5	concentrate	concentrate	VERB
iajs-3608	33	6	on	on	ADP
iajs-3608	33	7	how	how	SCONJ
iajs-3608	33	8	they	they	PRON
iajs-3608	33	9	typically	typically	ADV
iajs-3608	33	10	contribute	contribute	VERB
iajs-3608	33	11	to	to	ADP
iajs-3608	33	12	ecm	ecm	NOUN
iajs-3608	33	13	hydrolysis	hydrolysis	NOUN
iajs-3608	33	14	.	.	PUNCT
iajs-3608	34	1	(	(	PUNCT
iajs-3608	34	2	11	11	NUM
iajs-3608	34	3	)	)	PUNCT
iajs-3608	34	4	.	.	PUNCT
iajs-3608	35	1	gelatinase	gelatinase	PROPN
iajs-3608	35	2	a	a	DET
iajs-3608	35	3	(	(	PUNCT
iajs-3608	35	4	72	72	NUM
iajs-3608	35	5	kda	kda	NOUN
iajs-3608	35	6	)	)	PUNCT
iajs-3608	35	7	known	know	VERB
iajs-3608	35	8	as	as	ADP
iajs-3608	35	9	mmp-2	mmp-2	NUM
iajs-3608	35	10	and	and	CCONJ
iajs-3608	35	11	gelatinase	gelatinase	PROPN
iajs-3608	35	12	b	b	PROPN
iajs-3608	35	13	(	(	PUNCT
iajs-3608	35	14	92	92	NUM
iajs-3608	35	15	kda	kda	NOUN
iajs-3608	35	16	)	)	PUNCT
iajs-3608	35	17	which	which	PRON
iajs-3608	35	18	is	be	AUX
iajs-3608	35	19	mmp-9	mmp-9	NUM
iajs-3608	35	20	,	,	PUNCT
iajs-3608	35	21	are	be	AUX
iajs-3608	35	22	mostly	mostly	ADV
iajs-3608	35	23	associated	associate	VERB
iajs-3608	35	24	with	with	ADP
iajs-3608	35	25	the	the	DET
iajs-3608	35	26	malignant	malignant	ADJ
iajs-3608	35	27	phenotype	phenotype	NOUN
iajs-3608	35	28	of	of	ADP
iajs-3608	35	29	tumor	tumor	NOUN
iajs-3608	35	30	cells	cell	NOUN
iajs-3608	35	31	.	.	PUNCT
iajs-3608	36	1	the	the	DET
iajs-3608	36	2	increasing	increase	VERB
iajs-3608	36	3	number	number	NOUN
iajs-3608	36	4	of	of	ADP
iajs-3608	36	5	studies	study	NOUN
iajs-3608	36	6	shows	show	VERB
iajs-3608	36	7	that	that	SCONJ
iajs-3608	36	8	circulating	circulate	VERB
iajs-3608	36	9	mmp-9	mmp-9	NOUN
iajs-3608	36	10	and/or	and/or	CCONJ
iajs-3608	36	11	mmp-2	mmp-2	NUM
iajs-3608	36	12	levels	level	NOUN
iajs-3608	36	13	may	may	AUX
iajs-3608	36	14	be	be	AUX
iajs-3608	36	15	beneficial	beneficial	ADJ
iajs-3608	36	16	in	in	ADP
iajs-3608	36	17	assessing	assess	VERB
iajs-3608	36	18	prognosis	prognosis	NOUN
iajs-3608	36	19	or	or	CCONJ
iajs-3608	36	20	detecting	detect	VERB
iajs-3608	36	21	illnesses	illness	NOUN
iajs-3608	36	22	.	.	PUNCT
iajs-3608	37	1	(	(	PUNCT
iajs-3608	37	2	12	12	NUM
iajs-3608	37	3	)	)	PUNCT
iajs-3608	37	4	.	.	PUNCT
iajs-3608	38	1	as	as	SCONJ
iajs-3608	38	2	such	such	ADJ
iajs-3608	38	3	,	,	PUNCT
iajs-3608	38	4	this	this	DET
iajs-3608	38	5	study	study	NOUN
iajs-3608	38	6	aimed	aim	VERB
iajs-3608	38	7	to	to	PART
iajs-3608	38	8	access	access	VERB
iajs-3608	38	9	some	some	DET
iajs-3608	38	10	ways	way	NOUN
iajs-3608	38	11	towards	towards	ADP
iajs-3608	38	12	detection	detection	NOUN
iajs-3608	38	13	and	and	CCONJ
iajs-3608	38	14	determination	determination	NOUN
iajs-3608	38	15	of	of	ADP
iajs-3608	38	16	serum	serum	NOUN
iajs-3608	38	17	and	and	CCONJ
iajs-3608	38	18	renal	renal	ADJ
iajs-3608	38	19	mmp-2	mmp-2	PUNCT
iajs-3608	38	20	and	and	CCONJ
iajs-3608	38	21	mmp-9	mmp-9	NOUN
iajs-3608	38	22	of	of	ADP
iajs-3608	38	23	iraqi	iraqi	ADJ
iajs-3608	38	24	patients	patient	NOUN
iajs-3608	38	25	undergoing	undergo	VERB
iajs-3608	38	26	dialysis	dialysis	NOUN
iajs-3608	38	27	and	and	CCONJ
iajs-3608	38	28	to	to	PART
iajs-3608	38	29	find	find	VERB
iajs-3608	38	30	out	out	ADP
iajs-3608	38	31	crf	crf	PROPN
iajs-3608	38	32	association	association	NOUN
iajs-3608	38	33	with	with	ADP
iajs-3608	38	34	these	these	DET
iajs-3608	38	35	parameters	parameter	NOUN
iajs-3608	38	36	.	.	PUNCT
iajs-3608	39	1	2.materials	2.materials	NUM
iajs-3608	39	2	and	and	CCONJ
iajs-3608	39	3	methods	method	NOUN
iajs-3608	39	4	the	the	DET
iajs-3608	39	5	study	study	NOUN
iajs-3608	39	6	comprised	comprise	VERB
iajs-3608	39	7	60	60	NUM
iajs-3608	39	8	patients	patient	NOUN
iajs-3608	39	9	,	,	PUNCT
iajs-3608	39	10	all	all	PRON
iajs-3608	39	11	of	of	ADP
iajs-3608	39	12	whom	whom	PRON
iajs-3608	39	13	suffered	suffer	VERB
iajs-3608	39	14	from	from	ADP
iajs-3608	39	15	crf	crf	PROPN
iajs-3608	39	16	and	and	CCONJ
iajs-3608	39	17	were	be	AUX
iajs-3608	39	18	undergoing	undergo	VERB
iajs-3608	39	19	regular	regular	ADJ
iajs-3608	39	20	weekly	weekly	ADJ
iajs-3608	39	21	dialysis	dialysis	NOUN
iajs-3608	39	22	.	.	PUNCT
iajs-3608	40	1	blood	blood	NOUN
iajs-3608	40	2	and	and	CCONJ
iajs-3608	40	3	urine	urine	NOUN
iajs-3608	40	4	samples	sample	NOUN
iajs-3608	40	5	were	be	AUX
iajs-3608	40	6	collected	collect	VERB
iajs-3608	40	7	from	from	ADP
iajs-3608	40	8	each	each	DET
iajs-3608	40	9	patient	patient	NOUN
iajs-3608	40	10	;	;	PUNCT
iajs-3608	40	11	5	5	NUM
iajs-3608	40	12	ml	ml	NOUN
iajs-3608	40	13	of	of	ADP
iajs-3608	40	14	the	the	DET
iajs-3608	40	15	blood	blood	NOUN
iajs-3608	40	16	were	be	AUX
iajs-3608	40	17	obtained	obtain	VERB
iajs-3608	40	18	from	from	ADP
iajs-3608	40	19	patients	patient	NOUN
iajs-3608	40	20	.	.	PUNCT
iajs-3608	41	1	the	the	DET
iajs-3608	41	2	blood	blood	NOUN
iajs-3608	41	3	was	be	AUX
iajs-3608	41	4	transferred	transfer	VERB
iajs-3608	41	5	into	into	ADP
iajs-3608	41	6	a	a	DET
iajs-3608	41	7	gel	gel	NOUN
iajs-3608	41	8	tube	tube	NOUN
iajs-3608	41	9	and	and	CCONJ
iajs-3608	41	10	centrifuged	centrifuge	VERB
iajs-3608	41	11	at	at	ADP
iajs-3608	41	12	4000	4000	NUM
iajs-3608	41	13	rpm	rpm	NOUN
iajs-3608	41	14	for	for	ADP
iajs-3608	41	15	5	5	NUM
iajs-3608	41	16	minutes	minute	NOUN
iajs-3608	41	17	to	to	PART
iajs-3608	41	18	obtain	obtain	VERB
iajs-3608	41	19	serum	serum	NOUN
iajs-3608	41	20	and	and	CCONJ
iajs-3608	41	21	kept	keep	VERB
iajs-3608	41	22	frozen	freeze	VERB
iajs-3608	41	23	at	at	ADP
iajs-3608	41	24	-20	-20	PUNCT
iajs-3608	41	25	until	until	ADP
iajs-3608	41	26	the	the	DET
iajs-3608	41	27	time	time	NOUN
iajs-3608	41	28	of	of	ADP
iajs-3608	41	29	its	its	PRON
iajs-3608	41	30	use	use	NOUN
iajs-3608	41	31	.	.	PUNCT
iajs-3608	42	1	urine	urine	NOUN
iajs-3608	42	2	samples	sample	NOUN
iajs-3608	42	3	of	of	ADP
iajs-3608	42	4	the	the	DET
iajs-3608	42	5	studied	study	VERB
iajs-3608	42	6	cases	case	NOUN
iajs-3608	42	7	were	be	AUX
iajs-3608	42	8	collected	collect	VERB
iajs-3608	42	9	using	use	VERB
iajs-3608	42	10	a	a	DET
iajs-3608	42	11	disposable	disposable	ADJ
iajs-3608	42	12	,	,	PUNCT
iajs-3608	42	13	sterile	sterile	ADJ
iajs-3608	42	14	,	,	PUNCT
iajs-3608	42	15	plastic	plastic	ADJ
iajs-3608	42	16	urine	urine	NOUN
iajs-3608	42	17	cup	cup	NOUN
iajs-3608	42	18	from	from	ADP
iajs-3608	42	19	each	each	DET
iajs-3608	42	20	patient	patient	NOUN
iajs-3608	42	21	and	and	CCONJ
iajs-3608	42	22	then	then	ADV
iajs-3608	42	23	transferred	transfer	VERB
iajs-3608	42	24	to	to	ADP
iajs-3608	42	25	an	an	DET
iajs-3608	42	26	eppendorf	eppendorf	PROPN
iajs-3608	42	27	tube	tube	NOUN
iajs-3608	42	28	tightly	tightly	ADV
iajs-3608	42	29	closed	close	VERB
iajs-3608	42	30	by	by	ADP
iajs-3608	42	31	a	a	DET
iajs-3608	42	32	hinged	hinge	VERB
iajs-3608	42	33	lid	lid	NOUN
iajs-3608	42	34	labelled	label	VERB
iajs-3608	42	35	with	with	ADP
iajs-3608	42	36	a	a	DET
iajs-3608	42	37	special	special	ADJ
iajs-3608	42	38	identification	identification	NOUN
iajs-3608	42	39	number	number	NOUN
iajs-3608	42	40	for	for	ADP
iajs-3608	42	41	each	each	DET
iajs-3608	42	42	sample	sample	NOUN
iajs-3608	42	43	.	.	PUNCT
iajs-3608	43	1	samples	sample	NOUN
iajs-3608	43	2	were	be	AUX
iajs-3608	43	3	stored	store	VERB
iajs-3608	43	4	at	at	ADP
iajs-3608	43	5	-20	-20	NUM
iajs-3608	43	6	˚c	˚c	PROPN
iajs-3608	43	7	until	until	SCONJ
iajs-3608	43	8	immunological	immunological	ADJ
iajs-3608	43	9	examinations	examination	NOUN
iajs-3608	43	10	were	be	AUX
iajs-3608	43	11	carried	carry	VERB
iajs-3608	43	12	out	out	ADP
iajs-3608	43	13	.	.	PUNCT
iajs-3608	44	1	the	the	DET
iajs-3608	44	2	samples	sample	NOUN
iajs-3608	44	3	were	be	AUX
iajs-3608	44	4	collected	collect	VERB
iajs-3608	44	5	from	from	ADP
iajs-3608	44	6	patients	patient	NOUN
iajs-3608	44	7	who	who	PRON
iajs-3608	44	8	attended	attend	VERB
iajs-3608	44	9	hamida	hamida	PROPN
iajs-3608	44	10	al	al	PROPN
iajs-3608	44	11	-	-	PUNCT
iajs-3608	44	12	misfaa	misfaa	PROPN
iajs-3608	44	13	dialysis	dialysis	NOUN
iajs-3608	44	14	center	center	PROPN
iajs-3608	44	15	of	of	ADP
iajs-3608	44	16	al	al	PROPN
iajs-3608	44	17	-	-	PUNCT
iajs-3608	44	18	kadhimiyah	kadhimiyah	PROPN
iajs-3608	44	19	educational	educational	ADJ
iajs-3608	44	20	hospital	hospital	NOUN
iajs-3608	44	21	as	as	ADV
iajs-3608	44	22	well	well	ADV
iajs-3608	44	23	as	as	ADP
iajs-3608	44	24	the	the	DET
iajs-3608	44	25	dialysis	dialysis	NOUN
iajs-3608	44	26	center	center	NOUN
iajs-3608	44	27	of	of	ADP
iajs-3608	44	28	al	al	PROPN
iajs-3608	44	29	yarmouk	yarmouk	PROPN
iajs-3608	44	30	hospital	hospital	NOUN
iajs-3608	44	31	in	in	ADP
iajs-3608	44	32	baghdad	baghdad	PROPN
iajs-3608	44	33	in	in	ADP
iajs-3608	44	34	iraq	iraq	PROPN
iajs-3608	44	35	.	.	PUNCT
iajs-3608	45	1	the	the	DET
iajs-3608	45	2	collection	collection	NOUN
iajs-3608	45	3	took	take	VERB
iajs-3608	45	4	place	place	NOUN
iajs-3608	45	5	in	in	ADP
iajs-3608	45	6	the	the	DET
iajs-3608	45	7	time	time	NOUN
iajs-3608	45	8	frame	frame	NOUN
iajs-3608	45	9	between	between	ADP
iajs-3608	45	10	november	november	PROPN
iajs-3608	45	11	2022	2022	NUM
iajs-3608	45	12	and	and	CCONJ
iajs-3608	45	13	january	january	PROPN
iajs-3608	45	14	2023	2023	NUM
iajs-3608	45	15	.	.	PUNCT
iajs-3608	46	1	the	the	DET
iajs-3608	46	2	ages	age	NOUN
iajs-3608	46	3	of	of	ADP
iajs-3608	46	4	patients	patient	NOUN
iajs-3608	46	5	ranged	range	VERB
iajs-3608	46	6	between	between	ADP
iajs-3608	46	7	20	20	NUM
iajs-3608	46	8	and	and	CCONJ
iajs-3608	46	9	84	84	NUM
iajs-3608	46	10	.	.	PUNCT
iajs-3608	47	1	thirty	thirty	NUM
iajs-3608	47	2	(	(	PUNCT
iajs-3608	47	3	30	30	NUM
iajs-3608	47	4	)	)	PUNCT
iajs-3608	47	5	samples	sample	NOUN
iajs-3608	47	6	from	from	ADP
iajs-3608	47	7	apparently	apparently	ADV
iajs-3608	47	8	healthy	healthy	ADJ
iajs-3608	47	9	individuals	individual	NOUN
iajs-3608	47	10	were	be	AUX
iajs-3608	47	11	collected	collect	VERB
iajs-3608	47	12	as	as	ADV
iajs-3608	47	13	well	well	ADV
iajs-3608	47	14	.	.	PUNCT
iajs-3608	48	1	the	the	DET
iajs-3608	48	2	displayed	display	VERB
iajs-3608	48	3	study	study	NOUN
iajs-3608	48	4	involved	involve	VERB
iajs-3608	48	5	receiving	receive	VERB
iajs-3608	48	6	signed	sign	VERB
iajs-3608	48	7	consent	consent	NOUN
iajs-3608	48	8	from	from	ADP
iajs-3608	48	9	each	each	DET
iajs-3608	48	10	patient	patient	NOUN
iajs-3608	48	11	after	after	ADP
iajs-3608	48	12	verbally	verbally	ADV
iajs-3608	48	13	describing	describe	VERB
iajs-3608	48	14	what	what	PRON
iajs-3608	48	15	the	the	DET
iajs-3608	48	16	risks	risk	NOUN
iajs-3608	48	17	of	of	ADP
iajs-3608	48	18	the	the	DET
iajs-3608	48	19	procedure	procedure	NOUN
iajs-3608	48	20	were	be	AUX
iajs-3608	48	21	and	and	CCONJ
iajs-3608	48	22	why	why	SCONJ
iajs-3608	48	23	the	the	DET
iajs-3608	48	24	blood	blood	NOUN
iajs-3608	48	25	sample	sample	NOUN
iajs-3608	48	26	was	be	AUX
iajs-3608	48	27	being	be	AUX
iajs-3608	48	28	drawn	draw	VERB
iajs-3608	48	29	.	.	PUNCT
iajs-3608	49	1	all	all	DET
iajs-3608	49	2	patients	patient	NOUN
iajs-3608	49	3	with	with	ADP
iajs-3608	49	4	hematological	hematological	ADJ
iajs-3608	49	5	malignancies	malignancy	NOUN
iajs-3608	49	6	,	,	PUNCT
iajs-3608	49	7	anemia	anemia	NOUN
iajs-3608	49	8	,	,	PUNCT
iajs-3608	49	9	and	and	CCONJ
iajs-3608	49	10	pregnant	pregnant	ADJ
iajs-3608	49	11	women	woman	NOUN
iajs-3608	49	12	were	be	AUX
iajs-3608	49	13	excluded	exclude	VERB
iajs-3608	49	14	from	from	ADP
iajs-3608	49	15	our	our	PRON
iajs-3608	49	16	research	research	NOUN
iajs-3608	49	17	.	.	PUNCT
iajs-3608	50	1	the	the	DET
iajs-3608	50	2	hospital	hospital	NOUN
iajs-3608	50	3	's	's	PART
iajs-3608	50	4	ethics	ethic	NOUN
iajs-3608	50	5	and	and	CCONJ
iajs-3608	50	6	the	the	DET
iajs-3608	50	7	college	college	NOUN
iajs-3608	50	8	of	of	ADP
iajs-3608	50	9	science	science	NOUN
iajs-3608	50	10	,	,	PUNCT
iajs-3608	50	11	university	university	NOUN
iajs-3608	50	12	of	of	ADP
iajs-3608	50	13	baghdad	baghdad	PROPN
iajs-3608	50	14	ethics	ethic	NOUN
iajs-3608	50	15	committee	committee	PROPN
iajs-3608	50	16	approved	approve	VERB
iajs-3608	50	17	the	the	DET
iajs-3608	50	18	research	research	NOUN
iajs-3608	50	19	(	(	PUNCT
iajs-3608	50	20	ref	ref	NOUN
iajs-3608	50	21	.	.	PUNCT
iajs-3608	50	22	:	:	PUNCT
iajs-3608	51	1	csec/0922/0080	csec/0922/0080	NOUN
iajs-3608	51	2	,	,	PUNCT
iajs-3608	51	3	appendix	appendix	VERB
iajs-3608	51	4	a	a	PRON
iajs-3608	51	5	)	)	PUNCT
iajs-3608	51	6	.	.	PUNCT
iajs-3608	52	1	patients	patient	NOUN
iajs-3608	52	2	were	be	AUX
iajs-3608	52	3	informed	inform	VERB
iajs-3608	52	4	of	of	ADP
iajs-3608	52	5	the	the	DET
iajs-3608	52	6	study	study	NOUN
iajs-3608	52	7	's	's	PART
iajs-3608	52	8	goals	goal	NOUN
iajs-3608	52	9	and	and	CCONJ
iajs-3608	52	10	advantages	advantage	NOUN
iajs-3608	52	11	,	,	PUNCT
iajs-3608	52	12	and	and	CCONJ
iajs-3608	52	13	they	they	PRON
iajs-3608	52	14	received	receive	VERB
iajs-3608	52	15	assurances	assurance	NOUN
iajs-3608	52	16	regarding	regard	VERB
iajs-3608	52	17	its	its	PRON
iajs-3608	52	18	risks	risk	NOUN
iajs-3608	52	19	and	and	CCONJ
iajs-3608	52	20	rewards	reward	NOUN
iajs-3608	52	21	.	.	PUNCT
iajs-3608	53	1	each	each	DET
iajs-3608	53	2	patient	patient	NOUN
iajs-3608	53	3	was	be	AUX
iajs-3608	53	4	asked	ask	VERB
iajs-3608	53	5	to	to	PART
iajs-3608	53	6	fill	fill	VERB
iajs-3608	53	7	ihjpas	ihjpa	NOUN
iajs-3608	53	8	.	.	PUNCT
iajs-3608	54	1	2025	2025	NUM
iajs-3608	54	2	,	,	PUNCT
iajs-3608	54	3	38(4	38(4	NUM
iajs-3608	54	4	)	)	PUNCT
iajs-3608	54	5	12	12	NUM
iajs-3608	54	6	out	out	ADP
iajs-3608	54	7	a	a	DET
iajs-3608	54	8	questionnaire	questionnaire	NOUN
iajs-3608	54	9	that	that	PRON
iajs-3608	54	10	included	include	VERB
iajs-3608	54	11	general	general	ADJ
iajs-3608	54	12	and	and	CCONJ
iajs-3608	54	13	specific	specific	ADJ
iajs-3608	54	14	information	information	NOUN
iajs-3608	54	15	and	and	CCONJ
iajs-3608	54	16	if	if	SCONJ
iajs-3608	54	17	they	they	PRON
iajs-3608	54	18	were	be	AUX
iajs-3608	54	19	in	in	ADP
iajs-3608	54	20	agreement	agreement	NOUN
iajs-3608	54	21	.	.	PUNCT
iajs-3608	55	1	2.1.immunological	2.1.immunological	NUM
iajs-3608	55	2	detection	detection	NOUN
iajs-3608	55	3	of	of	ADP
iajs-3608	55	4	mmp-2	mmp-2	NUM
iajs-3608	55	5	and	and	CCONJ
iajs-3608	55	6	mmp-9	mmp-9	NOUN
iajs-3608	55	7	by	by	ADP
iajs-3608	55	8	elisa	elisa	NOUN
iajs-3608	55	9	procedure	procedure	NOUN
iajs-3608	55	10	soluble	soluble	ADJ
iajs-3608	55	11	mmp-2	mmp-2	PUNCT
iajs-3608	55	12	(	(	PUNCT
iajs-3608	55	13	catalogue	catalogue	NOUN
iajs-3608	55	14	no	no	INTJ
iajs-3608	55	15	.	.	PUNCT
iajs-3608	56	1	sl	sl	PROPN
iajs-3608	56	2	1151hu-1	1151hu-1	NUM
iajs-3608	56	3	)	)	PUNCT
iajs-3608	56	4	,	,	PUNCT
iajs-3608	56	5	mmp-9	mmp-9	NOUN
iajs-3608	56	6	(	(	PUNCT
iajs-3608	56	7	catalogue	catalogue	NOUN
iajs-3608	56	8	no	no	INTJ
iajs-3608	56	9	.	.	PUNCT
iajs-3608	57	1	sl	sl	PROPN
iajs-3608	57	2	1157hu	1157hu	NOUN
iajs-3608	57	3	)	)	PUNCT
iajs-3608	57	4	,	,	PUNCT
iajs-3608	57	5	and	and	CCONJ
iajs-3608	57	6	four	four	NUM
iajs-3608	57	7	kits	kit	NOUN
iajs-3608	57	8	were	be	AUX
iajs-3608	57	9	used	use	VERB
iajs-3608	57	10	in	in	ADP
iajs-3608	57	11	the	the	DET
iajs-3608	57	12	study	study	NOUN
iajs-3608	57	13	to	to	PART
iajs-3608	57	14	measure	measure	VERB
iajs-3608	57	15	levels	level	NOUN
iajs-3608	57	16	in	in	ADP
iajs-3608	57	17	both	both	CCONJ
iajs-3608	57	18	serum	serum	NOUN
iajs-3608	57	19	and	and	CCONJ
iajs-3608	57	20	urine	urine	NOUN
iajs-3608	57	21	based	base	VERB
iajs-3608	57	22	on	on	ADP
iajs-3608	57	23	the	the	DET
iajs-3608	57	24	principle	principle	NOUN
iajs-3608	57	25	of	of	ADP
iajs-3608	57	26	the	the	DET
iajs-3608	57	27	sandwich	sandwich	NOUN
iajs-3608	57	28	,	,	PUNCT
iajs-3608	57	29	quantitative	quantitative	ADJ
iajs-3608	57	30	human	human	ADJ
iajs-3608	57	31	enzyme	enzyme	NOUN
iajs-3608	57	32	-	-	PUNCT
iajs-3608	57	33	linked	link	VERB
iajs-3608	57	34	immunosorbent	immunosorbent	NOUN
iajs-3608	57	35	assay	assay	NOUN
iajs-3608	57	36	kit	kit	NOUN
iajs-3608	57	37	according	accord	VERB
iajs-3608	57	38	to	to	ADP
iajs-3608	57	39	the	the	DET
iajs-3608	57	40	manufacturing	manufacture	VERB
iajs-3608	57	41	company	company	NOUN
iajs-3608	57	42	(	(	PUNCT
iajs-3608	57	43	sunlong	sunlong	PROPN
iajs-3608	57	44	biotech	biotech	PROPN
iajs-3608	57	45	co.	co.	PROPN
iajs-3608	57	46	,	,	PUNCT
iajs-3608	57	47	ltd	ltd	PROPN
iajs-3608	57	48	)	)	PUNCT
iajs-3608	57	49	.	.	PUNCT
iajs-3608	58	1	2.2the	2.2the	DET
iajs-3608	58	2	statistical	statistical	ADJ
iajs-3608	58	3	analysis	analysis	NOUN
iajs-3608	58	4	the	the	DET
iajs-3608	58	5	statistical	statistical	ADJ
iajs-3608	58	6	analysis	analysis	NOUN
iajs-3608	58	7	system	system	NOUN
iajs-3608	58	8	(	(	PUNCT
iajs-3608	58	9	sas	sas	PROPN
iajs-3608	58	10	)	)	PUNCT
iajs-3608	58	11	(	(	PUNCT
iajs-3608	58	12	2018	2018	NUM
iajs-3608	58	13	)	)	PUNCT
iajs-3608	58	14	was	be	AUX
iajs-3608	58	15	used	use	VERB
iajs-3608	58	16	to	to	PART
iajs-3608	58	17	detect	detect	VERB
iajs-3608	58	18	the	the	DET
iajs-3608	58	19	effect	effect	NOUN
iajs-3608	58	20	of	of	ADP
iajs-3608	58	21	different	different	ADJ
iajs-3608	58	22	factors	factor	NOUN
iajs-3608	58	23	in	in	ADP
iajs-3608	58	24	study	study	NOUN
iajs-3608	58	25	parameters	parameter	NOUN
iajs-3608	58	26	and	and	CCONJ
iajs-3608	58	27	quantitative	quantitative	ADJ
iajs-3608	58	28	characteristics	characteristic	NOUN
iajs-3608	58	29	,	,	PUNCT
iajs-3608	58	30	including	include	VERB
iajs-3608	58	31	age	age	NOUN
iajs-3608	58	32	,	,	PUNCT
iajs-3608	58	33	disease	disease	NOUN
iajs-3608	58	34	,	,	PUNCT
iajs-3608	58	35	and	and	CCONJ
iajs-3608	58	36	dialysis	dialysis	NOUN
iajs-3608	58	37	duration	duration	NOUN
iajs-3608	58	38	;	;	PUNCT
iajs-3608	58	39	the	the	DET
iajs-3608	58	40	mean	mean	NOUN
iajs-3608	58	41	and	and	CCONJ
iajs-3608	58	42	standard	standard	NOUN
iajs-3608	58	43	were	be	AUX
iajs-3608	58	44	calculated	calculate	VERB
iajs-3608	58	45	.	.	PUNCT
iajs-3608	59	1	to	to	PART
iajs-3608	59	2	make	make	VERB
iajs-3608	59	3	a	a	DET
iajs-3608	59	4	meaningful	meaningful	ADJ
iajs-3608	59	5	comparison	comparison	NOUN
iajs-3608	59	6	between	between	ADP
iajs-3608	59	7	means	mean	NOUN
iajs-3608	59	8	,	,	PUNCT
iajs-3608	59	9	a	a	DET
iajs-3608	59	10	t	t	NOUN
iajs-3608	59	11	-	-	PUNCT
iajs-3608	59	12	test	test	NOUN
iajs-3608	59	13	was	be	AUX
iajs-3608	59	14	performed	perform	VERB
iajs-3608	59	15	.	.	PUNCT
iajs-3608	60	1	in	in	ADP
iajs-3608	60	2	this	this	DET
iajs-3608	60	3	study	study	NOUN
iajs-3608	60	4	,	,	PUNCT
iajs-3608	60	5	we	we	PRON
iajs-3608	60	6	used	use	VERB
iajs-3608	60	7	the	the	DET
iajs-3608	60	8	chi	chi	ADJ
iajs-3608	60	9	-	-	PUNCT
iajs-3608	60	10	square	square	ADJ
iajs-3608	60	11	test	test	NOUN
iajs-3608	60	12	to	to	PART
iajs-3608	60	13	compare	compare	VERB
iajs-3608	60	14	percentages	percentage	NOUN
iajs-3608	60	15	at	at	ADP
iajs-3608	60	16	0.05	0.05	NUM
iajs-3608	60	17	and	and	CCONJ
iajs-3608	60	18	0.01	0.01	NUM
iajs-3608	60	19	probability	probability	NOUN
iajs-3608	60	20	levels	level	NOUN
iajs-3608	60	21	.	.	PUNCT
iajs-3608	61	1	tables	table	NOUN
iajs-3608	61	2	and	and	CCONJ
iajs-3608	61	3	graphs	graph	NOUN
iajs-3608	61	4	were	be	AUX
iajs-3608	61	5	used	use	VERB
iajs-3608	61	6	to	to	PART
iajs-3608	61	7	display	display	VERB
iajs-3608	61	8	each	each	DET
iajs-3608	61	9	outcome	outcome	NOUN
iajs-3608	61	10	(	(	PUNCT
iajs-3608	61	11	13	13	NUM
iajs-3608	61	12	)	)	PUNCT
iajs-3608	61	13	.	.	PUNCT
iajs-3608	62	1	3.results	3.results	NUM
iajs-3608	63	1	3.1.distribution	3.1.distribution	NUM
iajs-3608	63	2	of	of	ADP
iajs-3608	63	3	sample	sample	NOUN
iajs-3608	63	4	study	study	NOUN
iajs-3608	63	5	according	accord	VERB
iajs-3608	63	6	to	to	ADP
iajs-3608	63	7	age	age	NOUN
iajs-3608	63	8	groups	group	NOUN
iajs-3608	63	9	in	in	ADP
iajs-3608	63	10	patients	patient	NOUN
iajs-3608	63	11	and	and	CCONJ
iajs-3608	63	12	control	control	VERB
iajs-3608	63	13	a	a	DET
iajs-3608	63	14	total	total	NOUN
iajs-3608	63	15	of	of	ADP
iajs-3608	63	16	60	60	NUM
iajs-3608	63	17	individuals	individual	NOUN
iajs-3608	63	18	with	with	ADP
iajs-3608	63	19	crf	crf	PROPN
iajs-3608	63	20	were	be	AUX
iajs-3608	63	21	divided	divide	VERB
iajs-3608	63	22	into	into	ADP
iajs-3608	63	23	three	three	NUM
iajs-3608	63	24	groups	group	NOUN
iajs-3608	63	25	.	.	PUNCT
iajs-3608	64	1	group	group	NOUN
iajs-3608	64	2	1	1	NUM
iajs-3608	64	3	contained	contain	VERB
iajs-3608	64	4	any	any	DET
iajs-3608	64	5	patient	patient	NOUN
iajs-3608	64	6	under	under	ADP
iajs-3608	64	7	the	the	DET
iajs-3608	64	8	age	age	NOUN
iajs-3608	64	9	of	of	ADP
iajs-3608	64	10	40	40	NUM
iajs-3608	64	11	,	,	PUNCT
iajs-3608	64	12	which	which	PRON
iajs-3608	64	13	included	include	VERB
iajs-3608	64	14	12	12	NUM
iajs-3608	64	15	individuals	individual	NOUN
iajs-3608	64	16	,	,	PUNCT
iajs-3608	64	17	accounting	account	VERB
iajs-3608	64	18	for	for	ADP
iajs-3608	64	19	20	20	NUM
iajs-3608	64	20	%	%	NOUN
iajs-3608	64	21	of	of	ADP
iajs-3608	64	22	all	all	DET
iajs-3608	64	23	samples	sample	NOUN
iajs-3608	64	24	.	.	PUNCT
iajs-3608	65	1	group	group	NOUN
iajs-3608	65	2	2	2	NUM
iajs-3608	65	3	included	include	VERB
iajs-3608	65	4	all	all	DET
iajs-3608	65	5	crf	crf	NOUN
iajs-3608	65	6	patients	patient	NOUN
iajs-3608	65	7	ranging	range	VERB
iajs-3608	65	8	in	in	ADP
iajs-3608	65	9	age	age	NOUN
iajs-3608	65	10	from	from	ADP
iajs-3608	65	11	41	41	NUM
iajs-3608	65	12	to	to	PART
iajs-3608	65	13	60	60	NUM
iajs-3608	65	14	years	year	NOUN
iajs-3608	65	15	.	.	PUNCT
iajs-3608	66	1	this	this	DET
iajs-3608	66	2	group	group	NOUN
iajs-3608	66	3	had	have	VERB
iajs-3608	66	4	33	33	NUM
iajs-3608	66	5	patients	patient	NOUN
iajs-3608	66	6	,	,	PUNCT
iajs-3608	66	7	accounting	account	VERB
iajs-3608	66	8	for	for	ADP
iajs-3608	66	9	(	(	PUNCT
iajs-3608	66	10	55	55	NUM
iajs-3608	66	11	%	%	NOUN
iajs-3608	66	12	)	)	PUNCT
iajs-3608	66	13	of	of	ADP
iajs-3608	66	14	the	the	DET
iajs-3608	66	15	samples	sample	NOUN
iajs-3608	66	16	.	.	PUNCT
iajs-3608	67	1	group	group	NOUN
iajs-3608	67	2	3	3	NUM
iajs-3608	67	3	included	include	VERB
iajs-3608	67	4	the	the	DET
iajs-3608	67	5	remaining	remain	VERB
iajs-3608	67	6	ages	age	NOUN
iajs-3608	67	7	,	,	PUNCT
iajs-3608	67	8	which	which	PRON
iajs-3608	67	9	included	include	VERB
iajs-3608	67	10	people	people	NOUN
iajs-3608	67	11	beyond	beyond	ADP
iajs-3608	67	12	the	the	DET
iajs-3608	67	13	age	age	NOUN
iajs-3608	67	14	of	of	ADP
iajs-3608	67	15	60	60	NUM
iajs-3608	67	16	.	.	PUNCT
iajs-3608	68	1	this	this	DET
iajs-3608	68	2	group	group	NOUN
iajs-3608	68	3	included	include	VERB
iajs-3608	68	4	15	15	NUM
iajs-3608	68	5	patients	patient	NOUN
iajs-3608	68	6	and	and	CCONJ
iajs-3608	68	7	accounted	account	VERB
iajs-3608	68	8	for	for	ADP
iajs-3608	68	9	25	25	NUM
iajs-3608	68	10	%	%	NOUN
iajs-3608	68	11	of	of	ADP
iajs-3608	68	12	the	the	DET
iajs-3608	68	13	total	total	ADJ
iajs-3608	68	14	samples	sample	NOUN
iajs-3608	68	15	.	.	PUNCT
iajs-3608	69	1	according	accord	VERB
iajs-3608	69	2	to	to	ADP
iajs-3608	69	3	the	the	DET
iajs-3608	69	4	statistical	statistical	ADJ
iajs-3608	69	5	analysis	analysis	NOUN
iajs-3608	69	6	,	,	PUNCT
iajs-3608	69	7	there	there	PRON
iajs-3608	69	8	was	be	VERB
iajs-3608	69	9	a	a	DET
iajs-3608	69	10	very	very	ADV
iajs-3608	69	11	significant	significant	ADJ
iajs-3608	69	12	difference	difference	NOUN
iajs-3608	69	13	between	between	ADP
iajs-3608	69	14	the	the	DET
iajs-3608	69	15	examined	examine	VERB
iajs-3608	69	16	groups	group	NOUN
iajs-3608	69	17	(	(	PUNCT
iajs-3608	69	18	p=0.0084	p=0.0084	PROPN
iajs-3608	69	19	)	)	PUNCT
iajs-3608	69	20	.	.	PUNCT
iajs-3608	70	1	the	the	DET
iajs-3608	70	2	age	age	NOUN
iajs-3608	70	3	range	range	NOUN
iajs-3608	70	4	of	of	ADP
iajs-3608	70	5	patients	patient	NOUN
iajs-3608	70	6	with	with	ADP
iajs-3608	70	7	crf	crf	PROPN
iajs-3608	70	8	was	be	AUX
iajs-3608	70	9	20–80	20–80	NUM
iajs-3608	70	10	years	year	NOUN
iajs-3608	70	11	,	,	PUNCT
iajs-3608	70	12	with	with	ADP
iajs-3608	70	13	a	a	DET
iajs-3608	70	14	mean	mean	NOUN
iajs-3608	70	15	of	of	ADP
iajs-3608	70	16	51.76	51.76	NUM
iajs-3608	70	17	±	±	NUM
iajs-3608	70	18	1.63	1.63	NUM
iajs-3608	70	19	,	,	PUNCT
iajs-3608	70	20	compared	compare	VERB
iajs-3608	70	21	to	to	ADP
iajs-3608	70	22	the	the	DET
iajs-3608	70	23	healthy	healthy	ADJ
iajs-3608	70	24	control	control	NOUN
iajs-3608	70	25	group	group	NOUN
iajs-3608	70	26	,	,	PUNCT
iajs-3608	70	27	which	which	PRON
iajs-3608	70	28	was	be	AUX
iajs-3608	70	29	almost	almost	ADV
iajs-3608	70	30	similar	similar	ADJ
iajs-3608	70	31	in	in	ADP
iajs-3608	70	32	age	age	NOUN
iajs-3608	70	33	,	,	PUNCT
iajs-3608	70	34	with	with	ADP
iajs-3608	70	35	a	a	DET
iajs-3608	70	36	mean	mean	NOUN
iajs-3608	70	37	of	of	ADP
iajs-3608	70	38	44.63	44.63	NUM
iajs-3608	70	39	±	±	NUM
iajs-3608	70	40	2.28	2.28	NUM
iajs-3608	70	41	;	;	PUNCT
iajs-3608	70	42	see	see	VERB
iajs-3608	70	43	figure	figure	NOUN
iajs-3608	70	44	1	1	NUM
iajs-3608	70	45	.	.	PUNCT
iajs-3608	70	46	figure	figure	NOUN
iajs-3608	70	47	1	1	NUM
iajs-3608	70	48	.	.	PUNCT
iajs-3608	70	49	comparison	comparison	NOUN
iajs-3608	70	50	between	between	ADP
iajs-3608	70	51	crf	crf	PROPN
iajs-3608	70	52	patients	patient	NOUN
iajs-3608	70	53	and	and	CCONJ
iajs-3608	70	54	control	control	NOUN
iajs-3608	70	55	groups	group	NOUN
iajs-3608	70	56	in	in	ADP
iajs-3608	70	57	age	age	NOUN
iajs-3608	70	58	.	.	PUNCT
iajs-3608	71	1	3.2.measurements	3.2.measurements	NUM
iajs-3608	71	2	of	of	ADP
iajs-3608	71	3	mmp-2	mmp-2	NUM
iajs-3608	71	4	and	and	CCONJ
iajs-3608	71	5	mmp-9	mmp-9	NOUN
iajs-3608	71	6	levels	level	NOUN
iajs-3608	71	7	3.2.1	3.2.1	NUM
iajs-3608	71	8	.	.	PUNCT
iajs-3608	72	1	comparison	comparison	NOUN
iajs-3608	72	2	between	between	ADP
iajs-3608	72	3	study	study	NOUN
iajs-3608	72	4	groups	group	NOUN
iajs-3608	72	5	in	in	ADP
iajs-3608	72	6	mmp-2	mmp-2	NUM
iajs-3608	72	7	in	in	ADP
iajs-3608	72	8	serum	serum	NOUN
iajs-3608	72	9	and	and	CCONJ
iajs-3608	72	10	urine	urine	NOUN
iajs-3608	72	11	mmp-2	mmp-2	PUNCT
iajs-3608	72	12	was	be	AUX
iajs-3608	72	13	found	find	VERB
iajs-3608	72	14	in	in	ADP
iajs-3608	72	15	all	all	PRON
iajs-3608	72	16	of	of	ADP
iajs-3608	72	17	the	the	DET
iajs-3608	72	18	control	control	NOUN
iajs-3608	72	19	group	group	NOUN
iajs-3608	72	20	's	's	PART
iajs-3608	72	21	sera	sera	NOUN
iajs-3608	72	22	and	and	CCONJ
iajs-3608	72	23	urine	urine	NOUN
iajs-3608	72	24	,	,	PUNCT
iajs-3608	72	25	with	with	ADP
iajs-3608	72	26	levels	level	NOUN
iajs-3608	72	27	ranging	range	VERB
iajs-3608	72	28	from	from	ADP
iajs-3608	72	29	0.74	0.74	NUM
iajs-3608	72	30	to	to	PART
iajs-3608	72	31	3.36	3.36	NUM
iajs-3608	72	32	ng	ng	NOUN
iajs-3608	72	33	/	/	SYM
iajs-3608	72	34	ml	ml	NOUN
iajs-3608	72	35	and	and	CCONJ
iajs-3608	72	36	levels	level	NOUN
iajs-3608	72	37	from	from	ADP
iajs-3608	72	38	0.33	0.33	NUM
iajs-3608	72	39	to	to	ADP
iajs-3608	72	40	2.66	2.66	NUM
iajs-3608	72	41	ng	ng	PROPN
iajs-3608	72	42	/	/	SYM
iajs-3608	72	43	ml	ml	PROPN
iajs-3608	72	44	,	,	PUNCT
iajs-3608	72	45	each	each	PRON
iajs-3608	72	46	,	,	PUNCT
iajs-3608	72	47	with	with	ADP
iajs-3608	72	48	a	a	DET
iajs-3608	72	49	mean	mean	NOUN
iajs-3608	72	50	of	of	ADP
iajs-3608	72	51	1.34	1.34	NUM
iajs-3608	72	52	±	±	NUM
iajs-3608	72	53	0.11	0.11	NUM
iajs-3608	72	54	ng	ng	PROPN
iajs-3608	72	55	/	/	SYM
iajs-3608	72	56	ml	ml	PROPN
iajs-3608	72	57	in	in	ADP
iajs-3608	72	58	sera	sera	NOUN
iajs-3608	72	59	and	and	CCONJ
iajs-3608	72	60	a	a	DET
iajs-3608	72	61	mean	mean	NOUN
iajs-3608	72	62	of	of	ADP
iajs-3608	72	63	0.975	0.975	NUM
iajs-3608	72	64	±	±	NUM
iajs-3608	72	65	0.12	0.12	NUM
iajs-3608	72	66	ng	ng	PROPN
iajs-3608	72	67	/	/	SYM
iajs-3608	72	68	ml	ml	X
iajs-3608	72	69	in	in	ADP
iajs-3608	72	70	urine	urine	NOUN
iajs-3608	72	71	,	,	PUNCT
iajs-3608	72	72	respectively	respectively	ADV
iajs-3608	72	73	.	.	PUNCT
iajs-3608	73	1	the	the	DET
iajs-3608	73	2	patient	patient	ADJ
iajs-3608	73	3	samples	sample	NOUN
iajs-3608	73	4	that	that	PRON
iajs-3608	73	5	surpassed	surpass	VERB
iajs-3608	73	6	the	the	DET
iajs-3608	73	7	cut	cut	NOUN
iajs-3608	73	8	-	-	PUNCT
iajs-3608	73	9	off	off	NOUN
iajs-3608	73	10	were	be	AUX
iajs-3608	73	11	considered	consider	VERB
iajs-3608	73	12	positive	positive	ADJ
iajs-3608	73	13	.	.	PUNCT
iajs-3608	74	1	levels	level	NOUN
iajs-3608	74	2	ranging	range	VERB
iajs-3608	74	3	from	from	ADP
iajs-3608	74	4	0.70	0.70	NUM
iajs-3608	74	5	to	to	ADP
iajs-3608	74	6	12.8	12.8	NUM
iajs-3608	74	7	ng	ng	NOUN
iajs-3608	74	8	/	/	SYM
iajs-3608	74	9	ml	ml	X
iajs-3608	74	10	in	in	ADP
iajs-3608	74	11	sera	sera	NOUN
iajs-3608	74	12	and	and	CCONJ
iajs-3608	74	13	levels	level	NOUN
iajs-3608	74	14	from	from	ADP
iajs-3608	74	15	0.26	0.26	NUM
iajs-3608	74	16	to	to	ADP
iajs-3608	74	17	24.9	24.9	NUM
iajs-3608	74	18	ng	ng	NOUN
iajs-3608	74	19	/	/	SYM
iajs-3608	74	20	ml	ml	X
iajs-3608	74	21	in	in	ADP
iajs-3608	74	22	urine	urine	NOUN
iajs-3608	74	23	,	,	PUNCT
iajs-3608	74	24	each	each	PRON
iajs-3608	74	25	with	with	ADP
iajs-3608	74	26	a	a	DET
iajs-3608	74	27	mean	mean	NOUN
iajs-3608	74	28	of	of	ADP
iajs-3608	74	29	2.88	2.88	NUM
iajs-3608	74	30	±0.38	±0.38	PROPN
iajs-3608	74	31	ng	ng	PROPN
iajs-3608	74	32	/	/	SYM
iajs-3608	74	33	ml	ml	PROPN
iajs-3608	74	34	in	in	ADP
iajs-3608	74	35	sera	sera	NOUN
iajs-3608	74	36	and	and	CCONJ
iajs-3608	74	37	a	a	DET
iajs-3608	74	38	mean	mean	NOUN
iajs-3608	74	39	of	of	ADP
iajs-3608	74	40	2.73	2.73	NUM
iajs-3608	74	41	±0.61	±0.61	NOUN
iajs-3608	74	42	ng	ng	PROPN
iajs-3608	74	43	/	/	SYM
iajs-3608	74	44	ml	ml	NOUN
iajs-3608	74	45	in	in	ADP
iajs-3608	74	46	urine	urine	NOUN
iajs-3608	74	47	,	,	PUNCT
iajs-3608	74	48	respectively	respectively	ADV
iajs-3608	74	49	,	,	PUNCT
iajs-3608	74	50	as	as	SCONJ
iajs-3608	74	51	shown	show	VERB
iajs-3608	74	52	in	in	ADP
iajs-3608	74	53	figures	figure	NOUN
iajs-3608	74	54	2	2	NUM
iajs-3608	74	55	and	and	CCONJ
iajs-3608	74	56	3	3	NUM
iajs-3608	74	57	.	.	NOUN
iajs-3608	74	58	40	40	NUM
iajs-3608	74	59	42	42	NUM
iajs-3608	74	60	44	44	NUM
iajs-3608	74	61	46	46	NUM
iajs-3608	74	62	48	48	NUM
iajs-3608	74	63	50	50	NUM
iajs-3608	74	64	52	52	NUM
iajs-3608	74	65	patients	patient	NOUN
iajs-3608	74	66	control	control	VERB
iajs-3608	74	67	51.76	51.76	NUM
iajs-3608	74	68	44.63	44.63	NUM
iajs-3608	74	69	a	a	DET
iajs-3608	74	70	g	g	PROPN
iajs-3608	74	71	e	e	X
iajs-3608	74	72	(	(	PUNCT
iajs-3608	74	73	y	y	PROPN
iajs-3608	74	74	ea	ea	PROPN
iajs-3608	74	75	r	r	NOUN
iajs-3608	74	76	)	)	PUNCT
iajs-3608	74	77	ihjpas	ihjpa	NOUN
iajs-3608	74	78	.	.	PUNCT
iajs-3608	75	1	2025	2025	NUM
iajs-3608	75	2	,	,	PUNCT
iajs-3608	75	3	38(4	38(4	NUM
iajs-3608	75	4	)	)	PUNCT
iajs-3608	75	5	13	13	NUM
iajs-3608	75	6	figure	figure	NOUN
iajs-3608	75	7	2	2	NUM
iajs-3608	75	8	.	.	PUNCT
iajs-3608	75	9	comparison	comparison	NOUN
iajs-3608	75	10	between	between	ADP
iajs-3608	75	11	crf	crf	PROPN
iajs-3608	75	12	patients	patient	NOUN
iajs-3608	75	13	and	and	CCONJ
iajs-3608	75	14	control	control	NOUN
iajs-3608	75	15	groups	group	NOUN
iajs-3608	75	16	in	in	ADP
iajs-3608	75	17	serum	serum	PROPN
iajs-3608	75	18	mmp-2	mmp-2	PROPN
iajs-3608	75	19	.	.	PUNCT
iajs-3608	76	1	figure	figure	NOUN
iajs-3608	76	2	3	3	NUM
iajs-3608	76	3	.	.	PUNCT
iajs-3608	76	4	comparison	comparison	NOUN
iajs-3608	76	5	between	between	ADP
iajs-3608	76	6	crf	crf	PROPN
iajs-3608	76	7	patients	patient	NOUN
iajs-3608	76	8	and	and	CCONJ
iajs-3608	76	9	control	control	NOUN
iajs-3608	76	10	groups	group	NOUN
iajs-3608	76	11	in	in	ADP
iajs-3608	76	12	mmp-2	mmp-2	NUM
iajs-3608	76	13	in	in	ADP
iajs-3608	76	14	urine	urine	NOUN
iajs-3608	76	15	.	.	PUNCT
iajs-3608	77	1	3.2.2.comparison	3.2.2.comparison	NUM
iajs-3608	77	2	between	between	ADP
iajs-3608	77	3	study	study	NOUN
iajs-3608	77	4	groups	group	NOUN
iajs-3608	77	5	in	in	ADP
iajs-3608	77	6	mmp-9	mmp-9	NOUN
iajs-3608	77	7	in	in	ADP
iajs-3608	77	8	serum	serum	NOUN
iajs-3608	77	9	and	and	CCONJ
iajs-3608	77	10	urine	urine	NOUN
iajs-3608	77	11	mmp-9	mmp-9	NOUN
iajs-3608	77	12	was	be	AUX
iajs-3608	77	13	found	find	VERB
iajs-3608	77	14	in	in	ADP
iajs-3608	77	15	all	all	PRON
iajs-3608	77	16	of	of	ADP
iajs-3608	77	17	the	the	DET
iajs-3608	77	18	control	control	NOUN
iajs-3608	77	19	group	group	NOUN
iajs-3608	77	20	's	's	PART
iajs-3608	77	21	sera	sera	NOUN
iajs-3608	77	22	and	and	CCONJ
iajs-3608	77	23	urine	urine	NOUN
iajs-3608	77	24	,	,	PUNCT
iajs-3608	77	25	with	with	ADP
iajs-3608	77	26	levels	level	NOUN
iajs-3608	77	27	ranging	range	VERB
iajs-3608	77	28	from	from	ADP
iajs-3608	77	29	6.234	6.234	NUM
iajs-3608	77	30	to	to	ADP
iajs-3608	77	31	19.14	19.14	NUM
iajs-3608	77	32	ng	ng	PROPN
iajs-3608	77	33	/	/	SYM
iajs-3608	77	34	ml	ml	NOUN
iajs-3608	77	35	and	and	CCONJ
iajs-3608	77	36	levels	level	NOUN
iajs-3608	77	37	from	from	ADP
iajs-3608	77	38	10.005	10.005	NUM
iajs-3608	77	39	to	to	ADP
iajs-3608	77	40	15.455	15.455	NUM
iajs-3608	77	41	ng	ng	NOUN
iajs-3608	77	42	/	/	SYM
iajs-3608	77	43	ml	ml	PROPN
iajs-3608	77	44	,	,	PUNCT
iajs-3608	77	45	each	each	PRON
iajs-3608	77	46	,	,	PUNCT
iajs-3608	77	47	with	with	ADP
iajs-3608	77	48	a	a	DET
iajs-3608	77	49	mean	mean	NOUN
iajs-3608	77	50	of	of	ADP
iajs-3608	77	51	10.64	10.64	NUM
iajs-3608	77	52	±	±	NUM
iajs-3608	77	53	0.65	0.65	NUM
iajs-3608	77	54	ng	ng	PROPN
iajs-3608	77	55	/	/	SYM
iajs-3608	77	56	ml	ml	X
iajs-3608	77	57	in	in	ADP
iajs-3608	77	58	sera	sera	NOUN
iajs-3608	77	59	and	and	CCONJ
iajs-3608	77	60	a	a	DET
iajs-3608	77	61	mean	mean	NOUN
iajs-3608	77	62	of	of	ADP
iajs-3608	77	63	11.54	11.54	NUM
iajs-3608	77	64	±	±	NUM
iajs-3608	77	65	0.27	0.27	NUM
iajs-3608	77	66	ng	ng	PROPN
iajs-3608	77	67	/	/	SYM
iajs-3608	77	68	ml	ml	X
iajs-3608	77	69	in	in	ADP
iajs-3608	77	70	urine	urine	NOUN
iajs-3608	77	71	,	,	PUNCT
iajs-3608	77	72	respectively	respectively	ADV
iajs-3608	77	73	.	.	PUNCT
iajs-3608	78	1	compared	compare	VERB
iajs-3608	78	2	to	to	ADP
iajs-3608	78	3	positive	positive	ADJ
iajs-3608	78	4	patient	patient	NOUN
iajs-3608	78	5	samples	sample	NOUN
iajs-3608	78	6	,	,	PUNCT
iajs-3608	78	7	those	those	PRON
iajs-3608	78	8	with	with	ADP
iajs-3608	78	9	a	a	DET
iajs-3608	78	10	value	value	NOUN
iajs-3608	78	11	greater	great	ADJ
iajs-3608	78	12	than	than	ADP
iajs-3608	78	13	the	the	DET
iajs-3608	78	14	cut	cut	NOUN
iajs-3608	78	15	-	-	PUNCT
iajs-3608	78	16	off	off	NOUN
iajs-3608	78	17	.	.	PUNCT
iajs-3608	79	1	levels	level	NOUN
iajs-3608	79	2	ranging	range	VERB
iajs-3608	79	3	from	from	ADP
iajs-3608	79	4	6.455	6.455	NUM
iajs-3608	79	5	to	to	ADP
iajs-3608	79	6	43.25	43.25	NUM
iajs-3608	79	7	ng	ng	NOUN
iajs-3608	79	8	/	/	SYM
iajs-3608	79	9	ml	ml	X
iajs-3608	79	10	in	in	ADP
iajs-3608	79	11	sera	sera	NOUN
iajs-3608	79	12	and	and	CCONJ
iajs-3608	79	13	levels	level	NOUN
iajs-3608	79	14	from	from	ADP
iajs-3608	79	15	10.395	10.395	NUM
iajs-3608	79	16	to	to	ADP
iajs-3608	79	17	63.185	63.185	NUM
iajs-3608	79	18	ng	ng	PROPN
iajs-3608	79	19	/	/	SYM
iajs-3608	79	20	ml	ml	NOUN
iajs-3608	79	21	in	in	ADP
iajs-3608	79	22	urine	urine	NOUN
iajs-3608	79	23	,	,	PUNCT
iajs-3608	79	24	each	each	PRON
iajs-3608	79	25	with	with	ADP
iajs-3608	79	26	a	a	DET
iajs-3608	79	27	mean	mean	NOUN
iajs-3608	79	28	of	of	ADP
iajs-3608	79	29	17.09	17.09	NUM
iajs-3608	79	30	±	±	NUM
iajs-3608	79	31	1.24	1.24	NUM
iajs-3608	79	32	ng	ng	PROPN
iajs-3608	79	33	/	/	SYM
iajs-3608	79	34	ml	ml	X
iajs-3608	79	35	in	in	ADP
iajs-3608	79	36	sera	sera	NOUN
iajs-3608	79	37	and	and	CCONJ
iajs-3608	79	38	a	a	DET
iajs-3608	79	39	mean	mean	NOUN
iajs-3608	79	40	of	of	ADP
iajs-3608	79	41	21.91	21.91	NUM
iajs-3608	79	42	±	±	NUM
iajs-3608	79	43	2.12	2.12	NUM
iajs-3608	79	44	ng	ng	PROPN
iajs-3608	79	45	/	/	SYM
iajs-3608	79	46	ml	ml	NOUN
iajs-3608	79	47	in	in	ADP
iajs-3608	79	48	urine	urine	NOUN
iajs-3608	79	49	,	,	PUNCT
iajs-3608	79	50	respectively	respectively	ADV
iajs-3608	79	51	,	,	PUNCT
iajs-3608	79	52	as	as	SCONJ
iajs-3608	79	53	shown	show	VERB
iajs-3608	79	54	in	in	ADP
iajs-3608	79	55	figures	figure	NOUN
iajs-3608	79	56	4	4	NUM
iajs-3608	79	57	and	and	CCONJ
iajs-3608	79	58	5	5	NUM
iajs-3608	79	59	.	.	X
iajs-3608	79	60	figure	figure	VERB
iajs-3608	79	61	4	4	NUM
iajs-3608	79	62	.	.	PUNCT
iajs-3608	79	63	comparison	comparison	NOUN
iajs-3608	79	64	between	between	ADP
iajs-3608	79	65	crf	crf	PROPN
iajs-3608	79	66	patients	patient	NOUN
iajs-3608	79	67	and	and	CCONJ
iajs-3608	79	68	control	control	NOUN
iajs-3608	79	69	groups	group	NOUN
iajs-3608	79	70	in	in	ADP
iajs-3608	79	71	serum	serum	NOUN
iajs-3608	79	72	mmp-9	mmp-9	NOUN
iajs-3608	79	73	.	.	PUNCT
iajs-3608	80	1	0	0	NUM
iajs-3608	80	2	0.5	0.5	NUM
iajs-3608	80	3	1	1	NUM
iajs-3608	80	4	1.5	1.5	NUM
iajs-3608	80	5	2	2	NUM
iajs-3608	80	6	2.5	2.5	NUM
iajs-3608	80	7	3	3	NUM
iajs-3608	80	8	patients	patient	NOUN
iajs-3608	80	9	control	control	VERB
iajs-3608	80	10	2.88	2.88	NUM
iajs-3608	80	11	1.34	1.34	NUM
iajs-3608	80	12	m	m	NOUN
iajs-3608	80	13	m	m	VERB
iajs-3608	80	14	p	p	ADJ
iajs-3608	80	15	2	2	NUM
iajs-3608	80	16	s	s	PART
iajs-3608	80	17	er	er	INTJ
iajs-3608	80	18	u	u	NOUN
iajs-3608	80	19	m	m	NOUN
iajs-3608	80	20	(	(	PUNCT
iajs-3608	80	21	n	n	PRON
iajs-3608	80	22	g	g	NOUN
iajs-3608	80	23	/m	/m	X
iajs-3608	80	24	l	l	NOUN
iajs-3608	80	25	)	)	PUNCT
iajs-3608	80	26	0	0	NUM
iajs-3608	80	27	0.5	0.5	NUM
iajs-3608	80	28	1	1	NUM
iajs-3608	80	29	1.5	1.5	NUM
iajs-3608	80	30	2	2	NUM
iajs-3608	80	31	2.5	2.5	NUM
iajs-3608	80	32	3	3	NUM
iajs-3608	80	33	patients	patient	NOUN
iajs-3608	80	34	control	control	VERB
iajs-3608	80	35	2.73	2.73	NUM
iajs-3608	80	36	0.975	0.975	NUM
iajs-3608	80	37	m	m	VERB
iajs-3608	80	38	m	m	VERB
iajs-3608	80	39	p	p	ADJ
iajs-3608	80	40	2	2	NUM
iajs-3608	80	41	u	u	NOUN
iajs-3608	80	42	ri	ri	NOUN
iajs-3608	80	43	n	n	ADP
iajs-3608	80	44	e	e	X
iajs-3608	80	45	(	(	PUNCT
iajs-3608	80	46	n	n	CCONJ
iajs-3608	80	47	g	g	PROPN
iajs-3608	80	48	/m	/m	X
iajs-3608	80	49	l	l	NOUN
iajs-3608	80	50	)	)	PUNCT
iajs-3608	80	51	0	0	NUM
iajs-3608	80	52	2	2	NUM
iajs-3608	80	53	4	4	NUM
iajs-3608	80	54	6	6	NUM
iajs-3608	80	55	8	8	NUM
iajs-3608	80	56	10	10	NUM
iajs-3608	80	57	12	12	NUM
iajs-3608	80	58	14	14	NUM
iajs-3608	80	59	16	16	NUM
iajs-3608	80	60	18	18	NUM
iajs-3608	80	61	patients	patient	NOUN
iajs-3608	80	62	control	control	VERB
iajs-3608	80	63	17.09	17.09	NUM
iajs-3608	80	64	10.64	10.64	NUM
iajs-3608	80	65	m	m	NOUN
iajs-3608	80	66	m	m	VERB
iajs-3608	80	67	p	p	NOUN
iajs-3608	80	68	9	9	NUM
iajs-3608	80	69	s	s	PART
iajs-3608	80	70	er	er	INTJ
iajs-3608	80	71	u	u	NOUN
iajs-3608	80	72	m	m	NOUN
iajs-3608	80	73	(	(	PUNCT
iajs-3608	80	74	n	n	PRON
iajs-3608	80	75	g	g	NOUN
iajs-3608	80	76	/m	/m	SYM
iajs-3608	80	77	l	l	NOUN
iajs-3608	80	78	)	)	PUNCT
iajs-3608	80	79	ihjpas	ihjpas	PROPN
iajs-3608	80	80	.	.	PUNCT
iajs-3608	81	1	2025	2025	NUM
iajs-3608	81	2	,	,	PUNCT
iajs-3608	81	3	38(4	38(4	NUM
iajs-3608	81	4	)	)	PUNCT
iajs-3608	81	5	14	14	NUM
iajs-3608	81	6	figure	figure	NOUN
iajs-3608	81	7	5	5	NUM
iajs-3608	81	8	.	.	PUNCT
iajs-3608	81	9	comparison	comparison	NOUN
iajs-3608	81	10	between	between	ADP
iajs-3608	81	11	crf	crf	PROPN
iajs-3608	81	12	patients	patient	NOUN
iajs-3608	81	13	and	and	CCONJ
iajs-3608	81	14	control	control	NOUN
iajs-3608	81	15	groups	group	NOUN
iajs-3608	81	16	in	in	ADP
iajs-3608	81	17	mmp-9	mmp-9	NOUN
iajs-3608	81	18	in	in	ADP
iajs-3608	81	19	urine	urine	NOUN
iajs-3608	81	20	.	.	PUNCT
iajs-3608	82	1	4.discussion	4.discussion	NUM
iajs-3608	82	2	long	long	ADJ
iajs-3608	82	3	-	-	PUNCT
iajs-3608	82	4	term	term	NOUN
iajs-3608	82	5	kidney	kidney	NOUN
iajs-3608	82	6	disease	disease	NOUN
iajs-3608	82	7	(	(	PUNCT
iajs-3608	82	8	ckd	ckd	NOUN
iajs-3608	82	9	)	)	PUNCT
iajs-3608	82	10	is	be	AUX
iajs-3608	82	11	mostly	mostly	ADV
iajs-3608	82	12	caused	cause	VERB
iajs-3608	82	13	by	by	ADP
iajs-3608	82	14	diabetes	diabete	NOUN
iajs-3608	82	15	.	.	PUNCT
iajs-3608	83	1	ckd	ckd	PROPN
iajs-3608	83	2	is	be	AUX
iajs-3608	83	3	marked	mark	VERB
iajs-3608	83	4	by	by	ADP
iajs-3608	83	5	mesangial	mesangial	ADJ
iajs-3608	83	6	expansion	expansion	NOUN
iajs-3608	83	7	,	,	PUNCT
iajs-3608	83	8	glomerulosclerosis	glomerulosclerosis	NOUN
iajs-3608	83	9	,	,	PUNCT
iajs-3608	83	10	tubular	tubular	ADJ
iajs-3608	83	11	atrophy	atrophy	NOUN
iajs-3608	83	12	,	,	PUNCT
iajs-3608	83	13	and	and	CCONJ
iajs-3608	83	14	interstitial	interstitial	ADJ
iajs-3608	83	15	fibrosis	fibrosis	NOUN
iajs-3608	83	16	.	.	PUNCT
iajs-3608	84	1	it	it	PRON
iajs-3608	84	2	has	have	AUX
iajs-3608	84	3	been	be	AUX
iajs-3608	84	4	linked	link	VERB
iajs-3608	84	5	to	to	ADP
iajs-3608	84	6	fibrosis	fibrosis	NOUN
iajs-3608	84	7	that	that	SCONJ
iajs-3608	84	8	mmps	mmp	NOUN
iajs-3608	84	9	are	be	AUX
iajs-3608	84	10	overexpressed	overexpresse	VERB
iajs-3608	84	11	and	and	CCONJ
iajs-3608	84	12	can	can	AUX
iajs-3608	84	13	break	break	VERB
iajs-3608	84	14	down	down	ADP
iajs-3608	84	15	products	product	NOUN
iajs-3608	84	16	to	to	PART
iajs-3608	84	17	make	make	VERB
iajs-3608	84	18	endothelial	endothelial	ADJ
iajs-3608	84	19	membrane	membrane	NOUN
iajs-3608	84	20	transition	transition	NOUN
iajs-3608	84	21	(	(	PUNCT
iajs-3608	84	22	emt	emt	PROPN
iajs-3608	84	23	)	)	PUNCT
iajs-3608	84	24	.	.	PUNCT
iajs-3608	85	1	a	a	DET
iajs-3608	85	2	study	study	NOUN
iajs-3608	85	3	revealed	reveal	VERB
iajs-3608	85	4	that	that	SCONJ
iajs-3608	85	5	the	the	DET
iajs-3608	85	6	frequency	frequency	NOUN
iajs-3608	85	7	of	of	ADP
iajs-3608	85	8	crf	crf	PROPN
iajs-3608	85	9	in	in	ADP
iajs-3608	85	10	children	child	NOUN
iajs-3608	85	11	starts	start	VERB
iajs-3608	85	12	at	at	ADP
iajs-3608	85	13	1	1	NUM
iajs-3608	85	14	%	%	NOUN
iajs-3608	85	15	,	,	PUNCT
iajs-3608	85	16	rapidly	rapidly	ADV
iajs-3608	85	17	increasing	increase	VERB
iajs-3608	85	18	to	to	ADP
iajs-3608	85	19	5	5	NUM
iajs-3608	85	20	%	%	NOUN
iajs-3608	85	21	by	by	ADP
iajs-3608	85	22	30	30	NUM
iajs-3608	85	23	years	year	NOUN
iajs-3608	85	24	and	and	CCONJ
iajs-3608	85	25	20	20	NUM
iajs-3608	85	26	%	%	NOUN
iajs-3608	85	27	by	by	ADP
iajs-3608	85	28	60	60	NUM
iajs-3608	85	29	years	year	NOUN
iajs-3608	85	30	(	(	PUNCT
iajs-3608	85	31	14	14	NUM
iajs-3608	85	32	)	)	PUNCT
iajs-3608	85	33	.	.	PUNCT
iajs-3608	86	1	another	another	DET
iajs-3608	86	2	study	study	NOUN
iajs-3608	86	3	conducted	conduct	VERB
iajs-3608	86	4	in	in	ADP
iajs-3608	86	5	2022	2022	NUM
iajs-3608	86	6	revealed	reveal	VERB
iajs-3608	86	7	that	that	SCONJ
iajs-3608	86	8	the	the	DET
iajs-3608	86	9	age	age	NOUN
iajs-3608	86	10	group	group	NOUN
iajs-3608	86	11	41	41	NUM
iajs-3608	86	12	-	-	SYM
iajs-3608	86	13	50	50	NUM
iajs-3608	86	14	years	year	NOUN
iajs-3608	86	15	had	have	VERB
iajs-3608	86	16	the	the	DET
iajs-3608	86	17	highest	high	ADJ
iajs-3608	86	18	incidence	incidence	NOUN
iajs-3608	86	19	of	of	ADP
iajs-3608	86	20	chronic	chronic	ADJ
iajs-3608	86	21	renal	renal	ADJ
iajs-3608	86	22	failure	failure	NOUN
iajs-3608	86	23	(	(	PUNCT
iajs-3608	86	24	26	26	NUM
iajs-3608	86	25	%	%	NOUN
iajs-3608	86	26	)	)	PUNCT
iajs-3608	86	27	,	,	PUNCT
iajs-3608	86	28	followed	follow	VERB
iajs-3608	86	29	by	by	ADP
iajs-3608	86	30	the	the	DET
iajs-3608	86	31	age	age	NOUN
iajs-3608	86	32	group	group	NOUN
iajs-3608	86	33	51	51	NUM
iajs-3608	86	34	-	-	SYM
iajs-3608	86	35	60	60	NUM
iajs-3608	86	36	years	year	NOUN
iajs-3608	86	37	(	(	PUNCT
iajs-3608	86	38	24	24	NUM
iajs-3608	86	39	%	%	NOUN
iajs-3608	86	40	)	)	PUNCT
iajs-3608	86	41	,	,	PUNCT
iajs-3608	86	42	and	and	CCONJ
iajs-3608	86	43	finally	finally	ADV
iajs-3608	86	44	,	,	PUNCT
iajs-3608	86	45	the	the	DET
iajs-3608	86	46	age	age	NOUN
iajs-3608	86	47	group	group	NOUN
iajs-3608	86	48	31	31	NUM
iajs-3608	86	49	-	-	SYM
iajs-3608	86	50	40	40	NUM
iajs-3608	86	51	years	year	NOUN
iajs-3608	86	52	(	(	PUNCT
iajs-3608	86	53	20	20	NUM
iajs-3608	86	54	%	%	NOUN
iajs-3608	86	55	)	)	PUNCT
iajs-3608	86	56	(	(	PUNCT
iajs-3608	86	57	15	15	NUM
iajs-3608	86	58	)	)	PUNCT
iajs-3608	86	59	.	.	PUNCT
iajs-3608	87	1	in	in	ADP
iajs-3608	87	2	this	this	DET
iajs-3608	87	3	case	case	NOUN
iajs-3608	87	4	,	,	PUNCT
iajs-3608	87	5	the	the	DET
iajs-3608	87	6	cause	cause	NOUN
iajs-3608	87	7	could	could	AUX
iajs-3608	87	8	potentially	potentially	ADV
iajs-3608	87	9	be	be	AUX
iajs-3608	87	10	damage	damage	NOUN
iajs-3608	87	11	to	to	ADP
iajs-3608	87	12	the	the	DET
iajs-3608	87	13	kidney	kidney	NOUN
iajs-3608	87	14	nephrons	nephron	NOUN
iajs-3608	87	15	.	.	PUNCT
iajs-3608	88	1	as	as	SCONJ
iajs-3608	88	2	nephrons	nephron	NOUN
iajs-3608	88	3	get	get	AUX
iajs-3608	88	4	injured	injure	VERB
iajs-3608	88	5	,	,	PUNCT
iajs-3608	88	6	they	they	PRON
iajs-3608	88	7	lose	lose	VERB
iajs-3608	88	8	their	their	PRON
iajs-3608	88	9	function	function	NOUN
iajs-3608	88	10	.	.	PUNCT
iajs-3608	89	1	if	if	SCONJ
iajs-3608	89	2	the	the	DET
iajs-3608	89	3	injury	injury	NOUN
iajs-3608	89	4	continues	continue	VERB
iajs-3608	89	5	,	,	PUNCT
iajs-3608	89	6	more	more	ADJ
iajs-3608	89	7	and	and	CCONJ
iajs-3608	89	8	more	more	ADJ
iajs-3608	89	9	nephrons	nephron	NOUN
iajs-3608	89	10	will	will	AUX
iajs-3608	89	11	die	die	VERB
iajs-3608	89	12	.	.	PUNCT
iajs-3608	90	1	and	and	CCONJ
iajs-3608	90	2	after	after	ADP
iajs-3608	90	3	a	a	DET
iajs-3608	90	4	certain	certain	ADJ
iajs-3608	90	5	age	age	NOUN
iajs-3608	90	6	,	,	PUNCT
iajs-3608	90	7	the	the	DET
iajs-3608	90	8	surviving	survive	VERB
iajs-3608	90	9	nephrons	nephron	NOUN
iajs-3608	90	10	are	be	AUX
iajs-3608	90	11	no	no	ADV
iajs-3608	90	12	longer	long	ADV
iajs-3608	90	13	capable	capable	ADJ
iajs-3608	90	14	of	of	ADP
iajs-3608	90	15	filtering	filter	VERB
iajs-3608	90	16	blood	blood	NOUN
iajs-3608	90	17	efficiently	efficiently	ADV
iajs-3608	90	18	enough	enough	ADV
iajs-3608	90	19	to	to	PART
iajs-3608	90	20	keep	keep	VERB
iajs-3608	90	21	the	the	DET
iajs-3608	90	22	body	body	NOUN
iajs-3608	90	23	healthy	healthy	ADJ
iajs-3608	90	24	.	.	PUNCT
iajs-3608	91	1	or	or	CCONJ
iajs-3608	91	2	because	because	SCONJ
iajs-3608	91	3	kidneys	kidney	NOUN
iajs-3608	91	4	are	be	AUX
iajs-3608	91	5	aging	age	VERB
iajs-3608	91	6	,	,	PUNCT
iajs-3608	91	7	kidney	kidney	NOUN
iajs-3608	91	8	function	function	NOUN
iajs-3608	91	9	appears	appear	VERB
iajs-3608	91	10	to	to	PART
iajs-3608	91	11	naturally	naturally	ADV
iajs-3608	91	12	decline	decline	VERB
iajs-3608	91	13	with	with	ADP
iajs-3608	91	14	age	age	NOUN
iajs-3608	91	15	.	.	PUNCT
iajs-3608	92	1	it	it	PRON
iajs-3608	92	2	especially	especially	ADV
iajs-3608	92	3	affects	affect	VERB
iajs-3608	92	4	those	those	DET
iajs-3608	92	5	people	people	NOUN
iajs-3608	92	6	who	who	PRON
iajs-3608	92	7	are	be	AUX
iajs-3608	92	8	aged	age	VERB
iajs-3608	92	9	75	75	NUM
iajs-3608	92	10	and	and	CCONJ
iajs-3608	92	11	more	more	ADJ
iajs-3608	92	12	(	(	PUNCT
iajs-3608	92	13	16	16	NUM
iajs-3608	92	14	)	)	PUNCT
iajs-3608	92	15	.	.	PUNCT
iajs-3608	93	1	the	the	DET
iajs-3608	93	2	current	current	ADJ
iajs-3608	93	3	study	study	NOUN
iajs-3608	93	4	found	find	VERB
iajs-3608	93	5	a	a	DET
iajs-3608	93	6	significant	significant	ADJ
iajs-3608	93	7	increase	increase	NOUN
iajs-3608	93	8	in	in	ADP
iajs-3608	93	9	mmp-2	mmp-2	DET
iajs-3608	93	10	concentration	concentration	NOUN
iajs-3608	93	11	levels	level	NOUN
iajs-3608	93	12	in	in	ADP
iajs-3608	93	13	sera	sera	NOUN
iajs-3608	93	14	compared	compare	VERB
iajs-3608	93	15	to	to	ADP
iajs-3608	93	16	control	control	NOUN
iajs-3608	93	17	levels	level	NOUN
iajs-3608	93	18	.	.	PUNCT
iajs-3608	94	1	the	the	DET
iajs-3608	94	2	majority	majority	NOUN
iajs-3608	94	3	of	of	ADP
iajs-3608	94	4	patients	patient	NOUN
iajs-3608	94	5	with	with	ADP
iajs-3608	94	6	diabetes	diabetes	NOUN
iajs-3608	94	7	and	and	CCONJ
iajs-3608	94	8	albuminuria	albuminuria	NOUN
iajs-3608	94	9	also	also	ADV
iajs-3608	94	10	had	have	AUX
iajs-3608	94	11	elevated	elevate	VERB
iajs-3608	94	12	mmp-2	mmp-2	PUNCT
iajs-3608	94	13	in	in	ADP
iajs-3608	94	14	their	their	PRON
iajs-3608	94	15	urine	urine	NOUN
iajs-3608	94	16	(	(	PUNCT
iajs-3608	94	17	17	17	NUM
iajs-3608	94	18	)	)	PUNCT
iajs-3608	94	19	.	.	PUNCT
iajs-3608	95	1	researchers	researcher	NOUN
iajs-3608	95	2	have	have	AUX
iajs-3608	95	3	also	also	ADV
iajs-3608	95	4	suggested	suggest	VERB
iajs-3608	95	5	that	that	SCONJ
iajs-3608	95	6	the	the	DET
iajs-3608	95	7	overexpression	overexpression	NOUN
iajs-3608	95	8	of	of	ADP
iajs-3608	95	9	mmp-2	mmp-2	PUNCT
iajs-3608	95	10	could	could	AUX
iajs-3608	95	11	lead	lead	VERB
iajs-3608	95	12	to	to	ADP
iajs-3608	95	13	the	the	DET
iajs-3608	95	14	development	development	NOUN
iajs-3608	95	15	of	of	ADP
iajs-3608	95	16	early	early	ADJ
iajs-3608	95	17	diabetic	diabetic	ADJ
iajs-3608	95	18	nephropathy	nephropathy	NOUN
iajs-3608	95	19	.	.	PUNCT
iajs-3608	96	1	researchers	researcher	NOUN
iajs-3608	96	2	found	find	VERB
iajs-3608	96	3	that	that	SCONJ
iajs-3608	96	4	25	25	NUM
iajs-3608	96	5	kidney	kidney	NOUN
iajs-3608	96	6	samples	sample	NOUN
iajs-3608	96	7	from	from	ADP
iajs-3608	96	8	patients	patient	NOUN
iajs-3608	96	9	with	with	ADP
iajs-3608	96	10	type	type	NOUN
iajs-3608	96	11	2	2	NUM
iajs-3608	96	12	diabetes	diabetes	NOUN
iajs-3608	96	13	had	have	VERB
iajs-3608	96	14	higher	high	ADJ
iajs-3608	96	15	mmp-2	mmp-2	ADJ
iajs-3608	96	16	expression	expression	NOUN
iajs-3608	96	17	than	than	ADP
iajs-3608	96	18	those	those	PRON
iajs-3608	96	19	from	from	ADP
iajs-3608	96	20	healthy	healthy	ADJ
iajs-3608	96	21	individuals	individual	NOUN
iajs-3608	96	22	(	(	PUNCT
iajs-3608	96	23	18	18	NUM
iajs-3608	96	24	)	)	PUNCT
iajs-3608	96	25	.	.	PUNCT
iajs-3608	97	1	a	a	DET
iajs-3608	97	2	study	study	NOUN
iajs-3608	97	3	observed	observe	VERB
iajs-3608	97	4	a	a	DET
iajs-3608	97	5	reduction	reduction	NOUN
iajs-3608	97	6	in	in	ADP
iajs-3608	97	7	renal	renal	ADJ
iajs-3608	97	8	mmp-2	mmp-2	PUNCT
iajs-3608	97	9	secretion	secretion	NOUN
iajs-3608	97	10	in	in	ADP
iajs-3608	97	11	the	the	DET
iajs-3608	97	12	kidney	kidney	NOUN
iajs-3608	97	13	tissues	tissue	NOUN
iajs-3608	97	14	of	of	ADP
iajs-3608	97	15	early	early	ADJ
iajs-3608	97	16	diabetic	diabetic	ADJ
iajs-3608	97	17	patients	patient	NOUN
iajs-3608	97	18	(	(	PUNCT
iajs-3608	97	19	19	19	NUM
iajs-3608	97	20	)	)	PUNCT
iajs-3608	97	21	.	.	PUNCT
iajs-3608	98	1	on	on	ADP
iajs-3608	98	2	the	the	DET
iajs-3608	98	3	other	other	ADJ
iajs-3608	98	4	hand	hand	NOUN
iajs-3608	98	5	,	,	PUNCT
iajs-3608	98	6	clinical	clinical	ADJ
iajs-3608	98	7	research	research	NOUN
iajs-3608	98	8	on	on	ADP
iajs-3608	98	9	human	human	ADJ
iajs-3608	98	10	urine	urine	NOUN
iajs-3608	98	11	revealed	reveal	VERB
iajs-3608	98	12	significantly	significantly	ADV
iajs-3608	98	13	higher	high	ADJ
iajs-3608	98	14	mmp	mmp	PROPN
iajs-3608	98	15	levels	level	NOUN
iajs-3608	98	16	in	in	ADP
iajs-3608	98	17	kidney	kidney	NOUN
iajs-3608	98	18	disease	disease	NOUN
iajs-3608	98	19	patients	patient	NOUN
iajs-3608	98	20	compared	compare	VERB
iajs-3608	98	21	to	to	ADP
iajs-3608	98	22	healthy	healthy	ADJ
iajs-3608	98	23	volunteers	volunteer	NOUN
iajs-3608	98	24	,	,	PUNCT
iajs-3608	98	25	and	and	CCONJ
iajs-3608	98	26	a	a	DET
iajs-3608	98	27	study	study	NOUN
iajs-3608	98	28	observed	observe	VERB
iajs-3608	98	29	increased	increase	VERB
iajs-3608	98	30	serum	serum	NOUN
iajs-3608	98	31	mmp-2	mmp-2	NUM
iajs-3608	98	32	levels	level	NOUN
iajs-3608	98	33	in	in	ADP
iajs-3608	98	34	patients	patient	NOUN
iajs-3608	98	35	with	with	ADP
iajs-3608	98	36	interstitial	interstitial	ADJ
iajs-3608	98	37	fibrosis	fibrosis	NOUN
iajs-3608	98	38	,	,	PUNCT
iajs-3608	98	39	kidney	kidney	NOUN
iajs-3608	98	40	transplants	transplant	NOUN
iajs-3608	98	41	,	,	PUNCT
iajs-3608	98	42	and	and	CCONJ
iajs-3608	98	43	progressive	progressive	ADJ
iajs-3608	98	44	kidney	kidney	NOUN
iajs-3608	98	45	fibrosis	fibrosis	NOUN
iajs-3608	98	46	(	(	PUNCT
iajs-3608	98	47	20	20	NUM
iajs-3608	98	48	)	)	PUNCT
iajs-3608	98	49	.	.	PUNCT
iajs-3608	99	1	mmp-2	mmp-2	X
iajs-3608	99	2	has	have	AUX
iajs-3608	99	3	been	be	AUX
iajs-3608	99	4	linked	link	VERB
iajs-3608	99	5	to	to	ADP
iajs-3608	99	6	the	the	DET
iajs-3608	99	7	development	development	NOUN
iajs-3608	99	8	of	of	ADP
iajs-3608	99	9	fibrosis	fibrosis	NOUN
iajs-3608	99	10	through	through	ADP
iajs-3608	99	11	stimulating	stimulate	VERB
iajs-3608	99	12	the	the	DET
iajs-3608	99	13	production	production	NOUN
iajs-3608	99	14	of	of	ADP
iajs-3608	99	15	fibroblast	fibroblast	ADJ
iajs-3608	99	16	growth	growth	NOUN
iajs-3608	99	17	factor	factor	NOUN
iajs-3608	99	18	(	(	PUNCT
iajs-3608	99	19	fgf	fgf	PROPN
iajs-3608	99	20	)	)	PUNCT
iajs-3608	99	21	.	.	PUNCT
iajs-3608	100	1	as	as	SCONJ
iajs-3608	100	2	ckd	ckd	PROPN
iajs-3608	100	3	develops	develop	VERB
iajs-3608	100	4	,	,	PUNCT
iajs-3608	100	5	renal	renal	ADJ
iajs-3608	100	6	interstitial	interstitial	ADJ
iajs-3608	100	7	fibrosis	fibrosis	NOUN
iajs-3608	100	8	decreases	decrease	VERB
iajs-3608	100	9	,	,	PUNCT
iajs-3608	100	10	preventing	prevent	VERB
iajs-3608	100	11	the	the	DET
iajs-3608	100	12	passage	passage	NOUN
iajs-3608	100	13	of	of	ADP
iajs-3608	100	14	oxygen	oxygen	NOUN
iajs-3608	100	15	and	and	CCONJ
iajs-3608	100	16	resulting	result	VERB
iajs-3608	100	17	in	in	ADP
iajs-3608	100	18	hypoxia	hypoxia	NOUN
iajs-3608	100	19	(	(	PUNCT
iajs-3608	100	20	11	11	NUM
iajs-3608	100	21	)	)	PUNCT
iajs-3608	100	22	.	.	PUNCT
iajs-3608	101	1	extracellular	extracellular	ADJ
iajs-3608	101	2	volume	volume	NOUN
iajs-3608	101	3	excess	excess	NOUN
iajs-3608	101	4	causes	cause	VERB
iajs-3608	101	5	interstitial	interstitial	ADJ
iajs-3608	101	6	fluid	fluid	ADJ
iajs-3608	101	7	space	space	NOUN
iajs-3608	101	8	hypoxia	hypoxia	NOUN
iajs-3608	101	9	and	and	CCONJ
iajs-3608	101	10	interstitial	interstitial	ADJ
iajs-3608	101	11	injury	injury	NOUN
iajs-3608	101	12	(	(	PUNCT
iajs-3608	101	13	21	21	NUM
iajs-3608	101	14	)	)	PUNCT
iajs-3608	101	15	.	.	PUNCT
iajs-3608	102	1	increased	increase	VERB
iajs-3608	102	2	mmp-2	mmp-2	NUM
iajs-3608	102	3	,	,	PUNCT
iajs-3608	102	4	one	one	NUM
iajs-3608	102	5	of	of	ADP
iajs-3608	102	6	numerous	numerous	ADJ
iajs-3608	102	7	biomarkers	biomarker	NOUN
iajs-3608	102	8	enhanced	enhance	VERB
iajs-3608	102	9	in	in	ADP
iajs-3608	102	10	circumstances	circumstance	NOUN
iajs-3608	102	11	characterized	characterize	VERB
iajs-3608	102	12	by	by	ADP
iajs-3608	102	13	increased	increase	VERB
iajs-3608	102	14	inflammation	inflammation	NOUN
iajs-3608	102	15	,	,	PUNCT
iajs-3608	102	16	is	be	AUX
iajs-3608	102	17	considered	consider	VERB
iajs-3608	102	18	to	to	PART
iajs-3608	102	19	represent	represent	VERB
iajs-3608	102	20	a	a	DET
iajs-3608	102	21	distinct	distinct	ADJ
iajs-3608	102	22	risk	risk	NOUN
iajs-3608	102	23	factor	factor	NOUN
iajs-3608	102	24	for	for	ADP
iajs-3608	102	25	the	the	DET
iajs-3608	102	26	development	development	NOUN
iajs-3608	102	27	of	of	ADP
iajs-3608	102	28	ckd	ckd	PROPN
iajs-3608	102	29	.	.	PUNCT
iajs-3608	103	1	in	in	ADP
iajs-3608	103	2	addition	addition	NOUN
iajs-3608	103	3	,	,	PUNCT
iajs-3608	103	4	it	it	PRON
iajs-3608	103	5	is	be	AUX
iajs-3608	103	6	possible	possible	ADJ
iajs-3608	103	7	that	that	SCONJ
iajs-3608	103	8	mmp-2	mmp-2	NUM
iajs-3608	103	9	and	and	CCONJ
iajs-3608	103	10	extracellular	extracellular	ADJ
iajs-3608	103	11	volume	volume	NOUN
iajs-3608	103	12	excess	excess	ADJ
iajs-3608	103	13	share	share	NOUN
iajs-3608	103	14	pathophysiological	pathophysiological	ADJ
iajs-3608	103	15	processes	process	NOUN
iajs-3608	103	16	in	in	ADP
iajs-3608	103	17	ckd	ckd	PROPN
iajs-3608	103	18	development	development	NOUN
iajs-3608	103	19	,	,	PUNCT
iajs-3608	103	20	such	such	ADJ
iajs-3608	103	21	as	as	ADP
iajs-3608	103	22	hypoxia	hypoxia	NOUN
iajs-3608	103	23	(	(	PUNCT
iajs-3608	103	24	22	22	NUM
iajs-3608	103	25	)	)	PUNCT
iajs-3608	103	26	.	.	PUNCT
iajs-3608	104	1	a	a	DET
iajs-3608	104	2	study	study	NOUN
iajs-3608	104	3	in	in	ADP
iajs-3608	104	4	2012	2012	NUM
iajs-3608	104	5	resulted	result	VERB
iajs-3608	104	6	in	in	ADP
iajs-3608	104	7	the	the	DET
iajs-3608	104	8	finding	finding	NOUN
iajs-3608	104	9	that	that	SCONJ
iajs-3608	104	10	,	,	PUNCT
iajs-3608	104	11	due	due	ADP
iajs-3608	104	12	to	to	ADP
iajs-3608	104	13	the	the	DET
iajs-3608	104	14	mmps	mmp	NOUN
iajs-3608	104	15	proteolytic	proteolytic	ADJ
iajs-3608	104	16	activity	activity	NOUN
iajs-3608	104	17	,	,	PUNCT
iajs-3608	104	18	it	it	PRON
iajs-3608	104	19	was	be	AUX
iajs-3608	104	20	found	find	VERB
iajs-3608	104	21	that	that	SCONJ
iajs-3608	104	22	it	it	PRON
iajs-3608	104	23	was	be	AUX
iajs-3608	104	24	much	much	ADV
iajs-3608	104	25	higher	high	ADJ
iajs-3608	104	26	in	in	ADP
iajs-3608	104	27	dkd	dkd	ADJ
iajs-3608	104	28	patients	patient	NOUN
iajs-3608	104	29	compared	compare	VERB
iajs-3608	104	30	to	to	ADP
iajs-3608	104	31	healthy	healthy	ADJ
iajs-3608	104	32	control	control	NOUN
iajs-3608	104	33	participants	participant	NOUN
iajs-3608	104	34	;	;	PUNCT
iajs-3608	104	35	urinary	urinary	ADJ
iajs-3608	104	36	mmp	mmp	PROPN
iajs-3608	104	37	activity	activity	NOUN
iajs-3608	104	38	was	be	AUX
iajs-3608	104	39	(	(	PUNCT
iajs-3608	104	40	94.5	94.5	NUM
iajs-3608	104	41	%	%	NOUN
iajs-3608	104	42	)	)	PUNCT
iajs-3608	104	43	in	in	ADP
iajs-3608	104	44	diabetic	diabetic	ADJ
iajs-3608	104	45	kidney	kidney	NOUN
iajs-3608	104	46	disease	disease	NOUN
iajs-3608	104	47	0	0	NUM
iajs-3608	104	48	5	5	NUM
iajs-3608	104	49	10	10	NUM
iajs-3608	104	50	15	15	NUM
iajs-3608	104	51	20	20	NUM
iajs-3608	104	52	25	25	NUM
iajs-3608	104	53	patients	patient	NOUN
iajs-3608	104	54	control	control	VERB
iajs-3608	104	55	21.91	21.91	NUM
iajs-3608	104	56	11.54	11.54	NUM
iajs-3608	104	57	m	m	NOUN
iajs-3608	104	58	m	m	VERB
iajs-3608	104	59	p	p	ADJ
iajs-3608	104	60	9	9	NUM
iajs-3608	104	61	u	u	NOUN
iajs-3608	104	62	ri	ri	PROPN
iajs-3608	104	63	n	n	ADP
iajs-3608	104	64	e	e	X
iajs-3608	104	65	(	(	PUNCT
iajs-3608	104	66	n	n	CCONJ
iajs-3608	104	67	g	g	PROPN
iajs-3608	104	68	/m	/m	SYM
iajs-3608	104	69	l	l	NOUN
iajs-3608	104	70	)	)	PUNCT
iajs-3608	104	71	ihjpas	ihjpas	PROPN
iajs-3608	104	72	.	.	PUNCT
iajs-3608	105	1	2025	2025	NUM
iajs-3608	105	2	,	,	PUNCT
iajs-3608	105	3	38(4	38(4	NUM
iajs-3608	105	4	)	)	PUNCT
iajs-3608	105	5	15	15	NUM
iajs-3608	105	6	patients	patient	NOUN
iajs-3608	105	7	(	(	PUNCT
iajs-3608	105	8	dkd	dkd	ADJ
iajs-3608	105	9	)	)	PUNCT
iajs-3608	105	10	,	,	PUNCT
iajs-3608	105	11	as	as	ADV
iajs-3608	105	12	well	well	ADV
iajs-3608	105	13	as	as	ADP
iajs-3608	105	14	(	(	PUNCT
iajs-3608	105	15	81.5	81.5	NUM
iajs-3608	105	16	%	%	NOUN
iajs-3608	105	17	)	)	PUNCT
iajs-3608	105	18	and	and	CCONJ
iajs-3608	105	19	(	(	PUNCT
iajs-3608	105	20	70	70	NUM
iajs-3608	105	21	%	%	NOUN
iajs-3608	105	22	)	)	PUNCT
iajs-3608	105	23	in	in	ADP
iajs-3608	105	24	diabetic	diabetic	ADJ
iajs-3608	105	25	controls	control	NOUN
iajs-3608	105	26	and	and	CCONJ
iajs-3608	105	27	healthy	healthy	ADJ
iajs-3608	105	28	volunteers	volunteer	NOUN
iajs-3608	105	29	,	,	PUNCT
iajs-3608	105	30	respectively	respectively	ADV
iajs-3608	105	31	.	.	PUNCT
iajs-3608	106	1	this	this	PRON
iajs-3608	106	2	contrasts	contrast	VERB
iajs-3608	106	3	with	with	ADP
iajs-3608	106	4	previous	previous	ADJ
iajs-3608	106	5	findings	finding	NOUN
iajs-3608	106	6	in	in	ADP
iajs-3608	106	7	renal	renal	ADJ
iajs-3608	106	8	tissue	tissue	NOUN
iajs-3608	106	9	,	,	PUNCT
iajs-3608	106	10	where	where	SCONJ
iajs-3608	106	11	decreased	decrease	VERB
iajs-3608	106	12	mmp	mmp	PROPN
iajs-3608	106	13	activity	activity	NOUN
iajs-3608	106	14	has	have	AUX
iajs-3608	106	15	been	be	AUX
iajs-3608	106	16	linked	link	VERB
iajs-3608	106	17	to	to	ADP
iajs-3608	106	18	ckd	ckd	PROPN
iajs-3608	106	19	scarring	scarring	NOUN
iajs-3608	106	20	and	and	CCONJ
iajs-3608	106	21	fibrosis	fibrosis	NOUN
iajs-3608	106	22	(	(	PUNCT
iajs-3608	106	23	23	23	NUM
iajs-3608	106	24	)	)	PUNCT
iajs-3608	106	25	.	.	PUNCT
iajs-3608	107	1	polycystic	polycystic	ADJ
iajs-3608	107	2	kidney	kidney	NOUN
iajs-3608	107	3	disease	disease	NOUN
iajs-3608	107	4	(	(	PUNCT
iajs-3608	107	5	pkd	pkd	PROPN
iajs-3608	107	6	)	)	PUNCT
iajs-3608	107	7	is	be	AUX
iajs-3608	107	8	the	the	DET
iajs-3608	107	9	most	most	ADV
iajs-3608	107	10	prevalent	prevalent	ADJ
iajs-3608	107	11	hereditary	hereditary	ADJ
iajs-3608	107	12	kidney	kidney	NOUN
iajs-3608	107	13	illness	illness	NOUN
iajs-3608	107	14	.	.	PUNCT
iajs-3608	108	1	a	a	DET
iajs-3608	108	2	study	study	NOUN
iajs-3608	108	3	revealed	reveal	VERB
iajs-3608	108	4	a	a	DET
iajs-3608	108	5	connection	connection	NOUN
iajs-3608	108	6	between	between	ADP
iajs-3608	108	7	mmp	mmp	PROPN
iajs-3608	108	8	dysregulation	dysregulation	NOUN
iajs-3608	108	9	and	and	CCONJ
iajs-3608	108	10	pkd	pkd	PROPN
iajs-3608	108	11	.	.	PROPN
iajs-3608	109	1	serum	serum	PROPN
iajs-3608	109	2	levels	level	NOUN
iajs-3608	109	3	of	of	ADP
iajs-3608	109	4	timp-1	timp-1	NUM
iajs-3608	109	5	,	,	PUNCT
iajs-3608	109	6	mmp-9	mmp-9	NOUN
iajs-3608	109	7	,	,	PUNCT
iajs-3608	109	8	and	and	CCONJ
iajs-3608	109	9	type	type	NOUN
iajs-3608	109	10	iv	iv	NUM
iajs-3608	109	11	collagen	collagen	NOUN
iajs-3608	109	12	(	(	PUNCT
iajs-3608	109	13	which	which	DET
iajs-3608	109	14	mmp-9	mmp-9	NOUN
iajs-3608	109	15	targets	target	NOUN
iajs-3608	109	16	)	)	PUNCT
iajs-3608	109	17	are	be	AUX
iajs-3608	109	18	higher	high	ADJ
iajs-3608	109	19	in	in	ADP
iajs-3608	109	20	people	people	NOUN
iajs-3608	109	21	with	with	ADP
iajs-3608	109	22	pkd	pkd	NOUN
iajs-3608	109	23	than	than	ADP
iajs-3608	109	24	in	in	ADP
iajs-3608	109	25	healthy	healthy	ADJ
iajs-3608	109	26	people	people	NOUN
iajs-3608	109	27	(	(	PUNCT
iajs-3608	109	28	24	24	NUM
iajs-3608	109	29	)	)	PUNCT
iajs-3608	109	30	.	.	PUNCT
iajs-3608	110	1	findings	finding	NOUN
iajs-3608	110	2	from	from	ADP
iajs-3608	110	3	a	a	DET
iajs-3608	110	4	study	study	NOUN
iajs-3608	110	5	done	do	VERB
iajs-3608	110	6	in	in	ADP
iajs-3608	110	7	2011	2011	NUM
iajs-3608	110	8	showed	show	VERB
iajs-3608	110	9	that	that	SCONJ
iajs-3608	110	10	mmp-9	mmp-9	NOUN
iajs-3608	110	11	seems	seem	VERB
iajs-3608	110	12	to	to	PART
iajs-3608	110	13	play	play	VERB
iajs-3608	110	14	a	a	DET
iajs-3608	110	15	part	part	NOUN
iajs-3608	110	16	in	in	ADP
iajs-3608	110	17	spreading	spread	VERB
iajs-3608	110	18	inflammation	inflammation	NOUN
iajs-3608	110	19	by	by	ADP
iajs-3608	110	20	creating	create	VERB
iajs-3608	110	21	collagen	collagen	NOUN
iajs-3608	110	22	fragments	fragment	NOUN
iajs-3608	110	23	that	that	PRON
iajs-3608	110	24	attract	attract	VERB
iajs-3608	110	25	neutrophils	neutrophil	NOUN
iajs-3608	110	26	and	and	CCONJ
iajs-3608	110	27	make	make	VERB
iajs-3608	110	28	them	they	PRON
iajs-3608	110	29	make	make	VERB
iajs-3608	110	30	more	more	ADJ
iajs-3608	110	31	mmp-9	mmp-9	NOUN
iajs-3608	110	32	(	(	PUNCT
iajs-3608	110	33	25	25	NUM
iajs-3608	110	34	)	)	PUNCT
iajs-3608	110	35	.	.	PUNCT
iajs-3608	111	1	additionally	additionally	ADV
iajs-3608	111	2	,	,	PUNCT
iajs-3608	111	3	research	research	NOUN
iajs-3608	111	4	suggests	suggest	VERB
iajs-3608	111	5	that	that	SCONJ
iajs-3608	111	6	gelatinases	gelatinase	NOUN
iajs-3608	111	7	could	could	AUX
iajs-3608	111	8	negatively	negatively	ADV
iajs-3608	111	9	impact	impact	VERB
iajs-3608	111	10	the	the	DET
iajs-3608	111	11	integrity	integrity	NOUN
iajs-3608	111	12	of	of	ADP
iajs-3608	111	13	the	the	DET
iajs-3608	111	14	kidney	kidney	NOUN
iajs-3608	111	15	basement	basement	NOUN
iajs-3608	111	16	membrane	membrane	NOUN
iajs-3608	111	17	,	,	PUNCT
iajs-3608	111	18	primarily	primarily	ADV
iajs-3608	111	19	composed	compose	VERB
iajs-3608	111	20	of	of	ADP
iajs-3608	111	21	type	type	NOUN
iajs-3608	111	22	iv	iv	NUM
iajs-3608	111	23	collagen	collagen	NOUN
iajs-3608	111	24	and	and	CCONJ
iajs-3608	111	25	laminin	laminin	NOUN
iajs-3608	111	26	,	,	PUNCT
iajs-3608	111	27	thereby	thereby	ADV
iajs-3608	111	28	promoting	promote	VERB
iajs-3608	111	29	the	the	DET
iajs-3608	111	30	development	development	NOUN
iajs-3608	111	31	of	of	ADP
iajs-3608	111	32	crf	crf	PROPN
iajs-3608	111	33	(	(	PUNCT
iajs-3608	111	34	26	26	NUM
iajs-3608	111	35	)	)	PUNCT
iajs-3608	111	36	.	.	PUNCT
iajs-3608	112	1	there	there	PRON
iajs-3608	112	2	are	be	VERB
iajs-3608	112	3	numerous	numerous	ADJ
iajs-3608	112	4	explanations	explanation	NOUN
iajs-3608	112	5	for	for	ADP
iajs-3608	112	6	elevated	elevated	ADJ
iajs-3608	112	7	serum	serum	NOUN
iajs-3608	112	8	and	and	CCONJ
iajs-3608	112	9	renal	renal	ADJ
iajs-3608	112	10	mmp-9	mmp-9	NOUN
iajs-3608	112	11	levels	level	NOUN
iajs-3608	112	12	in	in	ADP
iajs-3608	112	13	humans	human	NOUN
iajs-3608	112	14	;	;	PUNCT
iajs-3608	112	15	acute	acute	ADJ
iajs-3608	112	16	post	post	ADJ
iajs-3608	112	17	-	-	ADJ
iajs-3608	112	18	streptococcal	streptococcal	ADJ
iajs-3608	112	19	glomerulonephritis	glomerulonephritis	NOUN
iajs-3608	112	20	correlates	correlate	VERB
iajs-3608	112	21	with	with	ADP
iajs-3608	112	22	elevated	elevated	ADJ
iajs-3608	112	23	serum	serum	NOUN
iajs-3608	112	24	mmp-9	mmp-9	NOUN
iajs-3608	112	25	and	and	CCONJ
iajs-3608	112	26	increased	increase	VERB
iajs-3608	112	27	neutrophil	neutrophil	ADJ
iajs-3608	112	28	circulation	circulation	NOUN
iajs-3608	112	29	(	(	PUNCT
iajs-3608	112	30	27	27	NUM
iajs-3608	112	31	)	)	PUNCT
iajs-3608	112	32	.	.	PUNCT
iajs-3608	113	1	furthermore	furthermore	ADV
iajs-3608	113	2	,	,	PUNCT
iajs-3608	113	3	type	type	NOUN
iajs-3608	113	4	2	2	NUM
iajs-3608	113	5	diabetes	diabetes	NOUN
iajs-3608	113	6	patients	patient	NOUN
iajs-3608	113	7	showed	show	VERB
iajs-3608	113	8	elevated	elevated	ADJ
iajs-3608	113	9	urine	urine	NOUN
iajs-3608	113	10	mmp-9	mmp-9	NOUN
iajs-3608	113	11	levels	level	NOUN
iajs-3608	113	12	(	(	PUNCT
iajs-3608	113	13	28	28	NUM
iajs-3608	113	14	)	)	PUNCT
iajs-3608	113	15	.	.	PUNCT
iajs-3608	114	1	another	another	DET
iajs-3608	114	2	study	study	NOUN
iajs-3608	114	3	resulted	result	VERB
iajs-3608	114	4	in	in	ADP
iajs-3608	114	5	mmp-9	mmp-9	VERB
iajs-3608	114	6	being	be	AUX
iajs-3608	114	7	considerably	considerably	ADV
iajs-3608	114	8	higher	high	ADJ
iajs-3608	114	9	in	in	ADP
iajs-3608	114	10	both	both	DET
iajs-3608	114	11	non	non	ADJ
iajs-3608	114	12	-	-	ADJ
iajs-3608	114	13	albuminuric	albuminuric	ADJ
iajs-3608	114	14	and	and	CCONJ
iajs-3608	114	15	albuminuric	albuminuric	ADJ
iajs-3608	114	16	individuals	individual	NOUN
iajs-3608	114	17	(	(	PUNCT
iajs-3608	114	18	29	29	NUM
iajs-3608	114	19	)	)	PUNCT
iajs-3608	114	20	.	.	PUNCT
iajs-3608	115	1	furthermore	furthermore	ADV
iajs-3608	115	2	,	,	PUNCT
iajs-3608	115	3	the	the	DET
iajs-3608	115	4	study	study	NOUN
iajs-3608	115	5	found	find	VERB
iajs-3608	115	6	a	a	DET
iajs-3608	115	7	strong	strong	ADJ
iajs-3608	115	8	correlation	correlation	NOUN
iajs-3608	115	9	between	between	ADP
iajs-3608	115	10	mmp-9	mmp-9	VERB
iajs-3608	115	11	levels	level	NOUN
iajs-3608	115	12	and	and	CCONJ
iajs-3608	115	13	hba1c	hba1c	NOUN
iajs-3608	115	14	levels	level	NOUN
iajs-3608	115	15	,	,	PUNCT
iajs-3608	115	16	indicating	indicate	VERB
iajs-3608	115	17	a	a	DET
iajs-3608	115	18	link	link	NOUN
iajs-3608	115	19	with	with	ADP
iajs-3608	115	20	individuals	individual	NOUN
iajs-3608	115	21	with	with	ADP
iajs-3608	115	22	uncontrolled	uncontrolled	ADJ
iajs-3608	115	23	diabetes	diabete	NOUN
iajs-3608	115	24	.	.	PUNCT
iajs-3608	116	1	researchers	researcher	NOUN
iajs-3608	116	2	have	have	AUX
iajs-3608	116	3	found	find	VERB
iajs-3608	116	4	that	that	SCONJ
iajs-3608	116	5	higher	high	ADJ
iajs-3608	116	6	serum	serum	NOUN
iajs-3608	116	7	and/or	and/or	CCONJ
iajs-3608	116	8	urine	urine	NOUN
iajs-3608	116	9	levels	level	NOUN
iajs-3608	116	10	of	of	ADP
iajs-3608	116	11	mmp-2	mmp-2	NUM
iajs-3608	116	12	,	,	PUNCT
iajs-3608	116	13	-9	-9	ADV
iajs-3608	116	14	,	,	PUNCT
iajs-3608	116	15	and	and	CCONJ
iajs-3608	116	16	timps	timp	NOUN
iajs-3608	116	17	signal	signal	VERB
iajs-3608	116	18	an	an	DET
iajs-3608	116	19	early	early	ADJ
iajs-3608	116	20	stage	stage	NOUN
iajs-3608	116	21	of	of	ADP
iajs-3608	116	22	renal	renal	ADJ
iajs-3608	116	23	failure	failure	NOUN
iajs-3608	116	24	or	or	CCONJ
iajs-3608	116	25	its	its	PRON
iajs-3608	116	26	progression	progression	NOUN
iajs-3608	116	27	in	in	ADP
iajs-3608	116	28	persons	person	NOUN
iajs-3608	116	29	with	with	ADP
iajs-3608	116	30	ckd	ckd	PROPN
iajs-3608	116	31	,	,	PUNCT
iajs-3608	116	32	diabetic	diabetic	ADJ
iajs-3608	116	33	nephropathy	nephropathy	NOUN
iajs-3608	116	34	,	,	PUNCT
iajs-3608	116	35	and	and	CCONJ
iajs-3608	116	36	following	follow	VERB
iajs-3608	116	37	kidney	kidney	NOUN
iajs-3608	116	38	transplantation	transplantation	NOUN
iajs-3608	116	39	,	,	PUNCT
iajs-3608	116	40	although	although	SCONJ
iajs-3608	116	41	urinary	urinary	ADJ
iajs-3608	116	42	mmp-9	mmp-9	NOUN
iajs-3608	116	43	levels	level	NOUN
iajs-3608	116	44	in	in	ADP
iajs-3608	116	45	individuals	individual	NOUN
iajs-3608	116	46	with	with	ADP
iajs-3608	116	47	minimal	minimal	ADJ
iajs-3608	116	48	change	change	NOUN
iajs-3608	116	49	disorders	disorder	NOUN
iajs-3608	116	50	were	be	AUX
iajs-3608	116	51	not	not	PART
iajs-3608	116	52	higher	high	ADJ
iajs-3608	116	53	than	than	ADP
iajs-3608	116	54	in	in	ADP
iajs-3608	116	55	controls	control	NOUN
iajs-3608	116	56	(	(	PUNCT
iajs-3608	116	57	30	30	NUM
iajs-3608	116	58	)	)	PUNCT
iajs-3608	116	59	.	.	PUNCT
iajs-3608	117	1	therefore	therefore	ADV
iajs-3608	117	2	,	,	PUNCT
iajs-3608	117	3	the	the	DET
iajs-3608	117	4	approval	approval	NOUN
iajs-3608	117	5	of	of	ADP
iajs-3608	117	6	certain	certain	ADJ
iajs-3608	117	7	mmps	mmp	NOUN
iajs-3608	117	8	/	/	SYM
iajs-3608	117	9	timps	timps	NUM
iajs-3608	117	10	ratios	ratio	NOUN
iajs-3608	117	11	as	as	ADP
iajs-3608	117	12	prospective	prospective	ADJ
iajs-3608	117	13	early	early	ADJ
iajs-3608	117	14	markers	marker	NOUN
iajs-3608	117	15	of	of	ADP
iajs-3608	117	16	kidney	kidney	NOUN
iajs-3608	117	17	fibrosis	fibrosis	NOUN
iajs-3608	117	18	in	in	ADP
iajs-3608	117	19	children	child	NOUN
iajs-3608	117	20	with	with	ADP
iajs-3608	117	21	chronic	chronic	ADJ
iajs-3608	117	22	glomerulopathies	glomerulopathie	NOUN
iajs-3608	117	23	suggests	suggest	VERB
iajs-3608	117	24	their	their	PRON
iajs-3608	117	25	potential	potential	ADJ
iajs-3608	117	26	clinical	clinical	ADJ
iajs-3608	117	27	utility	utility	NOUN
iajs-3608	117	28	(	(	PUNCT
iajs-3608	117	29	31	31	NUM
iajs-3608	117	30	)	)	PUNCT
iajs-3608	117	31	.	.	PUNCT
iajs-3608	118	1	5.conclusion	5.conclusion	NUM
iajs-3608	118	2	total	total	ADJ
iajs-3608	118	3	mmp	mmp	PROPN
iajs-3608	118	4	activity	activity	NOUN
iajs-3608	118	5	can	can	AUX
iajs-3608	118	6	be	be	AUX
iajs-3608	118	7	easily	easily	ADV
iajs-3608	118	8	measured	measure	VERB
iajs-3608	118	9	in	in	ADP
iajs-3608	118	10	human	human	ADJ
iajs-3608	118	11	serum	serum	NOUN
iajs-3608	118	12	and	and	CCONJ
iajs-3608	118	13	urine	urine	NOUN
iajs-3608	118	14	.	.	PUNCT
iajs-3608	119	1	elevated	elevated	ADJ
iajs-3608	119	2	levels	level	NOUN
iajs-3608	119	3	of	of	ADP
iajs-3608	119	4	serum	serum	NOUN
iajs-3608	119	5	and	and	CCONJ
iajs-3608	119	6	renal	renal	ADJ
iajs-3608	119	7	mmp-2	mmp-2	PUNCT
iajs-3608	119	8	and	and	CCONJ
iajs-3608	119	9	mmp-9	mmp-9	NOUN
iajs-3608	119	10	are	be	AUX
iajs-3608	119	11	important	important	ADJ
iajs-3608	119	12	factors	factor	NOUN
iajs-3608	119	13	that	that	PRON
iajs-3608	119	14	worsen	worsen	VERB
iajs-3608	119	15	kidney	kidney	NOUN
iajs-3608	119	16	function	function	NOUN
iajs-3608	119	17	and	and	CCONJ
iajs-3608	119	18	contribute	contribute	VERB
iajs-3608	119	19	to	to	ADP
iajs-3608	119	20	the	the	DET
iajs-3608	119	21	development	development	NOUN
iajs-3608	119	22	of	of	ADP
iajs-3608	119	23	chronic	chronic	ADJ
iajs-3608	119	24	renal	renal	ADJ
iajs-3608	119	25	failure	failure	NOUN
iajs-3608	119	26	.	.	PUNCT
iajs-3608	120	1	conflict	conflict	NOUN
iajs-3608	120	2	of	of	ADP
iajs-3608	120	3	interest	interest	NOUN
iajs-3608	120	4	the	the	DET
iajs-3608	120	5	authors	author	NOUN
iajs-3608	120	6	declare	declare	VERB
iajs-3608	120	7	that	that	SCONJ
iajs-3608	120	8	they	they	PRON
iajs-3608	120	9	have	have	VERB
iajs-3608	120	10	no	no	DET
iajs-3608	120	11	conflicts	conflict	NOUN
iajs-3608	120	12	of	of	ADP
iajs-3608	120	13	interest	interest	NOUN
iajs-3608	120	14	.	.	PUNCT
iajs-3608	121	1	funding	funding	NOUN
iajs-3608	121	2	there	there	PRON
iajs-3608	121	3	is	be	VERB
iajs-3608	121	4	no	no	DET
iajs-3608	121	5	funding	funding	NOUN
iajs-3608	121	6	for	for	ADP
iajs-3608	121	7	the	the	DET
iajs-3608	121	8	article	article	NOUN
iajs-3608	121	9	.	.	PUNCT
iajs-3608	122	1	ethical	ethical	ADJ
iajs-3608	122	2	clearance	clearance	NOUN
iajs-3608	122	3	the	the	DET
iajs-3608	122	4	study	study	NOUN
iajs-3608	122	5	was	be	AUX
iajs-3608	122	6	conducted	conduct	VERB
iajs-3608	122	7	following	follow	VERB
iajs-3608	122	8	the	the	DET
iajs-3608	122	9	receipt	receipt	NOUN
iajs-3608	122	10	of	of	ADP
iajs-3608	122	11	participant	participant	ADJ
iajs-3608	122	12	consent	consent	NOUN
iajs-3608	122	13	and	and	CCONJ
iajs-3608	122	14	ethical	ethical	ADJ
iajs-3608	122	15	approval	approval	NOUN
iajs-3608	122	16	from	from	ADP
iajs-3608	122	17	the	the	DET
iajs-3608	122	18	ethics	ethic	NOUN
iajs-3608	122	19	committee	committee	PROPN
iajs-3608	122	20	of	of	ADP
iajs-3608	122	21	the	the	DET
iajs-3608	122	22	biology	biology	NOUN
iajs-3608	122	23	department	department	NOUN
iajs-3608	122	24	at	at	ADP
iajs-3608	122	25	the	the	DET
iajs-3608	122	26	university	university	PROPN
iajs-3608	122	27	of	of	ADP
iajs-3608	122	28	baghdad	baghdad	PROPN
iajs-3608	122	29	's	's	PART
iajs-3608	122	30	college	college	NOUN
iajs-3608	122	31	of	of	ADP
iajs-3608	122	32	science	science	NOUN
iajs-3608	122	33	(	(	PUNCT
iajs-3608	122	34	csec/0922/0080	csec/0922/0080	NOUN
iajs-3608	122	35	)	)	PUNCT
iajs-3608	122	36	.	.	PUNCT
iajs-3608	123	1	this	this	DET
iajs-3608	123	2	procedure	procedure	NOUN
iajs-3608	123	3	is	be	AUX
iajs-3608	123	4	in	in	ADP
iajs-3608	123	5	line	line	NOUN
iajs-3608	123	6	with	with	ADP
iajs-3608	123	7	the	the	DET
iajs-3608	123	8	guidelines	guideline	NOUN
iajs-3608	123	9	set	set	VERB
iajs-3608	123	10	forth	forth	ADP
iajs-3608	123	11	by	by	ADP
iajs-3608	123	12	the	the	DET
iajs-3608	123	13	iraqi	iraqi	PROPN
iajs-3608	123	14	ministry	ministry	PROPN
iajs-3608	123	15	of	of	ADP
iajs-3608	123	16	health	health	PROPN
iajs-3608	123	17	and	and	CCONJ
iajs-3608	123	18	environment	environment	NOUN
iajs-3608	123	19	.	.	PUNCT
iajs-3608	124	1	references	reference	NOUN
iajs-3608	124	2	1	1	NUM
iajs-3608	124	3	.	.	PUNCT
iajs-3608	124	4	khan	khan	PROPN
iajs-3608	124	5	s	s	PROPN
iajs-3608	124	6	,	,	PUNCT
iajs-3608	124	7	iqbal	iqbal	PROPN
iajs-3608	124	8	s	s	PROPN
iajs-3608	124	9	,	,	PUNCT
iajs-3608	124	10	khan	khan	PROPN
iajs-3608	124	11	mn	mn	PROPN
iajs-3608	124	12	,	,	PUNCT
iajs-3608	124	13	khan	khan	PROPN
iajs-3608	124	14	mn	mn	PROPN
iajs-3608	124	15	.	.	PROPN
iajs-3608	124	16	left	leave	VERB
iajs-3608	124	17	ventricular	ventricular	ADJ
iajs-3608	124	18	hypertrophy	hypertrophy	NOUN
iajs-3608	124	19	among	among	ADP
iajs-3608	124	20	non	non	ADJ
iajs-3608	124	21	-	-	ADJ
iajs-3608	124	22	diabetics	diabetic	NOUN
iajs-3608	124	23	pre	pre	ADJ
iajs-3608	124	24	-	-	NOUN
iajs-3608	124	25	dialysis	dialysis	ADJ
iajs-3608	124	26	patients	patient	NOUN
iajs-3608	124	27	with	with	ADP
iajs-3608	124	28	chronic	chronic	ADJ
iajs-3608	124	29	kidney	kidney	NOUN
iajs-3608	124	30	disease	disease	NOUN
iajs-3608	124	31	in	in	ADP
iajs-3608	124	32	local	local	ADJ
iajs-3608	124	33	population	population	NOUN
iajs-3608	124	34	.	.	PUNCT
iajs-3608	125	1	res	re	NOUN
iajs-3608	125	2	health	health	PROPN
iajs-3608	125	3	benefits	benefit	NOUN
iajs-3608	125	4	coconut	coconut	NOUN
iajs-3608	125	5	.	.	PUNCT
iajs-3608	126	1	2021	2021	NUM
iajs-3608	126	2	;	;	PUNCT
iajs-3608	126	3	32:76	32:76	NUM
iajs-3608	126	4	.	.	PUNCT
iajs-3608	127	1	https://doi.org/10.1053/j.ajkd.2005.04.031	https://doi.org/10.1053/j.ajkd.2005.04.031	NOUN
iajs-3608	127	2	.	.	PUNCT
iajs-3608	128	1	2	2	NUM
iajs-3608	128	2	.	.	X
iajs-3608	128	3	kuravatti	kuravatti	PROPN
iajs-3608	128	4	s	s	PROPN
iajs-3608	128	5	,	,	PUNCT
iajs-3608	128	6	david	david	PROPN
iajs-3608	128	7	mp	mp	PROPN
iajs-3608	128	8	,	,	PUNCT
iajs-3608	128	9	indira	indira	PROPN
iajs-3608	128	10	a.	a.	PROPN
iajs-3608	128	11	oral	oral	ADJ
iajs-3608	128	12	manifestations	manifestation	NOUN
iajs-3608	128	13	of	of	ADP
iajs-3608	128	14	chronic	chronic	ADJ
iajs-3608	128	15	kidney	kidney	NOUN
iajs-3608	128	16	disease	disease	NOUN
iajs-3608	128	17	—	—	PUNCT
iajs-3608	128	18	an	an	DET
iajs-3608	128	19	overview	overview	NOUN
iajs-3608	128	20	.	.	PUNCT
iajs-3608	129	1	int	int	NOUN
iajs-3608	129	2	j	j	PROPN
iajs-3608	129	3	contemp	contemp	PROPN
iajs-3608	129	4	med	med	ADJ
iajs-3608	129	5	res	re	NOUN
iajs-3608	129	6	.	.	PROPN
iajs-3608	129	7	2016	2016	NUM
iajs-3608	129	8	;	;	PUNCT
iajs-3608	130	1	3:1149–1152	3:1149–1152	NUM
iajs-3608	130	2	.	.	PUNCT
iajs-3608	131	1	https://doi.org/10.1053/j.ajkd.2005.04.031	https://doi.org/10.1053/j.ajkd.2005.04.031	NOUN
iajs-3608	131	2	ihjpas	ihjpas	PROPN
iajs-3608	131	3	.	.	PUNCT
iajs-3608	132	1	2025	2025	NUM
iajs-3608	132	2	,	,	PUNCT
iajs-3608	132	3	38(4	38(4	NUM
iajs-3608	132	4	)	)	PUNCT
iajs-3608	132	5	16	16	NUM
iajs-3608	133	1	http://www.ijcmr.com/uploads/7/7/4/6/77464738/_oral_manifestations_of_chronic_kidney_diseas	http://www.ijcmr.com/uploads/7/7/4/6/77464738/_oral_manifestations_of_chronic_kidney_disea	NOUN
iajs-3608	133	2	e	e	X
iajs-3608	133	3	-	-	NOUN
iajs-3608	133	4	an_overview_.pdf	an_overview_.pdf	NOUN
iajs-3608	133	5	.	.	PUNCT
iajs-3608	134	1	3	3	X
iajs-3608	134	2	.	.	X
iajs-3608	134	3	alobaidi	alobaidi	PROPN
iajs-3608	134	4	s.	s.	PROPN
iajs-3608	134	5	knowledge	knowledge	PROPN
iajs-3608	134	6	of	of	ADP
iajs-3608	134	7	chronic	chronic	ADJ
iajs-3608	134	8	kidney	kidney	NOUN
iajs-3608	134	9	disease	disease	NOUN
iajs-3608	134	10	among	among	ADP
iajs-3608	134	11	the	the	DET
iajs-3608	134	12	population	population	NOUN
iajs-3608	134	13	of	of	ADP
iajs-3608	134	14	saudi	saudi	PROPN
iajs-3608	134	15	arabia	arabia	PROPN
iajs-3608	134	16	evaluated	evaluate	VERB
iajs-3608	134	17	using	use	VERB
iajs-3608	134	18	a	a	DET
iajs-3608	134	19	validated	validated	ADJ
iajs-3608	134	20	questionnaire	questionnaire	NOUN
iajs-3608	134	21	:	:	PUNCT
iajs-3608	134	22	a	a	DET
iajs-3608	134	23	cross	cross	ADJ
iajs-3608	134	24	-	-	ADJ
iajs-3608	134	25	sectional	sectional	ADJ
iajs-3608	134	26	study	study	NOUN
iajs-3608	134	27	.	.	PUNCT
iajs-3608	135	1	patient	patient	ADJ
iajs-3608	135	2	prefer	prefer	VERB
iajs-3608	135	3	adher.2021;15:1281–1288	adher.2021;15:1281–1288	NOUN
iajs-3608	135	4	.	.	PUNCT
iajs-3608	136	1	https://doi.org/10.2147/ppa.s315369	https://doi.org/10.2147/ppa.s315369	NUM
iajs-3608	136	2	.	.	PUNCT
iajs-3608	137	1	4	4	X
iajs-3608	137	2	.	.	X
iajs-3608	137	3	jawad	jawad	PROPN
iajs-3608	137	4	a	a	PROPN
iajs-3608	137	5	,	,	PUNCT
iajs-3608	137	6	al	al	PROPN
iajs-3608	137	7	-	-	PUNCT
iajs-3608	137	8	mulla	mulla	PROPN
iajs-3608	137	9	a	a	PRON
iajs-3608	137	10	,	,	PUNCT
iajs-3608	137	11	zardlekawee	zardlekawee	NOUN
iajs-3608	137	12	as	as	ADP
iajs-3608	137	13	.	.	PUNCT
iajs-3608	137	14	levels	level	NOUN
iajs-3608	137	15	of	of	ADP
iajs-3608	137	16	trace	trace	NOUN
iajs-3608	137	17	and	and	CCONJ
iajs-3608	137	18	essential	essential	ADJ
iajs-3608	137	19	elements	element	NOUN
iajs-3608	137	20	in	in	ADP
iajs-3608	137	21	sera	sera	NOUN
iajs-3608	137	22	of	of	ADP
iajs-3608	137	23	chronic	chronic	ADJ
iajs-3608	137	24	renal	renal	ADJ
iajs-3608	137	25	failure	failure	NOUN
iajs-3608	137	26	patients	patient	NOUN
iajs-3608	137	27	before	before	ADP
iajs-3608	137	28	and	and	CCONJ
iajs-3608	137	29	after	after	ADP
iajs-3608	137	30	dialysis	dialysis	NOUN
iajs-3608	137	31	.	.	PUNCT
iajs-3608	138	1	ibn	ibn	PROPN
iajs-3608	138	2	al	al	PROPN
iajs-3608	138	3	-	-	PUNCT
iajs-3608	138	4	haitham	haitham	PROPN
iajs-3608	138	5	j	j	PROPN
iajs-3608	138	6	pure	pure	PROPN
iajs-3608	138	7	appl	appl	PROPN
iajs-3608	138	8	sci	sci	PROPN
iajs-3608	138	9	.	.	PROPN
iajs-3608	138	10	2009	2009	NUM
iajs-3608	138	11	;	;	PUNCT
iajs-3608	138	12	22(4):1	22(4):1	X
iajs-3608	138	13	-	-	SYM
iajs-3608	138	14	8	8	NUM
iajs-3608	138	15	.	.	PUNCT
iajs-3608	138	16	https://jih.uobaghdad.edu.iq/index.php/j/article/view/1133	https://jih.uobaghdad.edu.iq/index.php/j/article/view/1133	NOUN
iajs-3608	138	17	.	.	PUNCT
iajs-3608	139	1	5	5	X
iajs-3608	139	2	.	.	X
iajs-3608	139	3	izhar	izhar	PROPN
iajs-3608	139	4	u	u	PROPN
iajs-3608	139	5	,	,	PUNCT
iajs-3608	139	6	ullah	ullah	PROPN
iajs-3608	139	7	a	a	PRON
iajs-3608	139	8	,	,	PUNCT
iajs-3608	139	9	rehman	rehman	PROPN
iajs-3608	139	10	n	n	CCONJ
iajs-3608	139	11	,	,	PUNCT
iajs-3608	139	12	khan	khan	PROPN
iajs-3608	139	13	ku	ku	PROPN
iajs-3608	139	14	,	,	PUNCT
iajs-3608	139	15	ziaullah	ziaullah	PROPN
iajs-3608	139	16	mss	mss	PROPN
iajs-3608	139	17	.	.	PROPN
iajs-3608	140	1	frequency	frequency	PROPN
iajs-3608	140	2	of	of	ADP
iajs-3608	140	3	hepatitis	hepatitis	PROPN
iajs-3608	140	4	c	c	PROPN
iajs-3608	140	5	virus	virus	NOUN
iajs-3608	140	6	in	in	ADP
iajs-3608	140	7	chronic	chronic	ADJ
iajs-3608	140	8	kidney	kidney	NOUN
iajs-3608	140	9	disease	disease	NOUN
iajs-3608	140	10	patients	patient	NOUN
iajs-3608	140	11	on	on	ADP
iajs-3608	140	12	regular	regular	ADJ
iajs-3608	140	13	hemodialysis	hemodialysis	NOUN
iajs-3608	140	14	at	at	ADP
iajs-3608	140	15	tertiary	tertiary	ADJ
iajs-3608	140	16	care	care	NOUN
iajs-3608	140	17	hospital	hospital	NOUN
iajs-3608	140	18	.	.	PUNCT
iajs-3608	141	1	2021	2021	NUM
iajs-3608	141	2	.	.	PUNCT
iajs-3608	142	1	https://doi.org/10.53350/pjmhs2115123909	https://doi.org/10.53350/pjmhs2115123909	PROPN
iajs-3608	142	2	6	6	NUM
iajs-3608	142	3	.	.	PUNCT
iajs-3608	142	4	khan	khan	PROPN
iajs-3608	142	5	az	az	PROPN
iajs-3608	142	6	,	,	PUNCT
iajs-3608	142	7	alam	alam	PROPN
iajs-3608	142	8	sa	sa	PROPN
iajs-3608	142	9	,	,	PUNCT
iajs-3608	142	10	mahmood	mahmood	PROPN
iajs-3608	142	11	mbur	mbur	PROPN
iajs-3608	142	12	,	,	PUNCT
iajs-3608	142	13	khan	khan	PROPN
iajs-3608	142	14	ra	ra	PROPN
iajs-3608	142	15	,	,	PUNCT
iajs-3608	142	16	ikram	ikram	NOUN
iajs-3608	142	17	t.	t.	NOUN
iajs-3608	142	18	the	the	DET
iajs-3608	142	19	frequency	frequency	NOUN
iajs-3608	142	20	of	of	ADP
iajs-3608	142	21	infections	infection	NOUN
iajs-3608	142	22	of	of	ADP
iajs-3608	142	23	arteriovenous	arteriovenous	ADJ
iajs-3608	142	24	fistula	fistula	NOUN
iajs-3608	142	25	in	in	ADP
iajs-3608	142	26	patients	patient	NOUN
iajs-3608	142	27	on	on	ADP
iajs-3608	142	28	dialysis	dialysis	NOUN
iajs-3608	142	29	with	with	ADP
iajs-3608	142	30	chronic	chronic	ADJ
iajs-3608	142	31	kidney	kidney	NOUN
iajs-3608	142	32	disease	disease	NOUN
iajs-3608	142	33	.	.	PUNCT
iajs-3608	143	1	j	j	PROPN
iajs-3608	143	2	med	med	PROPN
iajs-3608	143	3	sci	sci	PROPN
iajs-3608	143	4	.	.	PROPN
iajs-3608	143	5	2016	2016	NUM
iajs-3608	143	6	;	;	PUNCT
iajs-3608	143	7	24:224	24:224	NUM
iajs-3608	143	8	–	–	PUNCT
iajs-3608	143	9	227	227	NUM
iajs-3608	143	10	.	.	NOUN
iajs-3608	143	11	7	7	NUM
iajs-3608	143	12	.	.	X
iajs-3608	143	13	fernandez	fernandez	NOUN
iajs-3608	143	14	-	-	PUNCT
iajs-3608	143	15	patron	patron	NOUN
iajs-3608	143	16	c	c	PROPN
iajs-3608	143	17	,	,	PUNCT
iajs-3608	143	18	kassiri	kassiri	PROPN
iajs-3608	143	19	z	z	PROPN
iajs-3608	143	20	,	,	PUNCT
iajs-3608	143	21	leung	leung	PROPN
iajs-3608	143	22	d.	d.	PROPN
iajs-3608	143	23	modulation	modulation	NOUN
iajs-3608	143	24	of	of	ADP
iajs-3608	143	25	systemic	systemic	ADJ
iajs-3608	143	26	metabolism	metabolism	NOUN
iajs-3608	143	27	by	by	ADP
iajs-3608	143	28	mmp-2	mmp-2	NOUN
iajs-3608	143	29	:	:	PUNCT
iajs-3608	143	30	from	from	ADP
iajs-3608	143	31	mmp-2	mmp-2	DET
iajs-3608	143	32	deficiency	deficiency	NOUN
iajs-3608	143	33	in	in	ADP
iajs-3608	143	34	mice	mouse	NOUN
iajs-3608	143	35	to	to	ADP
iajs-3608	143	36	mmp-2	mmp-2	VERB
iajs-3608	143	37	deficiency	deficiency	NOUN
iajs-3608	143	38	in	in	ADP
iajs-3608	143	39	patients	patient	NOUN
iajs-3608	143	40	.	.	PUNCT
iajs-3608	144	1	compr	compr	PROPN
iajs-3608	144	2	physiol	physiol	PROPN
iajs-3608	144	3	.	.	PUNCT
iajs-3608	145	1	2016	2016	NUM
iajs-3608	145	2	;	;	PUNCT
iajs-3608	145	3	6:1935–1949	6:1935–1949	NUM
iajs-3608	145	4	.	.	PUNCT
iajs-3608	146	1	https://doi.org/10.1002/cphy.c160010	https://doi.org/10.1002/cphy.c160010	PROPN
iajs-3608	146	2	.	.	PROPN
iajs-3608	147	1	8	8	NUM
iajs-3608	147	2	.	.	PUNCT
iajs-3608	147	3	shimoda	shimoda	PROPN
iajs-3608	147	4	m.	m.	PROPN
iajs-3608	147	5	extracellular	extracellular	ADJ
iajs-3608	147	6	vesicle	vesicle	NOUN
iajs-3608	147	7	-	-	PUNCT
iajs-3608	147	8	associated	associate	VERB
iajs-3608	147	9	mmps	mmp	NOUN
iajs-3608	147	10	:	:	PUNCT
iajs-3608	147	11	a	a	DET
iajs-3608	147	12	modulator	modulator	NOUN
iajs-3608	147	13	of	of	ADP
iajs-3608	147	14	the	the	DET
iajs-3608	147	15	tissue	tissue	NOUN
iajs-3608	147	16	microenvironment	microenvironment	NOUN
iajs-3608	147	17	.	.	PUNCT
iajs-3608	148	1	adv	adv	PROPN
iajs-3608	148	2	clin	clin	PROPN
iajs-3608	148	3	chem	chem	PROPN
iajs-3608	148	4	.	.	PUNCT
iajs-3608	149	1	2019	2019	NUM
iajs-3608	149	2	;	;	PUNCT
iajs-3608	149	3	88:35	88:35	NUM
iajs-3608	149	4	-	-	SYM
iajs-3608	149	5	66	66	NUM
iajs-3608	149	6	.	.	PUNCT
iajs-3608	150	1	https://doi.org/10.1016/bs.acc.2018.10.006	https://doi.org/10.1016/bs.acc.2018.10.006	X
iajs-3608	150	2	.	.	PROPN
iajs-3608	150	3	9	9	NUM
iajs-3608	150	4	.	.	X
iajs-3608	150	5	parrish	parrish	PROPN
iajs-3608	150	6	ar	ar	PROPN
iajs-3608	150	7	.	.	PROPN
iajs-3608	150	8	matrix	matrix	NOUN
iajs-3608	150	9	metalloproteinases	metalloproteinase	NOUN
iajs-3608	150	10	in	in	ADP
iajs-3608	150	11	kidney	kidney	NOUN
iajs-3608	150	12	disease	disease	NOUN
iajs-3608	150	13	:	:	PUNCT
iajs-3608	150	14	role	role	NOUN
iajs-3608	150	15	in	in	ADP
iajs-3608	150	16	pathogenesis	pathogenesis	NOUN
iajs-3608	150	17	and	and	CCONJ
iajs-3608	150	18	potential	potential	NOUN
iajs-3608	150	19	as	as	ADP
iajs-3608	150	20	a	a	DET
iajs-3608	150	21	therapeutic	therapeutic	ADJ
iajs-3608	150	22	target	target	NOUN
iajs-3608	150	23	.	.	PUNCT
iajs-3608	151	1	prog	prog	NOUN
iajs-3608	151	2	mol	mol	ADP
iajs-3608	151	3	biol	biol	PROPN
iajs-3608	151	4	transl	transl	PROPN
iajs-3608	151	5	sci	sci	PROPN
iajs-3608	151	6	.	.	PROPN
iajs-3608	151	7	2017	2017	NUM
iajs-3608	151	8	;	;	PUNCT
iajs-3608	151	9	148:31–65	148:31–65	NUM
iajs-3608	151	10	.	.	PUNCT
iajs-3608	151	11	https://doi.org/10.1016/bs.pmbts.2017.03.001	https://doi.org/10.1016/bs.pmbts.2017.03.001	NUM
iajs-3608	151	12	.	.	PUNCT
iajs-3608	152	1	10	10	NUM
iajs-3608	152	2	.	.	PUNCT
iajs-3608	153	1	tan	tan	PROPN
iajs-3608	153	2	rj	rj	PROPN
iajs-3608	153	3	,	,	PUNCT
iajs-3608	153	4	liu	liu	PROPN
iajs-3608	153	5	y.	y.	PROPN
iajs-3608	153	6	matrix	matrix	NOUN
iajs-3608	153	7	metalloproteinases	metalloproteinase	NOUN
iajs-3608	153	8	in	in	ADP
iajs-3608	153	9	kidney	kidney	NOUN
iajs-3608	153	10	homeostasis	homeostasis	NOUN
iajs-3608	153	11	and	and	CCONJ
iajs-3608	153	12	diseases	disease	NOUN
iajs-3608	153	13	.	.	PUNCT
iajs-3608	154	1	am	be	AUX
iajs-3608	154	2	j	j	PROPN
iajs-3608	154	3	physiol	physiol	PROPN
iajs-3608	154	4	renal	renal	PROPN
iajs-3608	154	5	physiol	physiol	PROPN
iajs-3608	154	6	.	.	PUNCT
iajs-3608	155	1	2012;302	2012;302	NUM
iajs-3608	155	2	:	:	PUNCT
iajs-3608	155	3	f1351	f1351	NOUN
iajs-3608	155	4	–	–	PUNCT
iajs-3608	155	5	f1361	f1361	NOUN
iajs-3608	155	6	.	.	PUNCT
iajs-3608	156	1	https://doi.org/10.1152/ajprenal.00037.2012	https://doi.org/10.1152/ajprenal.00037.2012	PROPN
iajs-3608	156	2	.	.	PROPN
iajs-3608	156	3	11	11	NUM
iajs-3608	156	4	.	.	PUNCT
iajs-3608	157	1	cheng	cheng	PROPN
iajs-3608	157	2	z	z	PROPN
iajs-3608	157	3	,	,	PUNCT
iajs-3608	157	4	limbu	limbu	PROPN
iajs-3608	157	5	mh	mh	PROPN
iajs-3608	157	6	,	,	PUNCT
iajs-3608	157	7	wang	wang	PROPN
iajs-3608	157	8	z	z	PROPN
iajs-3608	157	9	,	,	PUNCT
iajs-3608	157	10	liu	liu	PROPN
iajs-3608	157	11	j	j	PROPN
iajs-3608	157	12	,	,	PUNCT
iajs-3608	157	13	liu	liu	PROPN
iajs-3608	157	14	l	l	PROPN
iajs-3608	157	15	,	,	PUNCT
iajs-3608	157	16	zhang	zhang	PROPN
iajs-3608	157	17	x	x	PROPN
iajs-3608	157	18	,	,	PUNCT
iajs-3608	157	19	chen	chen	PROPN
iajs-3608	157	20	p	p	PROPN
iajs-3608	157	21	,	,	PUNCT
iajs-3608	157	22	liu	liu	PROPN
iajs-3608	157	23	b.	b.	PROPN
iajs-3608	157	24	mmp-2	mmp-2	NUM
iajs-3608	157	25	and	and	CCONJ
iajs-3608	157	26	9	9	NUM
iajs-3608	157	27	in	in	ADP
iajs-3608	157	28	chronic	chronic	ADJ
iajs-3608	157	29	kidney	kidney	NOUN
iajs-3608	157	30	disease	disease	NOUN
iajs-3608	157	31	.	.	PUNCT
iajs-3608	158	1	int	int	PROPN
iajs-3608	158	2	j	j	PROPN
iajs-3608	158	3	mol	mol	ADP
iajs-3608	158	4	sci	sci	PROPN
iajs-3608	158	5	.	.	PROPN
iajs-3608	158	6	2017	2017	NUM
iajs-3608	158	7	;	;	PUNCT
iajs-3608	158	8	18:776	18:776	NUM
iajs-3608	158	9	.	.	PUNCT
iajs-3608	159	1	https://doi.org/10.3390/ijms18040776	https://doi.org/10.3390/ijms18040776	PROPN
iajs-3608	159	2	.	.	PUNCT
iajs-3608	160	1	12	12	NUM
iajs-3608	160	2	.	.	PUNCT
iajs-3608	160	3	björklund	björklund	PROPN
iajs-3608	160	4	m	m	PROPN
iajs-3608	160	5	,	,	PUNCT
iajs-3608	160	6	koivunen	koivunen	PROPN
iajs-3608	160	7	e.	e.	PROPN
iajs-3608	160	8	gelatinase	gelatinase	PROPN
iajs-3608	160	9	-	-	PUNCT
iajs-3608	160	10	mediated	mediate	VERB
iajs-3608	160	11	migration	migration	NOUN
iajs-3608	160	12	and	and	CCONJ
iajs-3608	160	13	invasion	invasion	NOUN
iajs-3608	160	14	of	of	ADP
iajs-3608	160	15	cancer	cancer	NOUN
iajs-3608	160	16	cells	cell	NOUN
iajs-3608	160	17	.	.	PUNCT
iajs-3608	161	1	biochim	biochim	PROPN
iajs-3608	161	2	biophys	biophys	PROPN
iajs-3608	161	3	acta	acta	PROPN
iajs-3608	161	4	rev	rev	PROPN
iajs-3608	161	5	cancer	cancer	NOUN
iajs-3608	161	6	.	.	PUNCT
iajs-3608	162	1	2005	2005	NUM
iajs-3608	162	2	;	;	PUNCT
iajs-3608	162	3	1755:37–69	1755:37–69	X
iajs-3608	162	4	.	.	PUNCT
iajs-3608	162	5	https://doi.org/10.1016/j.bbcan.2005.03.001	https://doi.org/10.1016/j.bbcan.2005.03.001	VERB
iajs-3608	162	6	.	.	PUNCT
iajs-3608	163	1	13	13	NUM
iajs-3608	163	2	.	.	X
iajs-3608	163	3	sas	sas	PROPN
iajs-3608	163	4	.	.	PUNCT
iajs-3608	164	1	statistical	statistical	ADJ
iajs-3608	164	2	analysis	analysis	NOUN
iajs-3608	164	3	system	system	NOUN
iajs-3608	164	4	,	,	PUNCT
iajs-3608	164	5	user	user	NOUN
iajs-3608	164	6	’s	’s	PART
iajs-3608	164	7	guide	guide	NOUN
iajs-3608	164	8	.	.	PUNCT
iajs-3608	165	1	version	version	NOUN
iajs-3608	165	2	9.6	9.6	NUM
iajs-3608	165	3	,	,	PUNCT
iajs-3608	165	4	6th	6th	ADJ
iajs-3608	165	5	ed	ed	NOUN
iajs-3608	165	6	.	.	PUNCT
iajs-3608	166	1	cary	cary	PROPN
iajs-3608	166	2	,	,	PUNCT
iajs-3608	166	3	nc	nc	PROPN
iajs-3608	166	4	:	:	PROPN
iajs-3608	166	5	sas	sas	PROPN
iajs-3608	166	6	institute	institute	PROPN
iajs-3608	166	7	inc	inc	PROPN
iajs-3608	166	8	.	.	PROPN
iajs-3608	166	9	;	;	PUNCT
iajs-3608	166	10	2018	2018	NUM
iajs-3608	166	11	.	.	PUNCT
iajs-3608	167	1	14	14	NUM
iajs-3608	167	2	.	.	PUNCT
iajs-3608	167	3	chevalier	chevalier	NOUN
iajs-3608	167	4	rl	rl	PROPN
iajs-3608	167	5	.	.	PROPN
iajs-3608	167	6	bioenergetic	bioenergetic	PROPN
iajs-3608	167	7	evolution	evolution	NOUN
iajs-3608	167	8	explains	explain	VERB
iajs-3608	167	9	prevalence	prevalence	NOUN
iajs-3608	167	10	of	of	ADP
iajs-3608	167	11	low	low	ADJ
iajs-3608	167	12	nephron	nephron	NOUN
iajs-3608	167	13	number	number	NOUN
iajs-3608	167	14	at	at	ADP
iajs-3608	167	15	birth	birth	NOUN
iajs-3608	167	16	:	:	PUNCT
iajs-3608	167	17	risk	risk	NOUN
iajs-3608	167	18	factor	factor	NOUN
iajs-3608	167	19	for	for	ADP
iajs-3608	167	20	ckd	ckd	PROPN
iajs-3608	167	21	.	.	PUNCT
iajs-3608	168	1	kidney360	kidney360	PROPN
iajs-3608	168	2	.	.	PROPN
iajs-3608	168	3	2020	2020	NUM
iajs-3608	168	4	;	;	PUNCT
iajs-3608	168	5	1:863	1:863	NUM
iajs-3608	168	6	.	.	PUNCT
iajs-3608	169	1	https://doi.org/10.34067/kid.0002012020	https://doi.org/10.34067/kid.0002012020	NOUN
iajs-3608	169	2	15	15	NUM
iajs-3608	169	3	.	.	PUNCT
iajs-3608	170	1	goyal	goyal	PROPN
iajs-3608	170	2	s	s	PROPN
iajs-3608	170	3	,	,	PUNCT
iajs-3608	170	4	arshi	arshi	PROPN
iajs-3608	170	5	sj	sj	PROPN
iajs-3608	170	6	,	,	PUNCT
iajs-3608	170	7	agarwal	agarwal	PROPN
iajs-3608	170	8	b	b	PROPN
iajs-3608	170	9	,	,	PUNCT
iajs-3608	170	10	rao	rao	NOUN
iajs-3608	170	11	p	p	NOUN
iajs-3608	170	12	,	,	PUNCT
iajs-3608	170	13	chauhan	chauhan	PROPN
iajs-3608	170	14	s	s	PROPN
iajs-3608	170	15	,	,	PUNCT
iajs-3608	170	16	haritwal	haritwal	NOUN
iajs-3608	170	17	a.	a.	NOUN
iajs-3608	170	18	an	an	DET
iajs-3608	170	19	observational	observational	ADJ
iajs-3608	170	20	study	study	NOUN
iajs-3608	170	21	of	of	ADP
iajs-3608	170	22	epidemiological	epidemiological	ADJ
iajs-3608	170	23	factors	factor	NOUN
iajs-3608	170	24	among	among	ADP
iajs-3608	170	25	acute	acute	ADJ
iajs-3608	170	26	and	and	CCONJ
iajs-3608	170	27	chronic	chronic	ADJ
iajs-3608	170	28	renal	renal	ADJ
iajs-3608	170	29	failure	failure	NOUN
iajs-3608	170	30	patients	patient	NOUN
iajs-3608	170	31	in	in	ADP
iajs-3608	170	32	gujarat	gujarat	NOUN
iajs-3608	170	33	.	.	PUNCT
iajs-3608	171	1	eur	eur	PROPN
iajs-3608	171	2	j	j	PROPN
iajs-3608	171	3	mol	mol	PROPN
iajs-3608	171	4	clin	clin	PROPN
iajs-3608	171	5	med	med	PROPN
iajs-3608	171	6	.	.	PROPN
iajs-3608	171	7	2022	2022	NUM
iajs-3608	171	8	;	;	PUNCT
iajs-3608	171	9	9(1):359	9(1):359	NUM
iajs-3608	171	10	.	.	PUNCT
iajs-3608	172	1	16	16	NUM
iajs-3608	172	2	.	.	PUNCT
iajs-3608	173	1	rizvi	rizvi	PROPN
iajs-3608	173	2	smmh	smmh	PROPN
iajs-3608	173	3	.	.	PUNCT
iajs-3608	173	4	muhit	muhit	PROPN
iajs-3608	173	5	mdm	mdm	PROPN
iajs-3608	173	6	,	,	PUNCT
iajs-3608	173	7	tao	tao	PROPN
iajs-3608	173	8	s	s	PROPN
iajs-3608	173	9	,	,	PUNCT
iajs-3608	173	10	kalam	kalam	PROPN
iajs-3608	173	11	a	a	PROPN
iajs-3608	173	12	,	,	PUNCT
iajs-3608	173	13	rahman	rahman	PROPN
iajs-3608	173	14	l	l	PROPN
iajs-3608	173	15	,	,	PUNCT
iajs-3608	173	16	alom	alom	PROPN
iajs-3608	173	17	k	k	PROPN
iajs-3608	173	18	,	,	PUNCT
iajs-3608	173	19	islam	islam	PROPN
iajs-3608	173	20	s	s	PROPN
iajs-3608	173	21	,	,	PUNCT
iajs-3608	173	22	rahman	rahman	PROPN
iajs-3608	173	23	a	a	PROPN
iajs-3608	173	24	,	,	PUNCT
iajs-3608	173	25	jomaddaer	jomaddaer	PROPN
iajs-3608	173	26	m	m	PROPN
iajs-3608	173	27	,	,	PUNCT
iajs-3608	173	28	hossain	hossain	PROPN
iajs-3608	173	29	z	z	PROPN
iajs-3608	173	30	,	,	PUNCT
iajs-3608	173	31	chaity	chaity	PROPN
iajs-3608	173	32	hbs	hbs	PROPN
iajs-3608	173	33	.	.	PUNCT
iajs-3608	174	1	treatment	treatment	NOUN
iajs-3608	174	2	and	and	CCONJ
iajs-3608	174	3	prevention	prevention	NOUN
iajs-3608	174	4	of	of	ADP
iajs-3608	174	5	chronic	chronic	ADJ
iajs-3608	174	6	kidney	kidney	NOUN
iajs-3608	174	7	disease	disease	NOUN
iajs-3608	174	8	.	.	PUNCT
iajs-3608	175	1	north	north	NOUN
iajs-3608	175	2	am	be	AUX
iajs-3608	175	3	acad	acad	NOUN
iajs-3608	175	4	res	re	NOUN
iajs-3608	175	5	2023	2023	NUM
iajs-3608	175	6	;	;	PUNCT
iajs-3608	175	7	6(1	6(1	NUM
iajs-3608	175	8	):	):	PUNCT
iajs-3608	175	9	186	186	NUM
iajs-3608	175	10	-	-	SYM
iajs-3608	175	11	219	219	NUM
iajs-3608	175	12	.	.	PUNCT
iajs-3608	176	1	https://doi.org/10.5281/zenodo.7622530	https://doi.org/10.5281/zenodo.7622530	PROPN
iajs-3608	176	2	.	.	PUNCT
iajs-3608	176	3	17	17	NUM
iajs-3608	176	4	.	.	PUNCT
iajs-3608	177	1	garcia	garcia	PROPN
iajs-3608	177	2	-	-	PUNCT
iajs-3608	177	3	fernandez	fernandez	PROPN
iajs-3608	177	4	n	n	CCONJ
iajs-3608	177	5	,	,	PUNCT
iajs-3608	177	6	jacobs	jacobs	PROPN
iajs-3608	177	7	-	-	PUNCT
iajs-3608	177	8	cachá	cachá	PROPN
iajs-3608	177	9	c	c	PROPN
iajs-3608	177	10	,	,	PUNCT
iajs-3608	177	11	mora	mora	PROPN
iajs-3608	177	12	-	-	PUNCT
iajs-3608	177	13	gutiérrez	gutiérrez	PROPN
iajs-3608	177	14	jm	jm	PROPN
iajs-3608	177	15	,	,	PUNCT
iajs-3608	177	16	vergara	vergara	PROPN
iajs-3608	177	17	a	a	PROPN
iajs-3608	177	18	,	,	PUNCT
iajs-3608	177	19	orbe	orbe	PROPN
iajs-3608	177	20	j	j	PROPN
iajs-3608	177	21	,	,	PUNCT
iajs-3608	177	22	soler	soler	PROPN
iajs-3608	177	23	mj	mj	PROPN
iajs-3608	177	24	.	.	PROPN
iajs-3608	177	25	matrix	matrix	NOUN
iajs-3608	177	26	metalloproteinases	metalloproteinase	NOUN
iajs-3608	177	27	in	in	ADP
iajs-3608	177	28	diabetic	diabetic	ADJ
iajs-3608	177	29	kidney	kidney	NOUN
iajs-3608	177	30	disease	disease	NOUN
iajs-3608	177	31	.	.	PUNCT
iajs-3608	178	1	j	j	PROPN
iajs-3608	178	2	clin	clin	PROPN
iajs-3608	178	3	med	med	PROPN
iajs-3608	178	4	.	.	PUNCT
iajs-3608	179	1	2020	2020	NUM
iajs-3608	179	2	;	;	PUNCT
iajs-3608	180	1	9:472	9:472	NUM
iajs-3608	180	2	.	.	PUNCT
iajs-3608	181	1	https://doi.org/10.3390/jcm9020472	https://doi.org/10.3390/jcm9020472	NOUN
iajs-3608	181	2	.	.	PUNCT
iajs-3608	182	1	18	18	NUM
iajs-3608	182	2	.	.	PUNCT
iajs-3608	183	1	kostov	kostov	PROPN
iajs-3608	183	2	k	k	PROPN
iajs-3608	183	3	,	,	PUNCT
iajs-3608	183	4	blazhev	blazhev	PROPN
iajs-3608	183	5	a.	a.	PROPN
iajs-3608	183	6	elevated	elevated	PROPN
iajs-3608	183	7	igg	igg	PROPN
iajs-3608	183	8	and	and	CCONJ
iajs-3608	183	9	igm	igm	NOUN
iajs-3608	183	10	autoantibodies	autoantibody	NOUN
iajs-3608	183	11	to	to	ADP
iajs-3608	183	12	advanced	advanced	ADJ
iajs-3608	183	13	glycation	glycation	NOUN
iajs-3608	183	14	end	end	NOUN
iajs-3608	183	15	products	product	NOUN
iajs-3608	183	16	of	of	ADP
iajs-3608	183	17	vascular	vascular	ADJ
iajs-3608	183	18	elastin	elastin	NOUN
iajs-3608	183	19	in	in	ADP
iajs-3608	183	20	hypertensive	hypertensive	ADJ
iajs-3608	183	21	patients	patient	NOUN
iajs-3608	183	22	with	with	ADP
iajs-3608	183	23	type	type	NOUN
iajs-3608	183	24	2	2	NUM
iajs-3608	183	25	diabetes	diabetes	NOUN
iajs-3608	183	26	:	:	PUNCT
iajs-3608	183	27	relevance	relevance	NOUN
iajs-3608	183	28	to	to	PART
iajs-3608	183	29	disease	disease	NOUN
iajs-3608	183	30	initiation	initiation	NOUN
iajs-3608	183	31	and	and	CCONJ
iajs-3608	183	32	progression	progression	NOUN
iajs-3608	183	33	.	.	PUNCT
iajs-3608	184	1	pathophysiology	pathophysiology	NOUN
iajs-3608	184	2	.	.	PUNCT
iajs-3608	185	1	2022	2022	NUM
iajs-3608	185	2	;	;	PUNCT
iajs-3608	186	1	29:426–434	29:426–434	NUM
iajs-3608	186	2	.	.	PUNCT
iajs-3608	187	1	https://doi.org/10.3390/pathophysiology29030034	https://doi.org/10.3390/pathophysiology29030034	NOUN
iajs-3608	187	2	.	.	PUNCT
iajs-3608	188	1	19	19	NUM
iajs-3608	188	2	.	.	PUNCT
iajs-3608	188	3	kuksal	kuksal	PROPN
iajs-3608	188	4	a	a	PRON
iajs-3608	188	5	,	,	PUNCT
iajs-3608	188	6	kunder	kunder	PROPN
iajs-3608	188	7	m	m	PROPN
iajs-3608	188	8	,	,	PUNCT
iajs-3608	188	9	balakrishna	balakrishna	PROPN
iajs-3608	188	10	s.	s.	PROPN
iajs-3608	188	11	effect	effect	NOUN
iajs-3608	188	12	of	of	ADP
iajs-3608	188	13	α1	α1	PROPN
iajs-3608	188	14	-	-	PUNCT
iajs-3608	188	15	at	at	NOUN
iajs-3608	188	16	on	on	ADP
iajs-3608	188	17	vegf	vegf	PROPN
iajs-3608	188	18	and	and	CCONJ
iajs-3608	188	19	mmp-2	mmp-2	NOUN
iajs-3608	188	20	in	in	ADP
iajs-3608	188	21	huvecs	huvec	NOUN
iajs-3608	188	22	exposed	expose	VERB
iajs-3608	188	23	to	to	ADP
iajs-3608	188	24	high	high	ADJ
iajs-3608	188	25	glucose	glucose	NOUN
iajs-3608	188	26	and	and	CCONJ
iajs-3608	188	27	hypoxia	hypoxia	NOUN
iajs-3608	188	28	:	:	PUNCT
iajs-3608	188	29	a	a	DET
iajs-3608	188	30	possible	possible	ADJ
iajs-3608	188	31	therapeutic	therapeutic	ADJ
iajs-3608	188	32	approach	approach	NOUN
iajs-3608	188	33	towards	towards	ADP
iajs-3608	188	34	diabetic	diabetic	ADJ
iajs-3608	188	35	retinopathy	retinopathy	NOUN
iajs-3608	188	36	.	.	PUNCT
iajs-3608	189	1	romanian	romanian	PROPN
iajs-3608	189	2	j	j	PROPN
iajs-3608	189	3	diabetes	diabetes	PROPN
iajs-3608	189	4	nutr	nutr	PROPN
iajs-3608	189	5	metab	metab	PROPN
iajs-3608	189	6	dis	dis	PROPN
iajs-3608	189	7	.	.	PUNCT
iajs-3608	190	1	2022	2022	NUM
iajs-3608	190	2	;	;	PUNCT
iajs-3608	190	3	29:310–315	29:310–315	PROPN
iajs-3608	190	4	.	.	PUNCT
iajs-3608	191	1	https://www.rjdnmd.org/index.php/rjdnmd/article/view/1102	https://www.rjdnmd.org/index.php/rjdnmd/article/view/1102	X
iajs-3608	191	2	.	.	PROPN
iajs-3608	192	1	20	20	NUM
iajs-3608	192	2	.	.	PUNCT
iajs-3608	193	1	al	al	PROPN
iajs-3608	193	2	alawi	alawi	PROPN
iajs-3608	194	1	i	i	PROPN
iajs-3608	194	2	,	,	PUNCT
iajs-3608	194	3	al	al	PROPN
iajs-3608	194	4	salmi	salmi	PROPN
iajs-3608	195	1	i	i	PRON
iajs-3608	195	2	,	,	PUNCT
iajs-3608	195	3	al	al	PROPN
iajs-3608	195	4	mawali	mawali	VERB
iajs-3608	195	5	a	a	PRON
iajs-3608	195	6	,	,	PUNCT
iajs-3608	195	7	al	al	PROPN
iajs-3608	195	8	maimani	maimani	PROPN
iajs-3608	195	9	y	y	PROPN
iajs-3608	195	10	,	,	PUNCT
iajs-3608	195	11	sayer	sayer	PROPN
iajs-3608	195	12	ja	ja	PROPN
iajs-3608	195	13	.	.	PROPN
iajs-3608	195	14	end	end	NOUN
iajs-3608	195	15	-	-	PUNCT
iajs-3608	195	16	stage	stage	NOUN
iajs-3608	195	17	kidney	kidney	NOUN
iajs-3608	195	18	failure	failure	NOUN
iajs-3608	195	19	in	in	ADP
iajs-3608	195	20	oman	oman	NOUN
iajs-3608	195	21	:	:	PUNCT
iajs-3608	195	22	an	an	DET
iajs-3608	195	23	analysis	analysis	NOUN
iajs-3608	195	24	of	of	ADP
iajs-3608	195	25	registry	registry	NOUN
iajs-3608	195	26	data	datum	NOUN
iajs-3608	195	27	with	with	ADP
iajs-3608	195	28	an	an	DET
iajs-3608	195	29	emphasis	emphasis	NOUN
iajs-3608	195	30	on	on	ADP
iajs-3608	195	31	congenital	congenital	ADJ
iajs-3608	195	32	and	and	CCONJ
iajs-3608	195	33	inherited	inherit	VERB
iajs-3608	195	34	renal	renal	ADJ
iajs-3608	195	35	diseases	disease	NOUN
iajs-3608	195	36	.	.	PUNCT
iajs-3608	196	1	int	int	NOUN
iajs-3608	196	2	j	j	PROPN
iajs-3608	196	3	nephrol	nephrol	NOUN
iajs-3608	196	4	.	.	PUNCT
iajs-3608	197	1	2017;2017	2017;2017	X
iajs-3608	197	2	.	.	PUNCT
iajs-3608	198	1	https://doi.org/10.1155/2017/6403985	https://doi.org/10.1155/2017/6403985	PROPN
iajs-3608	198	2	.	.	PUNCT
iajs-3608	198	3	http://www.ijcmr.com/uploads/7/7/4/6/77464738/_oral_manifestations_of_chronic_kidney_disease-an_overview_.pdf	http://www.ijcmr.com/uploads/7/7/4/6/77464738/_oral_manifestations_of_chronic_kidney_disease-an_overview_.pdf	PROPN
iajs-3608	198	4	http://www.ijcmr.com/uploads/7/7/4/6/77464738/_oral_manifestations_of_chronic_kidney_disease-an_overview_.pdf	http://www.ijcmr.com/uploads/7/7/4/6/77464738/_oral_manifestations_of_chronic_kidney_disease-an_overview_.pdf	PROPN
iajs-3608	198	5	https://doi.org/10.2147/ppa.s315369	https://doi.org/10.2147/ppa.s315369	DET
iajs-3608	198	6	https://jih.uobaghdad.edu.iq/index.php/j/article/view/1133	https://jih.uobaghdad.edu.iq/index.php/j/article/view/1133	NOUN
iajs-3608	198	7	https://doi.org/10.53350/pjmhs2115123909	https://doi.org/10.53350/pjmhs2115123909	PROPN
iajs-3608	199	1	https://doi.org/10.1002/cphy.c160010	https://doi.org/10.1002/cphy.c160010	PROPN
iajs-3608	199	2	https://doi.org/10.1016/bs.acc.2018.10.006	https://doi.org/10.1016/bs.acc.2018.10.006	PROPN
iajs-3608	199	3	https://doi.org/10.1016/bs.pmbts.2017.03.001	https://doi.org/10.1016/bs.pmbts.2017.03.001	PROPN
iajs-3608	199	4	https://doi.org/10.1152/ajprenal.00037.2012	https://doi.org/10.1152/ajprenal.00037.2012	PROPN
iajs-3608	199	5	https://doi.org/10.3390/ijms18040776	https://doi.org/10.3390/ijms18040776	NOUN
iajs-3608	199	6	https://doi.org/10.1016/j.bbcan.2005.03.001	https://doi.org/10.1016/j.bbcan.2005.03.001	VERB
iajs-3608	199	7	https://doi.org/10.34067/kid.0002012020	https://doi.org/10.34067/kid.0002012020	NOUN
iajs-3608	199	8	https://doi.org/10.5281/zenodo.7622530	https://doi.org/10.5281/zenodo.7622530	ADJ
iajs-3608	199	9	https://doi.org/10.3390/jcm9020472	https://doi.org/10.3390/jcm9020472	NOUN
iajs-3608	199	10	https://doi.org/10.3390/pathophysiology29030034	https://doi.org/10.3390/pathophysiology29030034	NOUN
iajs-3608	200	1	https://www.rjdnmd.org/index.php/rjdnmd/article/view/1102	https://www.rjdnmd.org/index.php/rjdnmd/article/view/1102	PRON
iajs-3608	200	2	https://doi.org/10.1155/2017/6403985	https://doi.org/10.1155/2017/6403985	NOUN
iajs-3608	200	3	ihjpas	ihjpa	NOUN
iajs-3608	200	4	.	.	PUNCT
iajs-3608	201	1	2025	2025	NUM
iajs-3608	201	2	,	,	PUNCT
iajs-3608	201	3	38(4	38(4	NUM
iajs-3608	201	4	)	)	PUNCT
iajs-3608	201	5	17	17	NUM
iajs-3608	201	6	21	21	NUM
iajs-3608	201	7	.	.	PUNCT
iajs-3608	202	1	kuriyama	kuriyama	PROPN
iajs-3608	202	2	s.	s.	PROPN
iajs-3608	202	3	a	a	DET
iajs-3608	202	4	potential	potential	ADJ
iajs-3608	202	5	mechanism	mechanism	NOUN
iajs-3608	202	6	of	of	ADP
iajs-3608	202	7	cardio	cardio	NOUN
iajs-3608	202	8	-	-	PUNCT
iajs-3608	202	9	renal	renal	ADJ
iajs-3608	202	10	protection	protection	NOUN
iajs-3608	202	11	with	with	ADP
iajs-3608	202	12	sodium	sodium	NOUN
iajs-3608	202	13	-	-	PUNCT
iajs-3608	202	14	glucose	glucose	NOUN
iajs-3608	202	15	cotransporter	cotransporter	NOUN
iajs-3608	202	16	2	2	NUM
iajs-3608	202	17	inhibitors	inhibitor	NOUN
iajs-3608	202	18	:	:	PUNCT
iajs-3608	202	19	amelioration	amelioration	NOUN
iajs-3608	202	20	of	of	ADP
iajs-3608	202	21	renal	renal	ADJ
iajs-3608	202	22	congestion	congestion	NOUN
iajs-3608	202	23	.	.	PUNCT
iajs-3608	203	1	kidney	kidney	NOUN
iajs-3608	203	2	blood	blood	NOUN
iajs-3608	203	3	press	press	NOUN
iajs-3608	203	4	res	re	NOUN
iajs-3608	203	5	.	.	PROPN
iajs-3608	203	6	2019	2019	NUM
iajs-3608	203	7	;	;	PUNCT
iajs-3608	203	8	44:449–456	44:449–456	PROPN
iajs-3608	203	9	.	.	PUNCT
iajs-3608	204	1	https://doi.org/10.1159/000501081	https://doi.org/10.1159/000501081	X
iajs-3608	204	2	.	.	PUNCT
iajs-3608	205	1	22	22	NUM
iajs-3608	205	2	.	.	PUNCT
iajs-3608	206	1	low	low	PROPN
iajs-3608	206	2	s	s	PROPN
iajs-3608	206	3	,	,	PUNCT
iajs-3608	206	4	pek	pek	PROPN
iajs-3608	206	5	s	s	PROPN
iajs-3608	206	6	,	,	PUNCT
iajs-3608	206	7	liu	liu	PROPN
iajs-3608	206	8	yl	yl	PROPN
iajs-3608	206	9	,	,	PUNCT
iajs-3608	206	10	moh	moh	PROPN
iajs-3608	206	11	a	a	NOUN
iajs-3608	206	12	,	,	PUNCT
iajs-3608	206	13	ang	ang	PROPN
iajs-3608	206	14	k	k	PROPN
iajs-3608	206	15	,	,	PUNCT
iajs-3608	206	16	tang	tang	VERB
iajs-3608	207	1	we	we	PRON
iajs-3608	207	2	,	,	PUNCT
iajs-3608	207	3	lim	lim	PROPN
iajs-3608	207	4	z	z	PROPN
iajs-3608	207	5	,	,	PUNCT
iajs-3608	207	6	subramaniam	subramaniam	PROPN
iajs-3608	207	7	t	t	PROPN
iajs-3608	207	8	,	,	PUNCT
iajs-3608	207	9	sum	sum	NOUN
iajs-3608	207	10	cf	cf	NOUN
iajs-3608	207	11	,	,	PUNCT
iajs-3608	207	12	lim	lim	PROPN
iajs-3608	207	13	cl	cl	PROPN
iajs-3608	207	14	.	.	PUNCT
iajs-3608	208	1	higher	high	ADJ
iajs-3608	208	2	extracellular	extracellular	ADJ
iajs-3608	208	3	water	water	NOUN
iajs-3608	208	4	to	to	ADP
iajs-3608	208	5	total	total	ADJ
iajs-3608	208	6	body	body	NOUN
iajs-3608	208	7	water	water	NOUN
iajs-3608	208	8	ratio	ratio	NOUN
iajs-3608	208	9	was	be	AUX
iajs-3608	208	10	associated	associate	VERB
iajs-3608	208	11	with	with	ADP
iajs-3608	208	12	chronic	chronic	ADJ
iajs-3608	208	13	kidney	kidney	NOUN
iajs-3608	208	14	disease	disease	NOUN
iajs-3608	208	15	progression	progression	NOUN
iajs-3608	208	16	in	in	ADP
iajs-3608	208	17	type	type	NOUN
iajs-3608	208	18	2	2	NUM
iajs-3608	208	19	diabetes	diabetes	NOUN
iajs-3608	208	20	.	.	PUNCT
iajs-3608	209	1	j	j	PROPN
iajs-3608	209	2	diabetes	diabetes	NOUN
iajs-3608	209	3	complications	complication	NOUN
iajs-3608	209	4	.	.	PUNCT
iajs-3608	210	1	2021	2021	NUM
iajs-3608	210	2	;	;	PUNCT
iajs-3608	210	3	35:107930	35:107930	NUM
iajs-3608	210	4	.	.	PUNCT
iajs-3608	211	1	https://doi.org/10.1016/j.jdiacomp.2021.107930	https://doi.org/10.1016/j.jdiacomp.2021.107930	NOUN
iajs-3608	211	2	.	.	PUNCT
iajs-3608	212	1	23	23	NUM
iajs-3608	212	2	.	.	X
iajs-3608	213	1	altemtam	altemtam	PROPN
iajs-3608	213	2	n	n	CCONJ
iajs-3608	213	3	,	,	PUNCT
iajs-3608	213	4	el	el	PROPN
iajs-3608	213	5	nahas	nahas	PROPN
iajs-3608	213	6	m	m	PROPN
iajs-3608	213	7	,	,	PUNCT
iajs-3608	213	8	johnson	johnson	PROPN
iajs-3608	213	9	t.	t.	PROPN
iajs-3608	213	10	urinary	urinary	PROPN
iajs-3608	213	11	matrix	matrix	NOUN
iajs-3608	213	12	metalloproteinase	metalloproteinase	NOUN
iajs-3608	213	13	activity	activity	NOUN
iajs-3608	213	14	in	in	ADP
iajs-3608	213	15	diabetic	diabetic	ADJ
iajs-3608	213	16	kidney	kidney	NOUN
iajs-3608	213	17	disease	disease	NOUN
iajs-3608	213	18	:	:	PUNCT
iajs-3608	213	19	a	a	DET
iajs-3608	213	20	potential	potential	ADJ
iajs-3608	213	21	marker	marker	NOUN
iajs-3608	213	22	of	of	ADP
iajs-3608	213	23	disease	disease	NOUN
iajs-3608	213	24	progression	progression	NOUN
iajs-3608	213	25	.	.	PUNCT
iajs-3608	214	1	nephron	nephron	PROPN
iajs-3608	214	2	extra	extra	NOUN
iajs-3608	214	3	.	.	PUNCT
iajs-3608	214	4	2012	2012	NUM
iajs-3608	214	5	;	;	PUNCT
iajs-3608	215	1	2:219–232	2:219–232	NUM
iajs-3608	215	2	.	.	PUNCT
iajs-3608	216	1	https://doi.org/10.1159/000339645	https://doi.org/10.1159/000339645	NOUN
iajs-3608	216	2	.	.	PUNCT
iajs-3608	217	1	24	24	NUM
iajs-3608	217	2	.	.	PUNCT
iajs-3608	217	3	asgari	asgari	PROPN
iajs-3608	217	4	r	r	PROPN
iajs-3608	217	5	,	,	PUNCT
iajs-3608	217	6	vaisi	vaisi	VERB
iajs-3608	217	7	-	-	PUNCT
iajs-3608	217	8	raygani	raygani	PROPN
iajs-3608	217	9	a	a	PROPN
iajs-3608	217	10	,	,	PUNCT
iajs-3608	217	11	aleagha	aleagha	PROPN
iajs-3608	217	12	mse	mse	PROPN
iajs-3608	217	13	,	,	PUNCT
iajs-3608	217	14	mohammadi	mohammadi	NOUN
iajs-3608	217	15	p	p	NOUN
iajs-3608	217	16	,	,	PUNCT
iajs-3608	217	17	bakhtiari	bakhtiari	PROPN
iajs-3608	217	18	m	m	PROPN
iajs-3608	217	19	,	,	PUNCT
iajs-3608	217	20	arghiani	arghiani	NOUN
iajs-3608	217	21	n.	n.	NOUN
iajs-3608	217	22	cd147	cd147	PROPN
iajs-3608	217	23	and	and	CCONJ
iajs-3608	217	24	mmps	mmp	NOUN
iajs-3608	217	25	as	as	ADP
iajs-3608	217	26	key	key	ADJ
iajs-3608	217	27	factors	factor	NOUN
iajs-3608	217	28	in	in	ADP
iajs-3608	217	29	physiological	physiological	ADJ
iajs-3608	217	30	and	and	CCONJ
iajs-3608	217	31	pathological	pathological	ADJ
iajs-3608	217	32	processes	process	NOUN
iajs-3608	217	33	.	.	PUNCT
iajs-3608	217	34	biomed	biome	VERB
iajs-3608	217	35	pharmacother	pharmacother	ADJ
iajs-3608	217	36	.	.	PUNCT
iajs-3608	218	1	2023	2023	NUM
iajs-3608	218	2	;	;	PUNCT
iajs-3608	218	3	157:113983	157:113983	NUM
iajs-3608	218	4	.	.	PUNCT
iajs-3608	219	1	https://doi.org/10.1016/j.biopha.2022.113983	https://doi.org/10.1016/j.biopha.2022.113983	PROPN
iajs-3608	219	2	25	25	NUM
iajs-3608	219	3	.	.	PUNCT
iajs-3608	219	4	xu	xu	PROPN
iajs-3608	220	1	x	x	PROPN
iajs-3608	220	2	,	,	PUNCT
iajs-3608	220	3	jackson	jackson	PROPN
iajs-3608	220	4	pl	pl	PROPN
iajs-3608	220	5	,	,	PUNCT
iajs-3608	220	6	tanner	tanner	NOUN
iajs-3608	220	7	s	s	PART
iajs-3608	220	8	,	,	PUNCT
iajs-3608	220	9	hardison	hardison	PROPN
iajs-3608	220	10	mt	mt	PROPN
iajs-3608	220	11	,	,	PUNCT
iajs-3608	220	12	abdul	abdul	PROPN
iajs-3608	220	13	roda	roda	PROPN
iajs-3608	220	14	m	m	PROPN
iajs-3608	220	15	,	,	PUNCT
iajs-3608	220	16	blalock	blalock	PROPN
iajs-3608	220	17	je	je	PROPN
iajs-3608	220	18	,	,	PUNCT
iajs-3608	220	19	gaggar	gaggar	NOUN
iajs-3608	220	20	a.	a.	NOUN
iajs-3608	220	21	a	a	DET
iajs-3608	220	22	self	self	NOUN
iajs-3608	220	23	-	-	PUNCT
iajs-3608	220	24	propagating	propagate	VERB
iajs-3608	220	25	matrix	matrix	NOUN
iajs-3608	220	26	metalloprotease-9	metalloprotease-9	PROPN
iajs-3608	220	27	(	(	PUNCT
iajs-3608	220	28	mmp-9	mmp-9	NUM
iajs-3608	220	29	)	)	PUNCT
iajs-3608	220	30	dependent	dependent	ADJ
iajs-3608	220	31	cycle	cycle	NOUN
iajs-3608	220	32	of	of	ADP
iajs-3608	220	33	chronic	chronic	ADJ
iajs-3608	220	34	neutrophilic	neutrophilic	ADJ
iajs-3608	220	35	inflammation	inflammation	NOUN
iajs-3608	220	36	.	.	PUNCT
iajs-3608	221	1	plos	plos	PROPN
iajs-3608	221	2	one	one	NUM
iajs-3608	221	3	.	.	PUNCT
iajs-3608	222	1	2011	2011	NUM
iajs-3608	222	2	;	;	PUNCT
iajs-3608	222	3	6	6	NUM
iajs-3608	222	4	:	:	PUNCT
iajs-3608	222	5	e15781	e15781	INTJ
iajs-3608	222	6	.	.	PUNCT
iajs-3608	223	1	https://doi.org/10.1371/journal.pone.0015781	https://doi.org/10.1371/journal.pone.0015781	PROPN
iajs-3608	223	2	26	26	NUM
iajs-3608	223	3	.	.	PUNCT
iajs-3608	223	4	ambade	ambade	NOUN
iajs-3608	223	5	as	as	ADP
iajs-3608	223	6	,	,	PUNCT
iajs-3608	223	7	hassoun	hassoun	NOUN
iajs-3608	223	8	pm	pm	NOUN
iajs-3608	223	9	,	,	PUNCT
iajs-3608	223	10	damico	damico	PROPN
iajs-3608	223	11	rl	rl	PROPN
iajs-3608	223	12	.	.	PUNCT
iajs-3608	223	13	basement	basement	PROPN
iajs-3608	223	14	membrane	membrane	NOUN
iajs-3608	223	15	extracellular	extracellular	ADJ
iajs-3608	223	16	matrix	matrix	NOUN
iajs-3608	223	17	proteins	protein	NOUN
iajs-3608	223	18	in	in	ADP
iajs-3608	223	19	pulmonary	pulmonary	ADJ
iajs-3608	223	20	vascular	vascular	NOUN
iajs-3608	223	21	and	and	CCONJ
iajs-3608	223	22	right	right	ADJ
iajs-3608	223	23	ventricular	ventricular	ADJ
iajs-3608	223	24	remodeling	remodeling	NOUN
iajs-3608	223	25	in	in	ADP
iajs-3608	223	26	pulmonary	pulmonary	ADJ
iajs-3608	223	27	hypertension	hypertension	NOUN
iajs-3608	223	28	.	.	PUNCT
iajs-3608	224	1	am	be	AUX
iajs-3608	224	2	j	j	PROPN
iajs-3608	224	3	respir	respir	NOUN
iajs-3608	224	4	cell	cell	NOUN
iajs-3608	224	5	mol	mol	ADP
iajs-3608	224	6	biol	biol	PROPN
iajs-3608	224	7	.	.	PUNCT
iajs-3608	225	1	2021	2021	NUM
iajs-3608	225	2	;	;	PUNCT
iajs-3608	226	1	65:245–258	65:245–258	PROPN
iajs-3608	226	2	.	.	PUNCT
iajs-3608	227	1	https://doi.org/10.1165/rcmb.2021-0091tr	https://doi.org/10.1165/rcmb.2021-0091tr	PROPN
iajs-3608	227	2	.	.	PUNCT
iajs-3608	228	1	27	27	NUM
iajs-3608	228	2	.	.	PUNCT
iajs-3608	228	3	musiała	musiała	PROPN
iajs-3608	228	4	a	a	PRON
iajs-3608	228	5	,	,	PUNCT
iajs-3608	228	6	donizy	donizy	NOUN
iajs-3608	228	7	p	p	NOUN
iajs-3608	228	8	,	,	PUNCT
iajs-3608	228	9	augustyniak	augustyniak	PROPN
iajs-3608	228	10	-	-	PUNCT
iajs-3608	228	11	bartosik	bartosik	PROPN
iajs-3608	228	12	h	h	PROPN
iajs-3608	228	13	,	,	PUNCT
iajs-3608	228	14	jakuszko	jakuszko	PROPN
iajs-3608	228	15	k	k	PROPN
iajs-3608	228	16	,	,	PUNCT
iajs-3608	228	17	banasik	banasik	PROPN
iajs-3608	228	18	m	m	PROPN
iajs-3608	228	19	,	,	PUNCT
iajs-3608	228	20	kościelska	kościelska	PROPN
iajs-3608	228	21	-	-	PUNCT
iajs-3608	228	22	kasprzak	kasprzak	NOUN
iajs-3608	228	23	k	k	PROPN
iajs-3608	228	24	,	,	PUNCT
iajs-3608	228	25	krajewska	krajewska	PROPN
iajs-3608	228	26	m	m	PROPN
iajs-3608	228	27	,	,	PUNCT
iajs-3608	228	28	kamińska	kamińska	PROPN
iajs-3608	228	29	d.	d.	PROPN
iajs-3608	228	30	biomarkers	biomarker	NOUN
iajs-3608	228	31	in	in	ADP
iajs-3608	228	32	primary	primary	ADJ
iajs-3608	228	33	focal	focal	ADJ
iajs-3608	228	34	segmental	segmental	ADJ
iajs-3608	228	35	glomerulosclerosis	glomerulosclerosis	NOUN
iajs-3608	228	36	in	in	ADP
iajs-3608	228	37	optimal	optimal	ADJ
iajs-3608	228	38	diagnostic	diagnostic	ADJ
iajs-3608	228	39	-	-	PUNCT
iajs-3608	228	40	therapeutic	therapeutic	ADJ
iajs-3608	228	41	strategy	strategy	NOUN
iajs-3608	228	42	.	.	PUNCT
iajs-3608	229	1	j	j	PROPN
iajs-3608	229	2	clin	clin	PROPN
iajs-3608	229	3	med	med	PROPN
iajs-3608	229	4	.	.	PUNCT
iajs-3608	229	5	2022	2022	NUM
iajs-3608	229	6	;	;	PUNCT
iajs-3608	229	7	11:3292	11:3292	NUM
iajs-3608	229	8	.	.	PUNCT
iajs-3608	230	1	https://doi.org/10.3390/jcm11123292	https://doi.org/10.3390/jcm11123292	NUM
iajs-3608	230	2	28	28	NUM
iajs-3608	230	3	.	.	PUNCT
iajs-3608	231	1	poulsen	poulsen	PROPN
iajs-3608	231	2	cg	cg	PROPN
iajs-3608	231	3	,	,	PUNCT
iajs-3608	231	4	rasmussen	rasmussen	PROPN
iajs-3608	231	5	dg	dg	PROPN
iajs-3608	231	6	,	,	PUNCT
iajs-3608	231	7	genovese	genovese	NOUN
iajs-3608	231	8	f	f	PROPN
iajs-3608	231	9	,	,	PUNCT
iajs-3608	231	10	hansen	hansen	PROPN
iajs-3608	231	11	tw	tw	PROPN
iajs-3608	231	12	,	,	PUNCT
iajs-3608	231	13	nielsen	nielsen	PROPN
iajs-3608	231	14	sh	sh	PROPN
iajs-3608	231	15	,	,	PUNCT
iajs-3608	231	16	reinhard	reinhard	PROPN
iajs-3608	231	17	h	h	PROPN
iajs-3608	231	18	,	,	PUNCT
iajs-3608	231	19	von	von	PROPN
iajs-3608	231	20	scholten	scholten	VERB
iajs-3608	231	21	bj	bj	NOUN
iajs-3608	231	22	,	,	PUNCT
iajs-3608	231	23	jacobsen	jacobsen	PROPN
iajs-3608	231	24	pk	pk	PROPN
iajs-3608	231	25	,	,	PUNCT
iajs-3608	231	26	parving	parve	VERB
iajs-3608	231	27	h	h	NOUN
iajs-3608	231	28	-	-	PUNCT
iajs-3608	231	29	h	h	NOUN
iajs-3608	231	30	,	,	PUNCT
iajs-3608	231	31	karsdal	karsdal	PROPN
iajs-3608	231	32	ma	ma	PROPN
iajs-3608	231	33	.	.	PROPN
iajs-3608	231	34	marker	marker	NOUN
iajs-3608	231	35	for	for	ADP
iajs-3608	231	36	kidney	kidney	NOUN
iajs-3608	231	37	fibrosis	fibrosis	NOUN
iajs-3608	231	38	is	be	AUX
iajs-3608	231	39	associated	associate	VERB
iajs-3608	231	40	with	with	ADP
iajs-3608	231	41	inflammation	inflammation	NOUN
iajs-3608	231	42	and	and	CCONJ
iajs-3608	231	43	deterioration	deterioration	NOUN
iajs-3608	231	44	of	of	ADP
iajs-3608	231	45	kidney	kidney	NOUN
iajs-3608	231	46	function	function	NOUN
iajs-3608	231	47	in	in	ADP
iajs-3608	231	48	people	people	NOUN
iajs-3608	231	49	with	with	ADP
iajs-3608	231	50	type	type	NOUN
iajs-3608	231	51	2	2	NUM
iajs-3608	231	52	diabetes	diabetes	NOUN
iajs-3608	231	53	and	and	CCONJ
iajs-3608	231	54	microalbuminuria	microalbuminuria	NOUN
iajs-3608	231	55	.	.	PUNCT
iajs-3608	232	1	plos	plos	PROPN
iajs-3608	232	2	one.2023	one.2023	NUM
iajs-3608	232	3	;	;	PUNCT
iajs-3608	232	4	18	18	NUM
iajs-3608	232	5	:	:	PUNCT
iajs-3608	232	6	e0283296	e0283296	NUM
iajs-3608	232	7	.	.	PUNCT
iajs-3608	232	8	https://doi.org/10.1371/journal.pone.0283296	https://doi.org/10.1371/journal.pone.0283296	VERB
iajs-3608	232	9	29	29	NUM
iajs-3608	232	10	.	.	PUNCT
iajs-3608	233	1	ntrinias	ntrinias	PROPN
iajs-3608	233	2	t	t	PROPN
iajs-3608	233	3	,	,	PUNCT
iajs-3608	233	4	papasotiriou	papasotiriou	NOUN
iajs-3608	233	5	m	m	PROPN
iajs-3608	233	6	,	,	PUNCT
iajs-3608	233	7	balta	balta	PROPN
iajs-3608	233	8	l	l	PROPN
iajs-3608	233	9	,	,	PUNCT
iajs-3608	233	10	kalavrizioti	kalavrizioti	PROPN
iajs-3608	234	1	d	d	X
iajs-3608	234	2	,	,	PUNCT
iajs-3608	234	3	vamvakas	vamvakas	PROPN
iajs-3608	234	4	s	s	PROPN
iajs-3608	234	5	,	,	PUNCT
iajs-3608	234	6	papachristou	papachristou	PROPN
iajs-3608	234	7	e	e	NOUN
iajs-3608	234	8	,	,	PUNCT
iajs-3608	234	9	goumenos	goumeno	NOUN
iajs-3608	234	10	ds	ds	PROPN
iajs-3608	234	11	.	.	PUNCT
iajs-3608	234	12	biomarkers	biomarker	NOUN
iajs-3608	234	13	in	in	ADP
iajs-3608	234	14	progressive	progressive	ADJ
iajs-3608	234	15	chronic	chronic	ADJ
iajs-3608	234	16	kidney	kidney	NOUN
iajs-3608	234	17	disease	disease	NOUN
iajs-3608	234	18	.	.	PUNCT
iajs-3608	235	1	still	still	ADV
iajs-3608	235	2	a	a	DET
iajs-3608	235	3	long	long	ADJ
iajs-3608	235	4	way	way	NOUN
iajs-3608	235	5	to	to	PART
iajs-3608	235	6	go	go	VERB
iajs-3608	235	7	.	.	PUNCT
iajs-3608	236	1	pril	pril	NOUN
iajs-3608	236	2	(	(	PUNCT
iajs-3608	236	3	makedon	makedon	NOUN
iajs-3608	236	4	akad	akad	NOUN
iajs-3608	236	5	nauk	nauk	VERB
iajs-3608	236	6	umet	umet	ADJ
iajs-3608	236	7	odd	odd	ADJ
iajs-3608	236	8	med	med	ADJ
iajs-3608	236	9	nauki	nauki	PROPN
iajs-3608	236	10	)	)	PUNCT
iajs-3608	236	11	.	.	PUNCT
iajs-3608	237	1	2019;40(3):27	2019;40(3):27	NUM
iajs-3608	237	2	-	-	SYM
iajs-3608	237	3	39	39	NUM
iajs-3608	237	4	.	.	PUNCT
iajs-3608	238	1	https://doi.org/10.2478/prilozi-2020-0002	https://doi.org/10.2478/prilozi-2020-0002	NOUN
iajs-3608	238	2	.	.	PUNCT
iajs-3608	239	1	30	30	NUM
iajs-3608	239	2	.	.	PUNCT
iajs-3608	240	1	hugo	hugo	PROPN
iajs-3608	240	2	a	a	PRON
iajs-3608	240	3	,	,	PUNCT
iajs-3608	240	4	rodrigues	rodrigues	PROPN
iajs-3608	240	5	t	t	PROPN
iajs-3608	240	6	,	,	PUNCT
iajs-3608	240	7	mader	mader	PROPN
iajs-3608	240	8	jk	jk	PROPN
iajs-3608	240	9	,	,	PUNCT
iajs-3608	240	10	knoll	knoll	PROPN
iajs-3608	240	11	w	w	PROPN
iajs-3608	240	12	,	,	PUNCT
iajs-3608	240	13	bouchiat	bouchiat	NOUN
iajs-3608	240	14	v	v	NOUN
iajs-3608	240	15	,	,	PUNCT
iajs-3608	240	16	boukherroub	boukherroub	NOUN
iajs-3608	240	17	r	r	NOUN
iajs-3608	240	18	,	,	PUNCT
iajs-3608	240	19	szunerits	szunerit	NOUN
iajs-3608	240	20	s.	s.	PROPN
iajs-3608	240	21	matrix	matrix	PROPN
iajs-3608	240	22	metalloproteinase	metalloproteinase	PROPN
iajs-3608	240	23	sensing	sense	VERB
iajs-3608	240	24	in	in	ADP
iajs-3608	240	25	wound	wound	ADJ
iajs-3608	240	26	fluids	fluid	NOUN
iajs-3608	240	27	:	:	PUNCT
iajs-3608	240	28	are	be	AUX
iajs-3608	240	29	graphene	graphene	NOUN
iajs-3608	240	30	-	-	PUNCT
iajs-3608	240	31	based	base	VERB
iajs-3608	240	32	field	field	NOUN
iajs-3608	240	33	effect	effect	NOUN
iajs-3608	240	34	transistors	transistor	VERB
iajs-3608	240	35	a	a	DET
iajs-3608	240	36	viable	viable	ADJ
iajs-3608	240	37	alternative	alternative	NOUN
iajs-3608	240	38	?	?	PUNCT
iajs-3608	241	1	biosens	biosen	NOUN
iajs-3608	241	2	bioelectron	bioelectron	VERB
iajs-3608	241	3	x.	x.	NOUN
iajs-3608	241	4	2023	2023	NUM
iajs-3608	241	5	;	;	PUNCT
iajs-3608	241	6	13:100305	13:100305	NUM
iajs-3608	241	7	.	.	PUNCT
iajs-3608	242	1	https://doi.org/10.1016/j.biosx.2023.100305	https://doi.org/10.1016/j.biosx.2023.100305	NOUN
iajs-3608	242	2	.	.	PUNCT
iajs-3608	243	1	31	31	NUM
iajs-3608	243	2	.	.	PUNCT
iajs-3608	244	1	bieniaś	bieniaś	PROPN
iajs-3608	244	2	b	b	PROPN
iajs-3608	244	3	,	,	PUNCT
iajs-3608	244	4	sikora	sikora	PROPN
iajs-3608	244	5	p.	p.	PROPN
iajs-3608	244	6	urinary	urinary	ADJ
iajs-3608	244	7	metalloproteinases	metalloproteinase	NOUN
iajs-3608	244	8	and	and	CCONJ
iajs-3608	244	9	tissue	tissue	NOUN
iajs-3608	244	10	inhibitors	inhibitor	NOUN
iajs-3608	244	11	of	of	ADP
iajs-3608	244	12	metalloproteinases	metalloproteinase	NOUN
iajs-3608	244	13	as	as	ADP
iajs-3608	244	14	potential	potential	ADJ
iajs-3608	244	15	early	early	ADJ
iajs-3608	244	16	biomarkers	biomarker	NOUN
iajs-3608	244	17	for	for	ADP
iajs-3608	244	18	renal	renal	ADJ
iajs-3608	244	19	fibrosis	fibrosis	NOUN
iajs-3608	244	20	in	in	ADP
iajs-3608	244	21	children	child	NOUN
iajs-3608	244	22	with	with	ADP
iajs-3608	244	23	nephrotic	nephrotic	ADJ
iajs-3608	244	24	syndrome	syndrome	NOUN
iajs-3608	244	25	.	.	PUNCT
iajs-3608	245	1	medicine	medicine	NOUN
iajs-3608	245	2	(	(	PUNCT
iajs-3608	245	3	baltimore	baltimore	PROPN
iajs-3608	245	4	)	)	PUNCT
iajs-3608	245	5	.	.	PUNCT
iajs-3608	246	1	2018;97	2018;97	X
iajs-3608	246	2	.	.	PUNCT
iajs-3608	246	3	https://doi.org/10.5680/lhuii000060	https://doi.org/10.5680/lhuii000060	PROPN
iajs-3608	246	4	.	.	PUNCT
iajs-3608	247	1	https://doi.org/10.1159/000501081	https://doi.org/10.1159/000501081	ADJ
iajs-3608	247	2	https://doi.org/10.1016/j.jdiacomp.2021.107930	https://doi.org/10.1016/j.jdiacomp.2021.107930	PROPN
iajs-3608	247	3	https://doi.org/10.1159/000339645	https://doi.org/10.1159/000339645	PUNCT
iajs-3608	247	4	https://doi.org/10.1016/j.biopha.2022.113983	https://doi.org/10.1016/j.biopha.2022.113983	PROPN
iajs-3608	247	5	https://doi.org/10.1371/journal.pone.0015781	https://doi.org/10.1371/journal.pone.0015781	PROPN
iajs-3608	247	6	https://doi.org/10.1165/rcmb.2021-0091tr	https://doi.org/10.1165/rcmb.2021-0091tr	PROPN
iajs-3608	247	7	https://doi.org/10.3390/jcm11123292	https://doi.org/10.3390/jcm11123292	NUM
iajs-3608	247	8	https://doi.org/10.1371/journal.pone.0283296	https://doi.org/10.1371/journal.pone.0283296	PROPN
iajs-3608	247	9	https://doi.org/10.2478/prilozi-2020-0002	https://doi.org/10.2478/prilozi-2020-0002	NOUN
iajs-3608	247	10	https://doi.org/10.1016/j.biosx.2023.100305	https://doi.org/10.1016/j.biosx.2023.100305	ADJ
iajs-3608	247	11	https://doi.org/10.5680/lhuii000060	https://doi.org/10.5680/lhuii000060	NOUN